MRI-guided electrophysiology for the assessment and ablation of ventricular tachycardia substrate by Mukherjee, Rahul
This electronic thesis or dissertation has been 
downloaded from the King’s Research Portal at 
https://kclpure.kcl.ac.uk/portal/  
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT 
Unless another licence is stated on the immediately following page this work is licensed 
under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International 
licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to copy, distribute and transmit the work
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any
way that suggests that they endorse you or your use of the work).
 Non Commercial: You may not use this work for commercial purposes.
 No Derivative Works - You may not alter, transform, or build upon this work.
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 
other rights are in no way affected by the above. 
The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 











MRI-guided electrophysiology for the assessment 











Dr Rahul Kumar Mukherjee 
 

















A dissertation submitted for the degree of 
 
Doctor of Philosophy 
 
School of Biomedical Engineering and Imaging Sciences 
 
King’s College London 
 






































Real-time magnetic resonance imaging (MRI)-guided electrophysiology (MR-EP) offers a 
number of potential advantages over conventional electroanatomic mapping (EAM) systems, 
including improved assessment of arrhythmia structural substrate using late gadolinium 
enhancement (LGE) scar imaging, navigation of catheters using dedicated tracking 
techniques and monitoring of ablation lesion formation with soft tissue visualisation. 
Registration errors due to changes in the volume, orientation, rhythm, cardiac or respiratory 
motion between the time of pre-procedural imaging and EAM, as is typical with image 
integration approaches, are also minimised during real-time MR-EP. Although the majority 
of real-time MR-EP studies published to date have focused on the atria, where significant 
challenges remain for accurate substrate evaluation, the full potential of substrate and lesion 
assessment afforded by such systems is likely to be realised in the context of ventricular 
tachycardia (VT) ablation.  
This thesis explores the use of a real-time MR-EP system for the assessment of structural and 
electrical substrate in the ventricle. Furthermore, the accuracy of the system is evaluated in 
the delivery of radiofrequency (RF) ablation lesions and online monitoring of lesions using 
dedicated imaging techniques. Chapters 1 and 2 review the literature on the electrophysiology 
of ventricular tachycardia and magnetic resonance imaging. Chapter 3 describes in detail the 
methods common to the data chapters including the animal model, imaging approaches and 
MR-EP workflow. In Chapter 4, a method of contrast delivery using a slow infusion of 
gadolinium (contrast steady-state) is used to enable LGE scar imaging over a prolonged 
period, thereby enhancing the spatial resolution of 3D sequences and improve the 
characterisation of structural substrate. A porcine ischaemia-reperfusion model is used to 
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compare post-contrast 3D sequences under consistent contrast conditions whilst the technique 
is also applied in a feasibility cohort of ischaemic cardiomyopathy patients.  
In Chapter 5, the contrast steady-state technique is then used to acquire high resolution 3D 
scar imaging in the porcine model with the real-time MR-EP system. The relationship 
between structural and electrical substrate with the system is assessed. In Chapter 6, the 
accuracy of the MR-EP system to deliver ablation lesions in target regions is evaluated and 
lesion sizes measured using temperature mapping (MR-thermometry and dosimetry) and a 
non-contrast sequence (gradient-echo with a long inversion time) are compared to gross 
pathological examination. Chapter 7 summarises the results and describes further studies to 
advance the field.  
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Ventricular tachycardia (VT) is an abnormal heart rhythm originating from the left or right 
ventricle and includes a spectrum of clinical disease that may occur in the presence or 
absence of structural heart disease ranging from benign, idiopathic premature ventricular 
complexes (PVC) to monomorphic or polymorphic VT (Tanawuttiwat et al. 2016). In the 
presence of structural heart disease, VT is a life-threatening cardiac arrhythmia and a major 
cause of sudden cardiac death, the incidence of which is estimated to range from 50-100 per 
100,000 in the general population (Rajat et al. 2012). Although the use of implantable 
cardioverter-defibrillators (ICDs) can reduce the risk of sudden cardiac death due to 
ventricular arrhythmias, recurrent ICD shocks can lead to psychological morbidity, reduce 
quality of life and have no impact on the underlying arrhythmogenic substrate (Poole et al. 
2008; Wissner et al. 2012).  
 
Anti-arrhythmic medications such as amiodarone can be used to suppress VT and reduce both 
appropriate and inappropriate ICD therapies (Santangeli et al. 2016) but have variable 
efficacy and are associated with significant adverse effects (Sapp et al. 2016). Catheter 
ablation using radiofrequency energy has emerged as a useful adjunct to ICD implantation 
and anti-arrhythmic medications in the management of VT. However, VT ablation remains 
limited by modest long-term success rates (Della Bella et al. 2013). Treatment failure can be 
due to the inability to deliver radiofrequency energy in a transmural fashion, difficulties in 
accessing regions of arrhythmogenic tissue and lack of robust procedural end-points. There 
are also significant procedural risks including vascular complications, cardiac tamponade, 
stroke and death. 
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The aim of this thesis is to develop and evaluate a real-time magnetic resonance imaging 
(MRI)-guided electrophysiology (MR-EP) solution for VT ablation which has the potential to 
improve the safety and efficacy of catheter ablation. This chapter provides an overview of the 
current classification of ventricular tachycardia, pathophysiology, electroanatomic mapping 
techniques and ablation strategies.  
 
1.1.1 Idiopathic ventricular tachycardia 
Around 10% of ventricular arrhythmias occur in the absence of structural heart disease 
defined by imaging and coronary angiography and are termed ‘idiopathic’ (Pathak et al. 
2019). The mechanisms underlying idiopathic VT include abnormal automaticity, triggered 
activity and re-entry. Increased automaticity or spontaneous depolarisation of a focal region 
of tissue can result in extrasystoles which can precipitate tachycardia. Triggered activity can 
occur when oscillations in the transmembrane potential during or after repolarisation of the 
cardiac action potential is sufficient to breach the threshold potential and generate a 
spontaneous action potential. If repolarisation of the original cardiac action potential is 
interrupted resulting in a second spontaneous potential, this is referred to as an early 
afterdepolarisation (EAD) whilst a spontaneous potential occurring after the end of full 
repolarisation is referred to as a delayed afterdepolarisation (DAD). These ‘triggered events’ 
can also lead to extrasystoles and precipitate VT. The majority of idiopathic VT, particularly 
those related to the outflow tracts, are due to triggered activity secondary to DADs 
(Dukkipati et al. 2017). Re-entry requires the presence of alternate pathways of conduction 
where unidirectional block in one pathway may lead to circus movement or ‘re-entry’ 
between the conventional and alternate pathways, culminating in tachycardia. 
Idiopathic VT can be classified according to the anatomic site of origin. The most common 
location is in the right ventricular outflow tract (RVOT) which accounts for 80% of 
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idiopathic VTs. Other cardiac structures in close proximity including the left ventricular 
outflow tract (LVOT), aortic cusp and pulmonary artery can also give rise to outflow tract 
tachycardias. Similar to atrial fibrillation, where sleeves of myocardial tissue extending into 
the pulmonary veins can trigger ectopic beats, myocardial sleeves extending into the great 
vessels (aorta and pulmonary artery) may account for outflow tract VT.  
 
The conduction system accounts for 10-15% of idiopathic VT with involvement of the left 
anterior or posterior fascicle. Fascicular VT is usually due to re-entry with a zone of slow 
conduction in the interventricular septum. These tachycardias are highly sensitive to the 
administration of calcium-channel blockers such as verapamil which can rapidly terminate 
the arrhythmia. VT may also originate from intra-cavitary structures such as the papillary 
muscles accounting for 5-12% of all idiopathic VT (Dukkipati et al. 2017). The 
posteromedial LV papillary muscle is the most common location followed by the 
anterolateral papillary muscle and rarely the right ventricular papillary muscles. The mitral 
and tricuspid annuli can also be a sources of idiopathic VT.  
 
In general, catheter ablation can be offered with or without a trial of medical therapy in 
patients with symptomatic idiopathic VT and is associated with a relatively low risk of 
complications. For outflow tract VT, catheter ablation is highly efficacious with significant 
reductions in PVC burden and recurrence-free survival of >80% at 1-year in selected cases 
(Ling et al. 2014; Bogun et al. 2007). Fascicular VT ablation has comparable procedural 
efficacy with an initial success rate of 87% after the index procedure and 93.5% after 
multiple procedures (Creta et al. 2019). Catheter ablation of papillary muscle VT can be more 
challenging due to their complex structures, deep location of sites of origin, poor catheter 
stability and contact force during ablation (Doppalapudi et al. 2008).  
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1.1.2 Ventricular tachycardia in structural heart disease 
 
Ventricular tachycardia associated with structural heart disease (SHD) is a major cause of 
sudden death and ICDs can be used for primary and secondary prevention in selected patients 
to reduce this risk. Catheter ablation may be considered as an adjunctive therapy in patients 
with recurrent VT who cannot tolerate anti-arrhythmic medications or where they prove 
ineffective (Deyell et al. 2018). The most common anatomic substrate for VT associated with 
SHD is scar-related re-entrant VT post myocardial infarction (Josephson ME et al. 1978).  
 
Following a myocardial infarction, there may be three different types of tissue present: dense 
scar which is electrically unexcitable, normal myocardium and borderzone tissue. Infarct 
heterogeneity can occur due to variability in myocardial perfusion, restoration of blood flow 
after an infarct following primary percutaneous coronary intervention and subsequent 
remodelling during the healing phase of the infarct (Schmidt et al. 2007). The infarct 
borderzone region may contain a mixture of non-excitable scar tissue and surviving 
‘channels’ of myocardial tissue. These regions provide the substrate for VT as a combination 
of slow conduction and fixed anatomical block from dense scar produce non-uniform 
anisotropy and promote re-entry (Ashikaga et al. 2007) - Figure 1-1. In ischaemic scar, the 
substrate for VT is mainly detected in the endocardium but epicardial substrate may 








Figure 1-1: Figure-of-eight re-entry circuit.  
Classical figure-of-eight re-entrant ventricular tachycardia circuit with an entrance, common isthmus and exit. The isthmus 
is bounded by two lateral lines of block which may be fixed or functional. Animal studies have demonstrated that conduction 
velocities are slowest at the inward curvature to the isthmus entrance, slightly faster at the outward curvature and almost 
normal in the central isthmus. The arrows denote the direction of electrical activation wavefronts. 
 
Not all patients with ischaemic scar develop VT - patients with larger regions of low voltage 
and electrogram fractionation (a sign of asynchronous activation in the region of the 
recording electrode) appear to have a greater risk of developing monomorphic VT (Haqqani 
et al. 2009). Furthermore, in patients post infarct with spontaneous VT, channels of surviving 
myocytes supporting VT are longer and have a reduced conduction velocity compared to 
channels that do not support VT (Nayyer et al. 2018; Nayyer et al. 2014). Non-ischaemic 
cardiomyopathies can also result in VT and can be more challenging to manage as substrate 
may be located in the endocardium, epicardium or in intramural myocardium (Nakahara et al. 
2010). In non-ischaemic dilated cardiomyopathy (DCM), the presence of myocardial 
replacement fibrosis can provide the substrate for re-entrant VT. The presence of mid wall 
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fibrosis on late gadolinium enhancement magnetic resonance imaging (LGE-MRI) is an 
independent risk factor for sudden cardiac death in this cohort (Gulati et al. 2013; Halliday et 
al. 2017). Other mechanisms for VT in DCM include enhanced automaticity, triggered 
activity and bundle-branch re-entry (Dukkipati et al. 2017). Frequently epicardial ablation 
may be required in addition to endocardial ablation in DCM, especially in the presence of 
inferolateral scars (Piers et al. 2013).  
 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterised by fibro-fatty 
replacement of RV myocardium occurring classically in the RV free wall, outflow tract and 
RV apex forming the so-called ‘triangle of dysplasia.’ Scar-related re-entry is the main 
mechanism of VT in these patients and can present early during the natural history of the 
disease (Sen-Chowdhry et al. 2006). In patients with hypertrophic cardiomyopathy (HCM), 
sudden cardiac death may be caused by ventricular fibrillation or polymorphic VT. 
Monomorphic VT is rare but can be caused by the presence of myocardial scar. Due to the 
increased wall thickness in HCM, combined endo-epicardial approaches to catheter ablation 
may also be required to fully eliminate VT substrate (Dukkipati et al. 2011).  
 
Sarcoidosis is a systemic inflammatory disorder characterised by non-caseating granulomas 
and can affect the heart in around 25% of cases (Dukkipati et al. 2017). Ventricular 
tachycardia can occur due to re-entry, triggered activity or abnormal automaticity but the 
inflammatory substrate is often best managed early using immunosuppression with 
corticosteroids and/or anti-arrhythmic medications. In selected cases resistant to medical 
management, catheter ablation may be considered but is associated with poor efficacy 
(Papageorgiou et al. 2018).  
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In this thesis, substrate assessment with MRI and evaluation of the MR-EP system for 
electroanatomic mapping and ablation will be assessed in models of ischaemic 
cardiomyopathy and the remainder of the thesis will focus on VT in this context.  
 
 
1.2 Electroanatomical mapping 
 
1.2.1 Background and technical aspects  
Intra-cardiac electrophysiological mapping can be used to infer local tissue structural 
characteristics, which may reveal pro-arrhythmic substrate and also provide a direct 
assessment of arrhythmia mechanism. Catheters introduced percutaneously record local 
electrograms (EGM), their characteristics including timing, amplitude and location and are 
used for substrate assessment and arrhythmia diagnosis. The EGM represents local electrical 
activity and is the difference between signals recorded from two electrodes. A unipolar EGM 
is the signal detected between one electrode at the recording site and an indifferent electrode 
at a point of zero reference. The unipolar signal incorporates both near and far-field signal 
components as the signal is a representation of myocardial electrical activity spanning the 
distance between electrodes. A bipolar EGM is the signal detected between a pair of closely 
spaced recording electrodes (comprising the recording bipole) and is created through 
subtraction of two unipolar EGMs. As a result, bipolar EGMs are less influenced by larger 
amplitude far-field signals from surrounding myocardium and are useful to evaluate the local 
characteristics of abnormal tissue.  
 
As unipolar signals are comprised of both local and remote influences, they are more 
susceptible to far-field influences but are of greatest use in locating sites of earliest activation 
or exit points of re-entrant circuits as information on the direction of impulse propagation can 
be derived (de Groot et al. 2003). Bipolar signals, although less susceptible to far-field 
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effects, are influenced by multiple factors including the catheter orientation relative to the 
surface tissue (angle of incidence), recording electrode size, inter-electrode spacing, direction 
of activation wavefront, filtering techniques and tissue contact (Tschabrunn et al. 2016).  
 
These extrinsic factors can introduce artefacts during EGM recordings in several ways. Poor 
catheter contact can lead to low-amplitude EGMs leading to potentially misleading 
annotation of regions of normal myocardium as scar. Catheter stability is also important 
during EGM recordings - catheter motion can artificially lead to recording of fractionated 
EGMs (low amplitude EGMs with high frequency deflections). The presence of 
electromagnetic interference (e.g. as is present inside a MRI scanner) can also introduce high 
frequency noise and obscure the timing and morphology of the local EGM. Signal filtering is 
used in the electrophysiology laboratory to enhance segments of the frequency spectrum 
whilst rejecting undesirable aspects of the spectrum. A combination of high-pass and low-
pass filters with or without an optional notch filter can be used to reject electrical 
interferences from DC voltages, baseline drift and suppress line-related noise to optimise the 
quality of signal acquisition. The application of filtering can attenuate peak-to-peak signal 
amplitude depending on the filter settings and needs careful interpretation. Given the 
additional sources of electromagnetic interference present during MR-EP procedures, 
filtering techniques have required re-interpretation and adaptation to preserve EGM fidelity 
and reduce artifacts induced by MR sequences during mapping inside the MRI environment 
(Elbes et al. 2017).  
 
Residual electrical activity within regions of scar may manifest as abnormal EGMs due to the 
transverse uncoupling of myocytes due to fibrosis. Abnormal EGMs can be categorised as 
fractionated, isolated and late (Bogun et al. 2005). A normal ventricular EGM may contain 
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sharp biphasic or triphasic deflections with an amplitude ≥ 3mV and duration <70ms. In 
contrast, a fractionated potential exhibits multiple deflections (≥ 3 deflections) from the 
isoelectric line or continuous electrical activity without an isoelectric line and typically an 
amplitude ≤0.5mV with duration ≥133ms (Rostock et al. 2006). These may reflect non-
uniform activation of a mass of surviving myocardial bundles within a region of scar. An 
isolated or disassociated potential is defined as a potential distinct and separated from the 
local ventricular EGM by an isoelectric interval or very low amplitude noise and of a 
duration >20ms at a gain of 40-80mm/mV (Hsia et al. 2009). These may represent electrical 
activation from surviving myocardial bundles insulated by dense scar and poorly coupled to 
remaining myocardium. EGMs containing isolated potentials may have double or multiple 
potentials. A higher incidence of these late potentials have been recorded near a VT isthmus 
compared to the entrance or exit sites (Hsia et al. 2009) - Figure 1-2.  
 
Figure 1-1: Normal and abnormal electrograms.  
Example tracings of normal and abnormal electrograms. Recordings from surface leads (I, aVF, V1), intra-cardiac 
recordings from the left ventricle and right ventricular apex are shown. Normal EGM (A) with an amplitude of 7.8mV and 
duration 65ms. Isolated potential (B) is clearly visible and separated from the ventricular EGM by 210ms. A fractionated 
electrogram (C) with an amplitude of 0.37mV and duration of 192ms is seen. An abnormal local electrogram is present (D) 
with an amplitude of 0.7mV and duration 112ms. Adapted with permission from Bogun et al 2005). 
More recently, (Jais et al. 2012) have sought to define abnormal EGMs in a more precise 
manner incorporating data on the amplitude and timing of potentials in relation to the QRS, 
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local or far-field signals. Local abnormal ventricular activities (LAVA) were defined as 
sharp, high-frequency ventricular potentials, distinct from the far-field ventricular EGM 
occurring during or after the far-field ventricular EGM in sinus rhythm or before the far-field 
ventricular EGM during VT. Elimination of LAVAs during VT ablation was associated with 
improved VT-free survival in a cohort of patients with structural heart disease (Jais et al. 
2012).  
 
1.2.2 Electroanatomic mapping systems 
 
Local electrophysiological data acquired from recording catheters such as activation time, 
unipolar or bipolar voltage and the presence of abnormal electrograms can be displayed on 
3D shells of cardiac chambers using contemporary electroanatomic mapping (EAM) systems. 
These provide a static representation of time-dependent electrical activation and can be used 
to assess underlying substrate and guide catheter ablation. All EAM systems provide three 
basic functions (Knackstedt et al. 2008): 
 
1. Non-fluoroscopic localisation and display of catheter position in real-time 
2. Reconstruction of 3D surface anatomy of cardiac chambers from serial acquisition of 
catheter localisation data 
3. Annotation of reconstructed surface geometry with local electrophysiological data and 
location of ablation lesions 
 
The major systems which are widely used in current electrophysiology practice include 
CARTO® (Biosense Webster), PRECISIONTM (Abbott) and RHYTHMIATM (Boston 
Scientific). Catheter location in conventional EAM systems is triangulated using magnetic-
based sensing and/or impedance-based tracking. The CARTO system uses magnetic-sensor 
based tracking incorporating a magneto-sensor in the tip of the catheter which measures 
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magnetic field strength around it. Magnetic generators are located beneath the patient on the 
operating table and allows the triangulation of catheter tip position and orientation based on 
magnetic field strength at the catheter tip. Additional patches are applied on the patient’s 
back to record inadvertent patient movement and correct navigational error (Gepstein et al. 
1997; Kautzner et al. 2003; Maury et al. 2018).  
 
Localisation of catheters with the PRECISION system is based on measurements of electrical 
impedance. Skin patches are applied to the patient’s chest through which a high frequency, 
low amplitude current is delivered to create a voltage gradient along the x,y and z-axes. A 
catheter then measures impedance changes to compute its location in 3D space in relation to 
the reference. In order to compensate for respiratory changes, the position of each intra-
cardiac electrode is determined during a period of recording and correlated to changes in 
intra-thoracic impedance as detected by the skin patches. By monitoring surface impedance 
changes, the system can then adjust electrode position accordingly. The RHYTHMIA system 
uses a combination of magnetic-sensor based and impedance-based tracking for catheter 
localisation. The accuracy of these tracking techniques has been estimated at 0.5mm for 
magnetic-sensor based tracking and 0.6mm for impedance-based tracking (Maury et al. 
2018).  
 
Using the localisation data provided by catheters, sequential movements made by 
manipulating the catheter around the cardiac chamber of interest can be used to generate 3D 
surface geometry. Electrical information can be collected, if required, at each contact site 
during the collection of points for geometry. Pre-procedural imaging data from cardiac 
computed tomography (CT) or MRI can also be merged through image integration with the 
3D reconstructions of chamber geometry to refine the accuracy of anatomical maps as well as 
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reducing errors from geometry acquisition. Imaging-derived data on arrhythmogenic 
substrate (e.g. wall thinning on CT or LGE on MRI) may be integrated into the navigation 
system during VT ablation procedures to inform additional mapping in regions of interest as 
well as to guide epicardial access in those patients with relevant substrate (Yamashita et al. 
2016).  
 
The 3D reconstructed shell is annotated with local electrophysiological data during an EAM 
procedure - Figure 1-3. Local activation time of the wavefront of depolarisation can be 
depicted using colour-coded maps with each colour representing a fixed time frame in the 
depolarisation cycle. An animation can also be created with all conventional EAM systems to 
represent wavefront propagation thereby permitting an appreciation of the dynamic pattern of 
activation. The amplitude of unipolar or bipolar EGMs can also be represented as colour-
coded voltage maps which allow discrimination between dense scar, borderzone regions and 
normal myocardium. Conventionally, a bipolar voltage threshold of ≤0.5mV is used to 
represent dense scar, 0.5-1.5mV is used to represent borderzone tissue and regions with a 
bipolar voltage >1.5mV is classified as normal myocardium. These thresholds were originally 
defined using point-by-point, non-contact, force-sensing mapping catheters and validated in 
models of ischaemic cardiomyopathy (Reddy et al. 2003). Recent data suggests that normal 
bipolar voltage thresholds are likely to be catheter and patient-specific and strict voltage cut-
offs may not be truly reflective of scar biology, especially in regions of scar heterogeneity 
(Mukherjee et al. 2018).  
 
Depending on the EAM system used, additional maps can be generated to display EGM 
fractionation and pace-maps can be used to evaluate the degree of overlap between a paced 
beat from a given site and a spontaneous beat of tachycardia (Hsia et al. 2003). Acquisition of 
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points can also be performed automatically using multi-polar catheters and preset electrogram 
acceptance criteria, thereby precluding the need to manually check and annotate each point. 
Threshold settings for cycle length tolerance, signal-to-noise threshold and force permit the 
collection of high-quality data reproducibly and with accuracy, which in turn can reduce 
procedure times.  
 
Figure 1-2: Three dimensional electroanatomical maps 
Example of three dimensional electroanatomical maps (inferior view) acquired using the CARTO system (Biosense 
Webster). Local activation time (LAT) (A) and voltage maps (B) acquired in sinus rhythm showing the left ventricle in a 
patient with a large inferior infarct. Scar is denoted in green/red/blue and healthy tissue in purple on the voltage map (B). 
NB: Upper threshold for scar shown on the voltage map is 0.52mV whilst standard presentation for low voltage is 0.5 - 
1.5mV.  
 
1.2.3 Activation mapping 
In order to localise exit sites and determine possible ablation targets, it is desirable to perform 
EAM either during spontaneous or induced VT. If spontaneous VT is not readily seen, 
programmed electrical stimulation can be performed at the start of a mapping procedure in 
order to initiate VT. Induction is typically performed through pacing from the RV apex with 
a current strength at twice the capture threshold and a pulse width of 2ms. Premature extra-
stimuli with progressively shorter coupling intervals can then be delivered down to the 
ventricular effective refractory period (VERP). If stimulation from the RV apex fails to 
induce VT, the procedure can be repeated from a different pacing site (e.g. RVOT or the left 
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ventricle) or a non-selective beta agonist (e.g. isoprenaline) administered (Tschabrunn et al. 
2016). If the VT is sustained and haemodynamically tolerated, activation mapping can then 
be performed using a mapping catheter and a fixed timing reference, typically a dominant 
QRS deflection on the surface ECG or a diagnostic catheter positioned elsewhere within the 
heart, often in the right ventricle (in the case of left ventricular VT). The site of earliest 
activation, prior to the QRS onset during VT may represent an exit site from the zone of 
myocardium harbouring the diastolic pathway. If using a single electrode catheter, a pre-
systolic potential may be seen near an exit site and as the catheter is moved further into the 
associated scar (away from the exit site), this potential may be seen in the mid-diastolic phase 
of the tachycardia. Using a multi-electrode catheter, continuous electrical activity consistent 
with a re-entrant circuit may be demonstrated using the different recording electrodes during 
activation mapping of VT - Figure 1-4.  
 
Activation mapping of a macro-re-entrant VT is considered complete when the following 
criteria are fulfilled (Anter et al. 2016):  
• ≥90% of the tachycardia cycle length is mapped 
• A common channel ‘isthmus’ is identified 
• Sufficient mapping density in regions of slow conduction is acquired to limit 




Figure 1-3: Activation map of ventricular tachycardia.  
Endocardial recordings made during activation mapping of ventricular tachycardia using a multi-electrode catheter. 
Continuous electrical activity is recorded throughout the tachycardia cycle length including in diastole representing the re-
entrant circuit. The bipolar voltage map with the mapping catheter positioned in the anteroseptum is shown on the right. 
Reproduced with permission from Tschabrunn et al. 2016.  
 
1.2.4 Entrainment mapping 
Following activation mapping, overdrive pacing can be performed at selected sites identified 
from the activation map in order to ‘entrain’ the tachycardia. Entrainment mapping can be 
performed during tachycardia in order to determine the mechanism of the arrhythmia and 
establish the relationship of an individual pacing site to the re-entry circuit and thereby 
identify the critical and non-critical parts of a circuit. Entrainment refers to continuous 
resetting of a re-entrant tachycardia through delivery of a series of consecutive beats in a 
pacing train where each pacing beat ‘resets’ the tachycardia - either through advancing or 
delaying the subsequent tachycardia beat. A re-entrant VT circuit will contain an ‘excitable 
gap’ whereby a wave of depolarisation will leave a region of tissue refractory to a further 
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stimulus for a given period of time prior to recovery. This is due to the refractory period of 
each point in the circuit being shorter than the time interval taken for the wavefront of 
depolarisation to propagate around the circuit once (Stevenson et al. 1997).  A critically 
timed pacing stimulus can therefore be programmed to enter and affect the tachycardia 
circuit.  
 
Following the application of a stimulus to a given site during VT, if the site has recovered 
and the stimulus is applied prior to the arrival of the next wavefront of depolarisation, the 
stimulus will capture the myocardium. This will lead to activation wavefronts that will travel 
in a direction which is orthodromic to the tachycardia wavefront and in an opposite direction 
(antidromic) to the tachycardia wavefront. The antidromic wavefront will collide with the 
head of the returning orthodromic wavefront from the tachycardia. However, the orthodromic 
wavefront generated from the pacing stimulus will traverse the circuit and reset the 
tachycardia. Following termination of pacing, the last paced beat will traverse the circuit at 
the pacing cycle length; depending on how far from a re-entrant circuit the pacing site lies, 
the returning orthodromic wavefront following the last paced beat will reach the pacing site 
in less than 30ms if within the circuit and in more than 30ms if outside the circuit.  
 
If the following features are present on pacing during tachycardia, it suggests that 
entrainment has occurred and proves re-entry as the mechanism of the tachycardia: 
 
• Constant fusion of complexes during pacing at a constant cycle length (the 
morphology of the paced complex is intermediate between that of a fully paced 
complex and a VT complex) 
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• Progressive fusion during pacing at different pacing rates (i.e. during pacing at faster 
rates, there is a progressive increase in the extent of myocardium activated from the 
pacing site ultimately leading to a fully paced complex) 
 
• Conduction block to an orthodromic site that terminates the tachycardia circuit which 
is followed by activation of that site by the paced wavefront from the opposite 
direction (Kumar et al. 2017) 
 
In order to determine the relationship of the pacing site relative to the VT circuit, the 
following electrophysiological parameters can be examined during or after entrainment: 
 
• Post-pacing interval (PPI) following entrainment 
• QRS configuration during entrainment 
• Stimulus-to-QRS interval (S-QRS) during entrainment 
 
The PPI after entrainment represents a measure of the proximity of the pacing site to the re-
entry circuit. A pacing site close to or within the re-entry circuit will give a PPI which is 
close to the tachycardia cycle length (TCL). If the pacing site is distant from the VT circuit 
and entrains the tachycardia (i.e. a bystander site), the PPI will be longer than the TCL by at 
least 30ms. Therefore, the difference between the PPI and TCL can be used to determine the 
likelihood an individual site is close to or within the circuit. In patients with post-infarct VT, 
ablation sites with a PPI-TCL during entrainment which was <30ms, had a higher likelihood 
of terminating VT (Stevenson et al. 1993). 
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The QRS configuration during entrainment is the result of the myocardial activation sequence 
from the pacing site. If the pacing site during entrainment is distant from the VT circuit, the 
QRS morphology will be altered and will be a product of the activation wavefront 
propagating from the pacing site and the activating wavefront coming out of the VT exit site 
(fused QRS). If the pacing site is within the re-entry circuit, pacing during VT will not 
change the surface QRS morphology, therefore there will be no fusion at the surface ECG 
level - this is referred to entrainment with concealed fusion. The ‘fusion’ may be detectable 
by local EGMs within the scar as a small mass of tissue is depolarised by the antidromic 
wavefront of the VT before collision with the orthodromic wavefront of the pacing stimulus 
(Kumar et al. 2017).  
 
The S-QRS interval is a representation of conduction time from the site of pacing to the VT 
circuit during entrainment with concealed fusion. If the pacing site is within the circuit, the 
time from the local EGM to surface QRS is also an indication of this conduction time, 
therefore the S-QRS interval during concealed fusion can be used to approximate the EGM-
QRS time during tachycardia. When pacing from a bystander site, the S-QRS time will not 
approximate the EGM-QRS interval (Stevenson et al. 1997). A S-QRS interval during 
entrainment with concealed fusion which is <70% of the TCL in a given pacing site has a 
higher likelihood of tachycardia termination during ablation and is likely to represent an 
isthmus site (Stevenson et al. 1997).  
 
Based on the above criteria, the different features of mapping sites from re-entrant circuits 
can be classified as isthmus sites, exit, inner and outer loop sites, adjacent and remote 




Figure 1-4: Entrainment mapping 
During entrainment with concealed fusion, a PPI-TCL ≤ 30ms, S-QRS to EGM-QRS ≤ 20ms or S-QRS <70% of TCL is 
likely to represent an isthmus site. Sites where these criteria are not met may be classified as inner loop sites, outer loop, 
adjacent bystander and remote bystander sites as shown above. Reproduced with permission from Stevenson et al. 1997. 
 
In order to perform either activation or entrainment mapping, VT has to be hemodynamically 
tolerated or the use of mechanical circulatory support devices established in unstable VT. 
Currently, the majority of VTs induced in the electrophysiology laboratory are not 
hemodynamically tolerated and alternative substrate-based strategies have developed to 
identify critical sites for VT. 
 
1.2.5 Pace-mapping 
Pace-mapping is a surrogate of the activation map in sinus rhythm to locate the origin of VT. 
During pace-mapping, the QRS morphology during pacing at a given site is examined and 
compared to the QRS morphology obtained from a 12-lead ECG recorded during the clinical 
VT. The QRS morphology within each lead can be assessed and if the morphology in all 12 
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leads during the clinical VT matches that of the pacing site, this is considered an ‘excellent’ 
site for ablation. If the QRS morphology from the paced site only matches 10-11 out of 12 
leads, this is considered a ‘good’ site. The degree of matching between the paced QRS and 
12-lead ECG of the clinical VT can be assessed both qualitatively or through the use of 
automated algorithms incorporated into clinical EAM systems which express the degree of 
matching as a percentage value through a correlation calculation.  
 
An additional parameter that can be obtained during pace-mapping in sinus rhythm is 
measurement of the S-QRS interval. This technique has been proposed as a means to locate 
the exit site of a VT circuit. A S-QRS delay of ≥ 40ms may indicate a region of slow 
conduction away from the pacing site whilst a S-QRS delay ≥ 80ms represents marked delay. 
VT ablation sites are more likely to be found in regions of marked S-QRS latency although 
the sensitivity is moderate (Brunckhorst et al. 2003). 
 
If the pacing site is located close to the exit site of an isthmus, there will be an ‘excellent’ 
matched QRS morphology and a short S-QRS interval. If the pacing site is moved within the 
isthmus, the matched QRS morphology should remain ‘excellent’ but the S-QRS interval 
should become longer. There may then be a sudden transition point within the core of the 
isthmus when the matched QRS morphology becomes poor when pacing closer to the 
entrance site. This is due to the activation wavefront spreading more rapidly to the entrance 
zone when pacing closer to the entrance, followed by ventricular depolarisation. When 
pacing closer to the exit zone, the activation wavefront will spread more rapidly to the exit 
and depolarise the ventricle from a different site, leading to a significantly different QRS 
morphology (de Chillou et al. 2014).  
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Following identification of an exit/entrance zone, pace-mapping can be performed around 
adjacent sites in order to identify the lateral boundaries of the isthmus and an isochronal 
colour-coded pace-map of correlation between QRS morphologies and/or S-QRS intervals 
generated. Catheter ablation can then be guided by the location of the VT isthmus, aiming to 
transect this region (de Chillou et al. 2017). There are a number of factors that can reduce the 
precision of pace-mapping such as large inter-electrode distances within the mapping catheter 
which may lead to a larger region of myocardial depolarisation and therefore reduce the 
spatial resolution of the technique. High-output pacing may also increase the likelihood of 
far-field capture. A high pacing rate could lead to small alterations in QRS morphology and 
pacing at a rate close to that of the clinical VT cycle length is recommended (de Chillou et al. 
2017).  
 
1.2.6 Substrate mapping during sinus rhythm 
Activation and entrainment mapping require that VT is both inducible and haemodynamically 
tolerated as a pre-requisite. Given that the majority of clinical VTs induced result in 
haemodynamic compromise, substrate-based strategies in sinus rhythm to identify VT 
ablation targets may serve as an alternative approach. Abnormal electrical substrate evaluated 
during sinus rhythm comprising low amplitude peak-to-peak voltage and abnormal EGM 
characteristics (e.g. split, isolated late potentials, fractionated potentials and LAVA) have 
been used to identify the critical target sites of re-entrant VT. 
 
Both bipolar and unipolar peak-to-peak voltage may be attenuated by abnormal myocardium. 
Using a combination of animal studies in a model of ischaemic cardiomyopathy (Callans et 
al. 1999), limited human histopathological evaluation (Deneke et al. 2005) and statistical 
definitions of normal voltages derived from values >95th centile of amplitude distributions 
from patients without scar (Marchlinski et al. 2000), a bipolar voltage cut-off of <1.5mV has 
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been universally implemented to define abnormal myocardium. A cut-off <0.5mV has been 
used to define dense scar and values 0.5-1.5mV to define borderzone tissue or regions with 
intermediate degrees of fibrosis. These values were largely validated for transmural scar 
whilst patchy scar may be missed using these cut-offs. Adjusting the bipolar voltage cut-offs 
to higher values (e.g. 2.0mV or 2.5mV) may identify a more confluent area of scar which 
incorporates all abnormal signals (Santangeli et al. 2016). Similarly, when voltage mapping 
identifies a large area of scar, adjustment of the lower bipolar voltage cut-off to <0.5mV (e.g. 
0.1mV or 0.2mV) will help identify dense fibrosis and may facilitate delineation of 
conduction channels within the scar (Hsia et al. 2006).  
 
Bipolar voltage mapping has a limited field of view, however which can lead to difficulty in 
the identification of intramural or epicardial substrate. Unipolar voltage mapping, with a 
larger field of view, has been used to identify epicardial substrate which is more prevalent in 
patients with non-ischaemic cardiomyopathy. Using statistical distributions of normal signal 
amplitude from a cohort of healthy patients, a unipolar voltage of >8.27mV has been used to 
define normal myocardium within the LV endocardium (Hutchinson et al. 2011) and 5.5mV 
in the thinner free wall of the RV (Polin et al. 2011).   
 
Abnormal EGMs recorded from mapping sites may also represent the substrate for VT. These 
signals may result from poor cell-to-cell coupling of surviving tissue within regions of 
fibrosis and represent anisotropic ‘zig-zag’ conduction (Santangeli et al. 2016). As discussion 
in Section 1.2.1, abnormal EGMs may be classified as fractionated, split, late, or as LAVA. 
Different investigators have adopted substrate-based ablation strategies aimed at eliminating 
all abnormal EGMs (e.g. late potential abolition, LAVA elimination or scar homogenisation) 
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(Arenal et al. 2013; Vergara et al. 2012; Silberbauer et al. 2014; Jais et al. 2012; Di Biase et 
al. 2012) with variable success rates.  
 
There are a number of factors that may affect these strategies including sampling bias in 
regions of abnormal substrate, use of different mapping catheters with variations in recording 
electrode size and inter-electrode spacing and the direction of activation wavefront during 
recording of EGMs. These factors may affect the detection, location and characterisation of 
abnormal signals and impact on the chosen ablation strategy (Santangeli et al. 2016). 
Recently, in an elegant study, (Anter et al. 2018) used high-resolution mapping in a porcine 
infarct model to generate activation maps, assess EGM shape, amplitude and conduction 
velocity. All electrophysiological parameters used to assess substrate in sinus rhythm had a 
poor specificity and positive predictive value (PPV) in the identification of the VT isthmus. 
For example, a bipolar voltage <1.5mV had a sensitivity of 72%, specificity of 56% and PPV 
of only 24% in identifying a VT isthmus location. Of the different EGM abnormalities, the 
presence of LAVA had the best sensitivity (82%) but all types of abnormal EGMs had poor 
specificity (38%-64%) and PPV (28% - 48%) (Anter et al. 2018). Interestingly, regions of 
local conduction velocity slowing - termed steep activation gradients, had the best specificity 
(80%) and PPV (60%) for isthmus identification.  These data highlight the limitation of 
substrate-based strategies to target VT ablation sites and emphasise the importance of 




There are several limitations of EAM as a means to assess VT substrate. Bipolar voltage is 
affected by several factors which are independent of the histological characteristics of the 
underlying tissue as discussed in Section 1.2.1. The assumption that low voltage means 
 37 
histological scar is therefore not necessarily accurate. Given that catheters with smaller 
electrodes with reduced inter-electrode spacing may be able to distinguish surviving 
myocardial bundles with greater sensitivity (Tschabrunn et al. 2016), catheter-specific 
thresholds may be needed to better define abnormal substrate. EGM configuration and timing 
is also affected by activation wavefront - late potentials may be visible during RV pacing but 
not during sinus rhythm and vice versa (Josephson and Anter, 2015). The regions of 
myocardium designated as harbouring LAVAs may be larger when the wavefront of 
propagation is perpendicular versus parallel to the line of block along the boundary of an 
isthmus (Martin et al. 2019).  
 
Activation mapping, whilst being the gold standard for accurate characterisation of the VT 
circuit, is only possible in a small proportion of VTs due to haemodynamic instability. The 
use of haemodynamic support devices may facilitate activation mapping in otherwise 
unstable VT but their use can result in significant complications with unclear clinical benefits 
(Luni et al. 2019). Problems with entrainment mapping include an inability to capture 
myocardium with consequent increases in the pacing output delivered. This can lead to a 
larger volume of tissue capture and result in misleading calculation of isthmus location and 
dimensions. There are also inherent limitations to pace-mapping - pacing in sinus rhythm 
from a point source may not mimic the pattern of impulse propagation of scar-related re-
entrant VT. The presence of functional block may only be apparent during tachycardia and 
may be absent during pace-mapping. S-QRS measurements during pace-mapping may 




The optimal mapping density within regions of scar in the ventricle remains unclear - a lower 
mapping resolution may underestimate the dimensions of VT target sites due to the 
interpolation of activation times in under-sampled areas (Anter et al. 2016). EAM is a time-
consuming procedure with mean procedural time of 3.5 ± 1.2 hours with a substrate 
modification protocol (Fernandez-Armenta et al. 2016); the addition of substrate mapping 
with different activation wavefronts or strategies to unmask slow conduction with 
extrastimulus pacing protocols (Acosta et al. 2018) can therefore be challenging to deliver in 
patients with a poor physiological reserve. Given the variety of mapping strategies, the 





1.3 Catheter ablation for ventricular tachycardia in structural heart disease 
1.3.1 General considerations 
Ablation strategies typically use a combination of activation and entrainment mapping, if 
possible, pace-mapping and assessment of substrate to delineate target sites. If VT induction 
is performed, at least two sites are selected with two different cycle lengths and up to three 
extra-stimuli at progressively shorter coupling intervals to attempt to stimulate VT (Emami et 
al. 2019). The morphology, cycle length and stability of all induced VTs are recorded. 
Activation and entrainment mapping can then be performed if the tachycardia is stable. If 
programmed stimulation is not performed and a substrate-based strategy is selected, local 
EGMs are recorded with the peak-to-peak voltage and EGM morphology assessed. 
Additionally, pace-mapping can be performed if a 12-lead ECG of the clinical VT is 
available and measurement of S-QRS intervals can be made.  
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1.3.2 Ablation strategies 
Activation mapping can be used to identify the earliest site of electrical activation during 
tachycardia. This data is useful to localise VT exit sites along the border of scar and 
potentially record EGMs during diastole which could represent critical components of the 
circuit and are targeted for catheter ablation (Santengeli et al. 2016). Diastolic activation may 
also be present in bystander sites which are not part of the circuit. Entrainment mapping uses 
overdrive pacing to locate target sites with a PPI-TCL ≤ 30ms, S-QRS - EGM-QRS ≤ 20ms 
or S-QRS which is <70% of the VT cycle length as discussed in Section 1.2.4. These sites are 
more likely to signify the location of an isthmus and successfully terminate VT. Pace-
mapping is a surrogate of the activation map - sites with an ‘excellent’ match of the paced 
QRS morphology to the clinical VT may be targeted for ablation. An abrupt change in QRS 
morphology within the mid-isthmus can also be used to unmask target sites for catheter 
ablation as discussed in Section 1.2.5.  
 
Substrate-based ablation strategies can be classified into those that target the entire abnormal 
substrate and those that target discrete regions within scar that have been shown to be 
relevant to the inducible tachycardia through physiologic manoeuvres. Strategies that target 
the entire abnormal substrate include late potential or LAVA elimination and scar 
homogenisation whilst strategies that target limited regions of substrate include scar 
dechanneling, linear ablation and core isolation (Santengeli et al. 2016).  
Late potentials have been targeted for ablation by several investigators (Arenal et al. 2003; 
Nogami et al. 2008; Vergara et al. 2012) but the definition of these potentials have varied 
significantly between studies. Sampling bias is a major limitation of this technique whilst late 
potential elimination is not always possible even with extensive ablation. Far-field potentials 
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from remote sites may contribute to persistence of a signal despite adequate ablation in a 
given site (Santangeli et al. 2016).  
 
LAVAs first decribed by (Jais et al. 2012) are a more precise definition of abnormal EGMs 
that may be related to VT circuits, however they suffer from similar limitations to that of late 
potential ablation including sampling bias. The optimal pacing strategy to systematically 
record LAVAs also remains unclear (Santangeli et al. 2016). Scar homogenisation represents 
an extensive ablation strategy whereby all abnormal EGMs within scar defined using 
conventional bipolar voltage criteria are targeted for ablation - Figure 1-6. This approach has 
been shown to be superior to limited ablation of clinical VT in ischaemic cardiomyopathy 
within the randomised multi-centre VISTA study (Di Biase et al. 2015). Additionally, in 
patients with non-ischaemic cardiomyopathy, a scar homogenisation approach improved 
freedom from VT compared to limited substrate-based ablation, although the success rate was 
lower than that of patients with ischaemic cardiomyopathy (Gokoglan et al. 2016).  
 
The scar homogenisation approach may be difficult to achieve in patients with large 
substrates without sufficient physiological reserve for extensive ablation. The strategy also 
invariably targets bystander regions that do not participate in the VT circuit.  
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Figure 1-5: Scar homogenisation  
Bipolar endocardial voltage map in a patient who has received extensive ablation (scar homogenisation). Red regions 
indicate scar whilst purple represents healthy myocardium. Red dots represent regions where ablation has been applied. 
Representative EGMs from sites targeted for ablation are shown. Reproduced with permission from Di Biase et al. 2012.  
 
Limited substrate-based strategies such as linear ablation aim to create contiguous lesions 
from the scar borderzone to an anatomic structure. The strategy is reliant on the use of pace-
mapping to identify VT exit sites within the abnormal substrate. Linear ablation was first 
described by (Marchlinski et al. 2000) who reported encouraging success rates (75% at 
median 8 months follow-up) in a small cohort of patients with structural heart disease and 
was subsequently used in the SMASH-VT trial (Reddy et al. 2007). However, it can be 
challenging to achieve conduction block across a linear lesion due to the need to deliver 
transmural lesions. The strategy also requires the presence of fixed anatomic barriers near the 
relevant substrate (Santangeli et al. 2016).  
 
Scar dechanneling is another substrate-based strategy that aims to identify channels of slow 
conduction using high-output, unipolar pacing within low voltage regions. Alternatively, a 
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high-density voltage map can be acquired and regions of abnormal EGMs marked within the 
substrate to locate channels which may contain surviving myocardial bundles. Scar 
dechanneling involves ablating inter-connected channels within the substrate and has been 
shown to have a shorter duration of radiofrequency application and improved event-free 
survival in those patients where complete conducting channel elimination was possible 
(Berruezo et al. 2015).  
 
The ‘core isolation’ approach involves identification of a discrete region of interest within 
scar using conventional methods (e.g. voltage mapping, pace-mapping, abnormal EGM 
localisation, entrainment mapping). The critical region identified is then ablated with lesions 
surrounding the region of interest or extending to anatomical barriers. The demonstration of 
electrical unexcitability of the core region of interest serves as the procedural end-point. Core 
isolation has been associated with good VT-free survival whilst also limiting the ablation 
target size (Tzou et al. 2015). The end-point of electrical isolation of the target region also 
serves as a reproducible end-point beyond VT inducibility.  
 
 
1.3.3 Procedural end-points 
Traditionally, following the end of a VT ablation procedure, programmed stimulation is 
applied to evaluate if VT remains inducible. The probabilistic nature of programmed 
stimulation makes it difficult to apply in a reproducible fashion. The presence of oedema 
around an ablation lesion site may inhibit induction of VT immediately after an ablation 
procedure whereas days or weeks after a procedure, after oedema has resolved, VT may once 
again become inducible. In patients with structural heart disease, anti-arrhythmics such as 
amiodarone are frequently used prior to VT ablation - their use may suppress inducibility 
both up-front and at the end of an ablation procedure.  
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Despite its limitations, non-inducibility has been widely implemented as a procedural end-
point during VT ablation. Some investigators have used non-inducibility of the clinical VT as 
a minimum end-point whilst others have used non-inducibility of all VTs as a more 
comprehensive end-point. In a large observational cohort, non-inducibility of all VTs was 
associated with improved cardiac mortality, compared to inducibility of non-documented VT 
and non-inducibility of clinical VT at the end of a procedure (Della Bella et al. 2013). A 
meta-analysis of non-inducibility as an end-point in post-infarct VT ablation however found 
no significant association between rates of non-inducibility and recurrence at follow-up 
(Santengeli et al. 2014).  
 
Non-invasive programmed stimulation (NIPS) whereby programmed stimulation is 
performed via the ICD a few days after VT ablation has also been used to identify patients at 
increased risk of recurrence (Frankel et al. 2012). Although not technically a procedural end-
point, NIPS-positive patients might benefit from early repeat ablation and the use of this end-
point warrants further investigation (Santangeli et al. 2014).  
 
For substrate-based ablation, additional end-points have been investigated depending on the 
ablation strategy used. The efficacy of linear ablation lesions has been assessed using the 
end-point of electrical unexcitability (failure of capture) during high-output pacing along the 
ablation line and demonstration of a change in QRS morphology during pacing from each 
side of the ablation line (Santangeli et al. 2014). Alternative surrogate parameters that can be 
used to support demonstration of effective lesion delivery include assessment of catheter-
tissue contact using intra-cardiac echocardiography (ICE), monitoring of impedance and 
elimination of high-frequency potentials that may represent near-field activation (Santangeli 
et al. 2014). There is, however, no established electrophysiological end-point that best 
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demonstrates completeness of linear lesions in the ventricle as the optimal pacing output 
required to demonstrate failure to capture within a region of pre-existing scar remains 
unknown. In addition, it is challenging to distinguish between block and severe conduction 
delay across a lesion line.  
 
Substrate-based strategies that aim to eliminate all abnormal EGMs have used a combination 
of demonstration of elimination of all abnormal EGMs during scar re-mapping and failure to 
capture with high-output pacing. Although the end-point of abnormal EGM elimination (e.g. 
LAVA elimination) has been shown to result in improvement in VT-recurrence and mortality 
in those patients in whom it could be achieved (Jais et al. 2012), this was only possible in 
70% of patients. The presence of late potentials may persist in regions of ablation and the 
demonstration of local capture with exit block during high-output pacing may be useful to 
determine if sufficient ablation has been performed (Santangeli et al. 2014). Complete 
elimination of abnormal EGMs may require time-consuming and extensive ablation whilst 
also inadvertently targeting bystander sites where late potentials may be recorded but do not 
participate in a VT circuit. Whether scar re-mapping from different pacing sites is required to 
demonstrate comprehensive elimination of abnormal EGMs also remains unclear and this 
strategy would prolong procedure times still further.   
 
Imaging techniques such as ICE or MRI represent alternative modalities to judge procedural 
end-points. ICE has been used to monitor lesion formation in real-time through 
demonstration of increased echogenicity within ablated tissue whilst lesion size on imaging 
appeared to correlate with size at pathology in a pre-clinical study (Ren et al. 2001). In this 
thesis, a method of evaluating ablation lesion formation in real-time using MRI temperature 
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mapping (MR-thermometry and dosimetry) is evaluated as a possible novel end-point for VT 
ablation.  
 
1.3.4 Clinical outcomes 
A number of clinical trials have examined the impact of catheter ablation on outcomes in 
patients with VT. In general, non-ischaemic cardiomyopathies (NICM) have been under-
represented with no randomised controlled trials investigating the role of catheter ablation. 
NICM patients tend to have worse outcomes after catheter ablation of VT compared to 
patients with ischaemic cardiomyopathy (Dinov et al. 2014). For the treatment of drug-
refractory VT storm, catheter ablation is generally considered a safe and effective strategy 
(Carbucicchio et al. 2008).  
 
In patients with ischaemic cardiomyopathy presenting with recurrent VT, the Euro-VT study 
suggested that catheter ablation could successfully terminate VT acutely in most patients but 
around 49% developed VT recurrence during follow-up (Tanner et al. 2010). The 
observational multi-centre Thermocool VT ablation trial enrolled 231 patients with ischaemic 
cardiomyopathy and recurrent monomorphic VT to undergo catheter ablation. The primary 
end-point was freedom from recurrent VT at 6 months, but this was only achieved in 53% of 
patients. There was a high 1-year mortality rate at 18% whilst procedure-related mortality 
was 3%.  
 
A number of randomised controlled trials have also been published investigating the safety 
and efficacy of VT ablation in ischaemic cardiomyopathy. In the SMASH-VT trial, patients 
with ischaemic cardiomyopathy who were randomised to receive catheter ablation in addition 
to ICD implantation had a reduced incidence of ICD therapies compared to patients who 
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received an ICD alone (Reddy et al. 2007). Patients did not receive anti-arrhythmic drugs in 
this trial and participants were enrolled who had experienced a single episode of VT or 
ventricular fibrillation, suggesting a low-risk population. In the VTACH study, patients with 
ischaemic cardiomyopathy and reduced left ventricular ejection fraction were randomised to 
receive either catheter ablation and an ICD or an ICD alone. Similar to the SMASH-VT 
study, prophylactic VT ablation prolonged the time to recurrence of VT in this cohort (Kuck 
et al. 2010). Amiodarone was used in around 35% of patients in each arm. At 2-year follow-
up, around 50% of patients in the ablation arm and 70% of patients in the control arm had a 
recurrence of VT however, suggesting that catheter ablation is insufficient as a stand-alone 
therapy in this cohort of patients.  
 
The VANISH trial investigated the role of catheter ablation versus an escalation of anti-
arrhythmic drug therapy in patients with ischaemic cardiomyopathy and an ICD in-situ who 
presented with recurrent VT. In this study, catheter ablation was associated with a lower rate 
of the primary composite end-point of death, VT storm or appropriate ICD shock versus an 
escalation of anti-arrhythmic drug therapy (Sapp et al. 2016). Around 65% of patients in 
VANISH were already on amiodarone at baseline, the mean LVEF was 31% in both arms 
and patients had to have either ≥3 episodes of VT treated with anti-tachycardia pacing, ≥1 
appropriate ICD shocks or ≥3 VT episodes within 24hrs at enrolment suggesting a higher-risk 
cohort compared to SMASH-VT. In these patients, catheter ablation clearly emerged as the 
favourable option over escalation of anti-arrhythmic medications.  
 
No improvement in all-cause or cardiovascular mortality has been demonstrated by any VT 
ablation clinical trial.  A recent meta-analysis of the main randomised trials in ischaemic 
cardiomyopathy found that the most consistent benefits of VT ablation was a reduction in 
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cardiovascular-related hospitalisations driven mainly by reductions in VT storm and ICD 
shocks (Maskoun et al. 2018). Although these trials were underpowered to detect a mortality 
benefit, the data highlights the need to improve the efficacy and safety of VT ablation.  
 
Clinical trials in VT ablation have proven to be difficult to perform with long enrolment 
periods, poor recruitment rates and high cross-over rates across study arms. During the course 
of long trials, iterative changes in ablation techniques, strategies and technologies have 
occurred making interpretation of trial results difficult (Mukherjee et al. 2017). There is also 
significant heterogeneity within trials regarding the mapping and ablation strategy - ablation 
being guided by either entrainment and activation mapping, pace-mapping or substrate-based 
strategies. The definition of acute procedural success also varies between trials with some 
studies targeting the clinical VT alone and defining success with non-inducibility of the 
clinical VT whilst others have targeted all inducible VTs or used a substrate-based strategy. 
The reproducibility of programmed stimulation to induce VT itself is variable. Even with 
substrate-based approaches, some approaches are considered complete and require extensive 
ablation (e.g. scar homogenisation) where the end-point may be anatomical or incomplete 
substrate modification strategies (e.g. core isolation) where isolation of segments may be 
demonstrated by the presence of exit block during pacing from within the isolated segment. 
 
Optimal ICD programming protocols have also changed over time with high-rate therapy and 
delayed ICD therapy associated with reduced episodes of inappropriate therapy and all-cause 
mortality compared to conventional programming (Moss et al. 2012).  More recently, the 
Substrate Modification Study (SMS) with contemporary ICD programming, randomised 
patients with ischaemic cardiomyopathy to catheter ablation plus ICD implantation versus 
ICD implant alone. There was a failure to meet the primary end-point of time to first VT 
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recurrence but catheter ablation did reduce the total number of ICD therapies during a follow-
up of 2.3 ± 1.1 years (Kuck et al. 2017).  
 
There is some evidence that patients are referred for catheter ablation late in the disease 
process. The CALYPSO pilot trial found that when screening patients into a trial of ablation 
versus anti-arrhythmic medications, around 41% of patients had already failed anti-
arrhythmic therapy prior to consideration of catheter ablation (Al-Khatib et al. 2015). A 
recent European Heart Rhythm Association (EHRA) survey found that around 62% of 
centres would perform ablation after the first episode of monomorphic VT in patients with 
ischaemic cardiomyopathy (Tilz et al. 2018); in non-ischaemic cardiomyopathy, catheter 
ablation was used first-line in around 37%. A meta-analysis investigating the impact of early 
versus late referral for VT ablation suggested reduced VT recurrence and acute complications 
with early referral in patients with structural heart disease but no differences in total mortality 
and acute success (Romero et al. 2018).  
 
As a consequence of the limitations to arrhythmia mechanism-directed RF energy delivery in 
the management of VT, there is increasing interest in substrate-based approaches that target 
the entire abnormal substrate. An extensive ablation strategy to homogenise scar and target 
any abnormal potentials in sinus rhythm was found to be superior to reduce VT recurrence 
compared to an approach where limited ablation of clinical VTs was performed in the multi-
centre VISTA trial (Di Biase et al. 2015). A meta-analysis investigating ablation strategy in 
patients with structural heart disease found that substrate modification was associated with a 
lower composite end-point of ventricular arrhythmia recurrence and all-cause mortality 
compared to standard ablation of stable VTs (43% relative risk reduction). Additionally, 
complete substrate modification (e.g. scar homogenisation) was associated with a lower 
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recurrence compared to substrate-based approaches with incomplete modification (e.g. core 
isolation) (Briceno et al. 2018).  
 
Scar dechanneling whereby the channels of ‘slow conduction’ within the abnormal substrate 
have been uncovered through physiologic manoeuvres and targeted with catheter ablation to 
connect regions of electrically unexcitable scar has also been used to achieve acute 
procedural non-inducibility and reduce VT burden during follow-up (Soejima et al. 2002). 
Recently, characterisation of scar channels from LGE-MRI based on pixel signal intensity 
thresholds has been integrated into the navigation system for VT ablation. Interestingly, a 
lower need for RF delivery, higher non-inducibility rate and improved VT-free survival was 
demonstrated using MRI-guided scar dechanneling compared to conventional ablation in a 
non-randomised study (Andreu et al. 2017). Such an approach highlights the potential value 
in using a structural-based approach to target segments of myocardium responsible for VT 











2 Magnetic resonance imaging 
This chapter discusses the principles of magnetic resonance imaging, its role in the non-
invasive characterisation of the underlying substrate responsible for ventricular arrhythmias 
and assessment of ablation lesions. The field of interventional magnetic resonance is also 
introduced and the technical aspects of performing electrophysiology procedures inside a 




Magnetic resonance imaging (MRI) is a non-invasive imaging modality that allows 
comprehensive assessment of cardiac anatomy and function. In addition, tissue 
characterisation techniques including contrast-enhanced MRI can be used to characterise 
myocardial scar and differentiate between disease processes (Ambale-Venkatesh and Lima, 
2015). MRI can also enable the online monitoring of temperature in different tissues as the 
magnetic properties of water protons are temperature-dependent (de Senneville et al. 2012), 
thereby permitting direct visualisation of RF-induced thermal injury.  
 
As noted in the previous chapter, VT in the presence of structural heart disease frequently 
involves re-entry around or within a region of ventricular scar. The presence of late 
gadolinium enhancement (LGE) on MRI may identify the fibrotic substrate of VT (Ashikaga 
et al. 2013) whilst regions of intermediate signal intensity between scar tissue and normal 
myocardium have been histologically validated as scar borderzone (BZ) (Pop et al. 2013) 
which may represent the imaging equivalent of slowly conducting tissue. Scar and scar BZ 
are 3D structures - LGE-MRI is the best available non-invasive technique to define these 
structures in 3D and is a powerful predictor of ventricular arrhythmia risk (Disertori et al. 
2016).  
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There are a number of potential benefits that the use of MRI in general and interventional 
MRI, in particular, could offer the electrophysiologist during VT ablation including 
assessment of structural substrate to complement functional electrophysiological assessment, 
accurate tracking of catheters to improve intra-procedural guidance and evaluation of ablation 
lesion formation with soft tissue visualisation (Mukherjee et al. 2019).  This chapter explores 
the basic principles of MRI, image reconstruction and pulse sequences. The application of 
MRI for scar assessment, temperature mapping and interventional procedures is also 
discussed.  
 
2.2 MRI physics 
 
2.2.1 Nuclear magnetic resonance phenomenon 
 
The primary source of the MR signal for imaging applications is the hydrogen atom 
consisting of a single positively-charged proton surrounded by a single negatively-charged 
electron. Hydrogen nuclei (1H) are abundant in water and fat within biological tissues and is 
ideally suited for MR imaging. Each nuclei with an odd mass (e.g. 1H) possesses a basic 
quantum mechanical property termed ‘spin’ which is a representation of intrinsic angular 
momentum. The spin of the positively-charged proton (1H) generates a small magnetic field 
and a magnetic moment. For a 1H nucleus, there are two possible spin states (i.e. direction of 
the angular momentum), e.g. ‘spin-up’ or ‘spin-down.’  
 
Conventionally, magnetic moments are randomly orientated but following the application of 
an external magnetic field (B0), magnetic moments align either with or against B0. Depending 
on the orientation of the spin states against B0, a difference in energy levels may occur (spin-
up = lower energy state; spin-down = higher energy state). The energy gap between the two 
spin states is related to the magnetic field strength and the gyromagnetic ratio (constant 
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specific to a particular atomic nucleus). At body temperature, the number of spins in each 
state are almost equal with a slight excess in the lower energy (spin-up) state. The excess of 
these proton magnetic moments can be combined to give the net magnetisation vector which 
at equilibrium is parallel to B0 (z-axis) and is given the value M0. When particles are placed 
within a static external magnetic field, they experience a force perpendicular to the 
orientation of angular momentum resulting in a circular motion termed ‘precession’. The 
precession frequency of a nucleus is proportional to the strength of B0 and the gyromagnetic 
ratio and is described in the Larmor equation: 
 
Equation 1: Larmor equation: 𝜔0 = 𝛾B0 
 
where 𝛾 is the gyromagnetic ratio (42.6 MHz/Tesla for 1H) and 𝜔0 is the Larmor frequency 
(which at 1.5T is 64MHz).  
 
2.2.2 Radiofrequency (RF) excitation 
 
In order to perform magnetic resonance imaging, the net magnetisation is displaced out of its 
alignment with B0 through the application of additional oscillating time-varying RF pulses 
(B1) perpendicular to B0. The B1 field can be produced by driving an electrical current 
through RF transmit coils. In order to flip the net magnetisation of the nuclear spins, B1 is 
applied at the Larmor frequency which enables spin transitions from low energy to high 
energy states resulting in excitation. The amplitude and duration of the RF pulse determines 
the degree of rotation of net magnetisation and is termed the ‘flip angle’. Following 
application of the RF pulse, net magnetisation can be split into two components - the 
longitudinal component that lies parallel to the z-axis (Mz) and the transverse component that 
lies perpendicular to the z-axis and within the plane of the x and y axes (Mxy).  
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Spin-echo based pulse sequences are initially preceded by a 90o RF excitation pulse that 
transfers M0 into the transverse plane leaving no component in the z-axis. This is followed by 
a 180o refocusing pulse which reverses the dephasing of spins due to B0 field inhomogeneity. 
If the RF excitation pulse leaves some component of net magnetisation in the z-axis and only 
transfers a proportion into the transverse plane, a lower flip angle is produced (<900) - this is 
typically used to generate the signal in gradient echo pulse sequences. A 180o pulse can also 
be used to flip M0 perpendicular to B0 prior to the application of an excitation pulse and is 
known as an inversion pulse - these are typically used in inversion recovery pulse sequences. 
Following cessation of the RF excitation pulse, the transverse magnetisation induces a current 




The process by which thermal equilibrium is re-established following the termination of a RF 
excitation pulse is termed relaxation as high energy protons decay back to low energy states. 
The time taken for decay of the z component of the net magnetisation (longitudinal 
relaxation) to reach 63% of its equilibrium value is defined as the T1 time. The time taken for 
decay of the xy component of net magnetisation (transverse relaxation) to 37% of its 
equilibrium value is defined as the T2 time. Both T1 and T2 relaxation are a function of the 
size and motion of the molecule upon which the 1H nucleus resides and therefore vary 
according to the tissue type, e.g. liquids (water/cerebrospinal fluid) have longer T1 and T2 
values than dense solids (fat). This information can therefore be used for tissue 
characterisation during imaging.   
 
As noted earlier, following cessation of the RF excitation pulse, transient fluctuations in coil 
voltage are created. This signal is called free induction decay (FID) which is produced as the 
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net transverse magnetisation decays as proton magnetic moments move out of phase to one 
another. The FID signal is a combined effect of T2 relaxation and additional de-phasing 
caused by inhomogeneity in the applied magnetic field - a process called T2*-decay. Pulse 
sequences used in MRI are manipulations of the FID signal involving application of 
dephasing and rephasing gradients to create calibrated changes in local magnetic fields and 
alter the Larmor frequency in a given direction. This results in ‘echoes’ that are used to 
measure, localise and encode MR signals in space.  
 
2.3 Pulse sequences 
The most common types of echoes used in MR pulse sequences are spin echoes and gradient 
echoes. Balanced steady-state free precession (bSSFP) sequences are created from a 
combination of spin echo and gradient echo. In general, without the application of pre-pulses, 
gradient echo and bSSFP sequences are bright-blood whilst spin echo sequences are black-
blood. During application of multiple RF pulses, the time interval between the centre of the 
RF pulse and the resulting echo is called the echo time (TE) whilst the time interval between 
successive excitation pulses is called the repetition time (TR). The common pulse sequences 
used in cardiac MRI are described in the section below.   
 
2.3.1 Spin echo 
 
A spin echo sequence is generated through the application of successive pulses - a 90o 
excitation pulse followed by a 180o refocusing pulse. After the 90o pulse, net magnetisation is 
tipped into the transverse plane; due to magnetic field inhomogeneities, individual protons 
precess at different rates causing dephasing. The 180o pulse, rephases these protons causing 
the FID to increase in amplitude (initial FID decays as a function of T2* but the 180o pulse 
rephasing results in an echo amplitude that is T2 weighted). The signal that rephases 
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following the 180o pulse is knows as a spin echo. Adjustment of the TE and TR allows 
images with different contrast weightings to be obtained.  
 
2.3.2 Gradient echo 
 
A gradient echo (GRE) signal is initiated with a single RF pulse which typically uses a flip 
angle <90o with a smaller degree of transverse magnetisation, but can have any value. 
Following the RF pulse, a FID signal is generated. An external magnetic field ‘gradient’ is 
then applied (causing a calibrated change in local magnetic field) leading to proton spins 
losing coherence and leading to a dephasing of transverse magnetisation and accelerated 
decay of the FID signal. A second gradient then reverses the phase shift to recover the FID 
signal and create the ‘gradient echo.’ GRE imaging is generally faster than spin echo 
sequences as only one RF pulse is applied and therefore TE is shorter. A low flip-angle 
excitation pulse can also allow for a short TR thereby enabling rapid imaging acquisitions.  
 
Whilst each RF pulse in a GRE sequence generates a FID signal, each pair of RF pulses 
generates a spin echo. If the TR is shorter than the T2 time, the FID signal persists as the 
‘echo’ component starts. The application of gradients can preserve or suppress either the FID 
or echo signals depending on the time, duration or strength of application. GRE sequences 
that aim to preserve coherence are called coherent GRE sequences whilst sequences that 
apply a gradient to dephase residual transverse magnetisation (spoiler gradients) are known 
as spoiled GRE.  
 
2.3.3 Balanced steady-state free precession (bSSFP) 
 
As noted above, a FID signal will occur after each RF pulse and a spin echo after successive 
pulses. However, if the TR between pulses is less than T2, transverse magnetisation will not 
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fully dephase and the signal from the FID and echo will merge. A pulse sequence where 
residual transverse magnetisation remains between RF pulses is known as steady state free 
precession (SSFP) - i.e. a type of coherent GRE sequence. Dedicated dephasing and 
rephasing gradients can then be used to refocus the FID and/or echo components of the 
signal. bSSFP sequences uses balanced gradients along the x, y and z axes that refocuses both 
the FID and echo components into a single echo. The result is higher signal-to-noise ratio 
(SNR) as the entire magnetisation vector is utilised to produce the signal and good contrast 
between blood and myocardium leading to its use as the work-horse of cardiac imaging.   
 
2.3.4 Inversion recovery pulse sequences 
 
A pre-pulse where longitudinal magnetisation (Mz) is inverted by a 180o pulse prior to the 
spin echo/gradient echo sequence is known as inversion recovery. The time delay between 
the 180o inversion pulse and the first RF excitation pulse is known as the inversion time (TI). 
After the application of the inversion pulse, the inverted tissue undergoes T1 relaxation 
during the TI interval. Different tissues will have varying T1 relaxation times. Therefore, 
altering the TI interval allows image contrast between tissues to be generated. In order to 
generate the MR signal (readout), the inversion recovery pre-pulse can be combined with 
additional pulses and associated gradients (e.g. spin echo, gradient echo or bSSFP) which 
may further produce a range of image contrasts.   
 
Inversion pulse application allows selective tissue suppression and is widely used in cardiac 
imaging. Following the inversion of longitudinal magnetisation of tissue, there is gradual 
recovery of magnetisation. If the TI is set a specific value, tissues with a longitudinal 
magnetisation of zero will have no signal at that time interval and will be ‘nulled.’ Inversion 
recovery pre-pulses are typically used in late gadolinium enhancement (LGE) imaging 
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whereby the paramagnetic molecule, gadolinium, which shortens T1 time, is used to 
differentiate between normal and pathological myocardium due to its delayed wash-out from 
the expanded interstitial space in pathological conditions (e.g. myocardial infarction).  
 
2.4 Slice selection, spatial encoding and image reconstruction 
 
2.4.1 Slice selection 
 
A combination of RF excitation pulses and gradient fields are used to initiate the image 
formation process and localise the MR signal in three dimensions. In order to selectively 
excite a slice of tissue, a gradient field (slice selection gradient - Gs) is applied during RF 
pulse transmission. Resonance of protons will only occur when the frequency of the RF pulse 
matches the Larmor frequency at a given position along the direction of the gradient. This has 
the effect of only selectively exciting protons which are perpendicular to the direction of 
gradient applied and therefore determines the slice of tissue which has been excited. The RF 
pulse is usually transmitted as a small range of frequencies (bandwidth) which defines the 
slice thickness.  
 
2.4.2 Phase encoding 
 
A second gradient called the phase encoding gradient (Gp) is then applied which temporarily 
alters the precession frequency of protons. As the magnetic field strength varies in various 
parts of the body, the application of Gp leads to a change in the relative phase of protons 
dependent on their position along the gradient. This allows the spatial position of protons to 
be mapped according to the phase differences of transverse magnetisation.  
 
2.4.3 Frequency encoding 
 
A third gradient called the frequency encoding gradient (Gf) is then applied in a direction 
perpendicular to the phase encoding gradient and alters the homogeneity of the main 
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magnetic field in a calibrated way. Similar to the phase encoding gradient, the frequency 
encoding gradient alters the precession of protons according to their position along the 
direction of Gf so that resonant frequency is changed as a function of spatial position.  
 
In combination, Gs, Gp and Gf allow 3D localisation of the MR signal by selecting a given 
slice and creating a phase shift along a particular axis and a frequency shift along a 
perpendicular axis in that slice.  
 
2.4.4 Image reconstruction 
 
A 2D image can be decomposed into sine waves which vary in frequency, amplitude, phase 
and direction. Spatial encoding using phase and frequency encoding enables an image to be 
recorded in this way and the resulting data points representing amplitudes and phases are 
recorded in a raw data matrix known as k-space. Image space comprised of all pixels that 
make up an image and k-space are inversely related. Within image space, all MR signals that 
have been phase and frequency encoded may contribute to a pixel which is part of that image 
space. Within k-space, each point of the MR signal occupies a particular location - i.e. each 
point in k-space represents the degree of spatial frequency contained in the image pixel 
(Ridgeway, 2010). In order to create an image pixel map from the frequency and phase 
information, a mathematical transformation (Fourier transformation) is required to decode the 
signals and reconstruct the final image.  
 
2.5 Scar imaging with late gadolinium enhancement 
 
2.5.1 Contrast-enhanced imaging 
 
Contrast-enhanced imaging following intravenous administration of contrast agents 
containing complexes of the small paramagnetic molecule, gadolinium is widely used in 
cardiac MRI. Gadolinium shortens T1 values in tissue where it accumulates. Following 
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administration, gadolinium is transferred from the intravascular space to the interstitial/extra-
vascular space. Wash-out of gadolinium-based agents are dependent on renal clearance. In 
normal cardiac tissue, there is a rapid wash-in and wash-out phase. In abnormal tissue such as 
scarred myocardium (e.g. following myocardial infarction), the interstitial space is expanded 
and therefore gadolinium accumulates in this space and exhibits a delayed wash-out phase.  
 
In order to identify abnormal tissue with gadolinium accumulation, late gadolinium 
enhancement (LGE) sequences are used which are T1-weighted pulse sequences preceded by 
an inversion recovery pulse. Signal from abnormal tissue has a bright signal on T1-weighted 
images. A TI is chosen where signal from normal myocardium is suppressed (nulled) thereby 
maximising the contrast between normal and scarred/fibrotic myocardium. A number of 
factors can affect the optimal nulling of myocardium including the time from contrast 
injection to acquisition, MR field strength, type of contrast agent, dose and pulse sequence 
used for image read-out.  
 
Conventionally, LGE imaging is performed 5-15 minutes following administration of 
contrast with a maximal dose of 0.2mmol/kg. After this period of time, the TI in both blood 
pool and myocardium increase as gadolinium wash-out occurs and therefore, conventionally, 
there is a narrow window to perform imaging and discriminate between normal and abnormal 
tissue. In this thesis, a technique to maintain the blood and myocardial TI in a steady-state 
through the application of a slow continuous infusion of gadolinium is presented to enable 
higher resolution scar imaging and compare different contrast-enhanced pulse sequences to 
identify the optimal method of substrate assessment. The slow infusion of continuous 
gadolinium to achieve ‘contrast steady-state’ was first applied to quantify diffuse myocardial 
fibrosis (Flett et al. 2010).  
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2.5.2 2D vs 3D imaging 
 
The reference LGE exam most commonly used for myocardial scar imaging is a 2D IR GRE 
sequence which is acquired using multiple breath-holds. During 2D imaging, tissue within a 
2D plane is excited during each breath-hold and a stack of multiple 2D images within a 
region of interest are acquired to create a 3D volume. In 3D imaging, an entire slab of tissue 
is excited and imaged. 3D imaging generally provides a better spatial resolution, signal-to-
noise ratio (SNR) and can be acquired with an isotropic resolution facilitating multi-planar 
reconstruction of images to aid interpretation. However, 3D imaging can require prolonged 
scan times during free-breathing acquisitions whilst both cardiac and respiratory motion, 
without correction, can corrupt the entire acquisition.  
 
For assessment of myocardial infarcts, 3D LGE can visualise scar with a better SNR and 
greater image sharpness demonstrating the complexity of heterogenous scars (Peters et al. 
2009) compared to 2D LGE. For routine diagnostic purposes, conventional 2D LGE may be 
sufficient but a higher spatial resolution will allow an improved assessment of scar 
morphology and peri-infarct tissue, which may be required to define ablation targets for VT 
ablation. Isotropic 3D LGE imaging will also allow for reconstruction and multi-planar 
reformatting in any imaging plane, further allowing assessment of scar tissue in different 
views and therefore aid the identification of channels of tissue that may be important in the 
maintenance of VT (Basha et al. 2017).  
 
2.5.3 Pulse sequence techniques for LGE imaging 
 
A number of approaches alternative to standard 2D IR GRE have been investigated for LGE 
scar imaging including phase sensitive inversion recovery (PSIR) reconstruction where the 
polarity of Mz is taken into account in addition to the magnitude of Mz (Kellman et al. 2002) 
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and reduces the variation in image quality related to selection of the optimal TI. Additional 
approaches include 3D LGE to improve spatial resolution and assessment of scar 
heterogeneity (Basha et al. 2017) and dark-blood LGE using an inversion pulse followed by 
T2 magnetisation preparation to simultaneously reduce normal myocardium and blood pool 
signal intensity and increase scar-blood contrast whilst preserving scar-myocardium contrast 
(Basha et al. 2018). Different pulse sequence read-outs after the inversion pulse (GRE vs 
SSFP) can also impact the visualisation of the infarct-blood boundary (Detsky et al. 2007).  
 
Some investigators have performed head-to-head comparisons of LGE sequences to 
determine the optimal imaging method for different applications. An improved contrast-to-
noise ratio (CNR) and qualitative image quality was reported in ischaemic cardiomyopathy 
patients using a 3D IR GRE technique compared to other breath-hold and free-breathing 2D 
and 3D techniques (Viallon et al. 2011). Similarly, in patients with structural heart disease 
referred for VT ablation, an improved matching to EAM-defined scar was reported using scar 
reconstruction following a 3D IR GRE sequence compared to 2D IR GRE and a 2D IR SSFP 
sequence (Andreu et al. 2015).  
 
However, given that the wash-in and wash-out kinetics of gadolinium following a single 
bolus will change the TI during extended scar imaging, it is difficult to be certain that 
consistent contrast distributions are present during comparison of multiple sequences. To 
identify the regions of tissue responsible for VT, high-resolution isotropic imaging is required 
which require prolonged scan times, during which TI may vary significantly. In this thesis, 
the use of contrast steady-state is applied to compare post-contrast sequences in an 
experimental model with consistent contrast conditions to determine the optimal imaging 
technique for 3D scar assessment.  
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2.5.4 Motion compensation for cardiac and respiratory motion 
 
Motion due to cardiac contraction or breathing can cause significant artifacts and result in 
blurred images affecting image quality. Broadly speaking, synchronisation with the cardiac 
cycle through the use of surface ECG electrodes is mandatory to account for cardiac motion. 
The peak of the R-wave of the ECG can be used as the reference to synchronise the MR 
sequence with the cardiac cycle. Following this, prospective gating can be applied, where 
data is acquired during a specific acquisition window within the R-R interval and images 
reconstructed. Alternatively, retrospective gating, where data is acquired continuously and 
subsequently re-ordered according to the phase of the cardiac cycle, can be used to 
reconstruct images and correct for cardiac motion.  
 
A number of techniques may be used to account for respiratory motion. The most 
straightforward approach is to acquire images during patient breath-holds. A 10-20s breath-
hold is typically used at end-expiration to acquire all the data required to reconstruct the 
image at a time when diaphragmatic motion is minimal.  Following a period of rest, the cycle 
is repeated to acquire consecutive slices.  
 
For patients unable to hold their breath or 3D scans that require prolonged imaging times, 
free-breathing acquisitions are necessary. A respiratory navigator beam can be used to enable 
either prospective or retrospective respiratory gating. The navigator is placed on the 
diaphragm over the lung-liver interface to detect motion of the lungs given that most of the 
motion is in the foot-head direction. A pre-pulse, called a navigator echo, is used before 
and/or after the image sequence to locate diaphragm position along the direction of the 
navigator beam. The signal from the navigator echo are displayed in columns or lines to 
measure respiratory motion through the duration of the sequence. A pre-defined gating 
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window is used to accept or reject data depending on whether the diaphragm was in the given 
window during the respiratory cycle, thereby accepting data only during a still period in the 
cycle (Lombardi et al. 2018) - Figure 2-1.  Single-shot acquisition techniques are also 
possible where all required data are acquired during a single heart beat and phase of the 
cardiac cycle. The 3D imaging sequences described in this thesis were acquired during free-
breathing using prospective respiratory gating.  
 
 
Figure 2-1: Respiratory navigator acceptance window 
 
2.5.5 Analysis and post-processing: core scar and borderzone assessment  
 
There are a number of imaging features that can be extracted from LGE-MRI that could be 
used to delineate the regions of tissue associated with VT substrate including pixel signal 
intensity, scar transmurality or tissue thickness and entropy of scar. Spatially complex scar 
containing a mixture of viable myocardium and electrically-inert scar is thought to represent 
the substrate for re-entrant VT. Critical isthmus and ablation termination sites have been 
localised to peri-infarct tissue, defined as regions of dense scar-borderzone transition on MRI 
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and in regions of scar with >75% transmurality (Piers et al. 2014). Scar heterogeneity with 
intermediate grades of viable tissue on MRI has been reported to be present at sites 
containing the critical isthmus for VT (Ashikaga et al. 2007) whilst successful ablation of 
heterogenous tissue has been associated with non-inducibility of VT in an animal model 
(Estner et al. 2011). 
 
Tissue characterisation algorithms based on pixel signal intensity have been used to define 
tissue as either binary (scar or normal myocardium) or ternary (dense scar, borderzone tissue, 
normal myocardium). These include the full-width at half maximum (FWHM) method 
whereby manual delineation of a region of interest (ROI) around a region of hyper-intense 
(scarred) myocardium is selected. The signal intensity at 50% of this value is then used as the 
threshold to define scar. Other approaches for scar quantification include the n-standard 
deviation (SD) method whereby a ROI in the remote (normal) myocardium is selected. 
Thresholds can then be selected based on pixel signal intensity values at 2-SD, 3-SD, 4-SD, 
5-SD or 6-SD to define scar. Manual quantification of scar has also been applied based on 
image segmentations. There is however no agreement on the optimal method or thresholds to 
categorise scar (Sramko et al. 2019) or any validation of the extent of borderzone tissue and 
dense scar in large animal models quantified from MRI using whole-mount histology (Pop et 
al. 2013).  
 
LGE dense scar and borderzone volume can vary significantly depending on the method used 
for quantification. Borderzone volume can be 2-3 fold higher using FWHM vs n-SD methods 
whilst dense scar values are higher using the n-SD method of quantification (Mesubi et al. 
2015). The FWHM technique appears to be the most reproducible however with the lowest 
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intra-observer and inter-observer variability (Flett et al. 2011). Differences in MR sequences 
could also lead to variability in VT substrate identification (Andreu et al. 2015).  
 
Recently, there has been interest in scar entropy, as a measure of tissue inhomogeneity which 
is independent of signal intensity thresholds to differentiate arrhythmogenic from non-
arrhythmogenic scar. High entropy within scar has been associated with an increased risk of 
ventricular arrhythmias (Androulakis et al. 2019; Gould et al. 2019).  
 
There are limitations in using imaging to define the critical regions of tissue responsible for 
VT - recently, high-resolution activation mapping data in a porcine infarct model has 
demonstrated the importance of functional block in defining the borders of a VT isthmus 
(Anter et al. 2016). Furthermore, a limited specificity of voltage and electrogram 
characteristics in sinus rhythm have been demonstrated (Anter et al. 2018) suggesting that 
imaging structural characteristics alone (where there is no equivalent of an electrical ‘stress 
test’) are unlikely to identify the optimal sites for ablation. Limitations in the image 
resolution of current clinical scans (1.4mm3, as reported in Andreu et al. 2015) can also lead 
to partial volume effects that may overestimate the volume of heterogenous tissue (Schelbert 
et al. 2010).  
 
2.5.6 Developments in magnetic resonance techniques to improve substrate assessment 
Acquisition of high-resolution imaging is required to detect smaller regions of scar and 
improve assessment of scar geometry in patients undergoing VT ablation (Basha et al. 2017). 
3D LGE imaging can allow acquisitions with a higher spatial resolution compared to 2D 
LGE but requires prolonged scan durations. Longer scans can lead to changes in contrast 
agent concentration over time or reduced respirator navigator efficiency due to irregular 
 66 
breathing patterns (Basha et al. 2017). The use of image acceleration techniques such as 
compressed sensing has enabled faster acquisition of 3D imaging of higher spatial resolution 
(1.2mm3) with acceptable scan duration, image quality and comparable scar characteristics to 
conventional 3D LGE (Basha et al. 2017). Parallel imaging with a stack-of-spirals acquisition 
technique has also been used to enable rapid 3D LGE acquisitions in a 12 heart beat-long 
breath-hold (Shin et al. 2014). 3D free-breathing self-navigating MR sequences have recently 
been described to overcome the errors associated with respiratory navigator placement and 
irregular breathing patterns enabling high-resolution visualisation of scar distribution and 
superior delineation of scar borders (Rutz et al. 2016). A new technique to reconstruct a high 
resolution image from multiple low resolution views of the same volume (super-resolution 
reconstruction - SRR) has also shown a good agreement with the bipolar voltage range of 
scar borderzone (Dzyubachyk et al. 2015). Further developments in these techniques may 
allow faster imaging with higher spatial resolution and advance the ability of clinical MRI 
protocols to identify areas of scar critical for re-entrant VT circuits.  
The development of dark-blood LGE (DB-LGE) sequences as a technical solution to sub-
optimal contrast between scar and blood pool offers promise for improved substrate 
assessment. DB-LGE sequences have been described that simultaneously reduce normal 
myocardium and blood pool signal intensity whilst enhancing scar-blood contrast and 
preserving scar-myocardium contrast (Basha et al. 2018; Kellman et al. 2016). Given that a 
large proportion of VTs appear to originate in the sub-endocardial region (Tschabrunn et al. 
2016), improved contrast between scar and blood pool may improve the detection of 
substrate in these areas.  
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2.6 Temperature mapping 
 
Tissue temperature distribution can be estimated using MRI as several MR parameters are 
temperature-dependent.  Intrinsic tissue magnetic properties such as the T1/T2 relaxation 
time, proton density, diffusion co-efficient, magnetisation transfer and proton resonance 
frequency (PRF) are sensitive to changes in temperature (Reike V et al. 2008). In cardiac RF 
ablation, due to the need for real-time application with fast imaging sequences, reduced 
sensitivity to motion, tissue independence, good temporal and spatial resolution, the PRF 
method for temperature mapping has been the most widely used for assessment in preference 
to other techniques.  
 
2.6.1 MR-thermometry with the PRF-shift technique 
 
The resonance frequency of water protons is temperature-dependent (de Senneville et al. 
2012) which is thought to be due to the result of rupture, stretching or bending of hydrogen 
bonds proportional to changes in temperature (Ishihara et al. 1995). PRF-shift based 
thermometry computation can be derived directly from the MR spectra or phase mapping. 
For phase mapping, relative temperature changes (∆T) can be calculated via differences in 
phase measurements to a reference phase at a given temperature as follows (Winter et al 
2016): 
 
Equation 2: PRF shift equation: 
  
 
where 𝛾 is the gyromagnetic ratio, TE is the echo time, α is the temperature dependent 
chemical shift of water (~0.009-0.01 ppm/oC, apart from in adipose tissue), B0 is the static 
magnetic field strength and ∆ φ is the phase variation.  
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A GRE sequence is most commonly used to compose temperature maps using gradient 
echoes with a long TE with optimisation to ensure adequate spatial and temporal resolution 
and good SNR. A series of reference images are initially acquired prior to RF ablation to 
derive phase of the baseline image. During and following RF ablation, further phase images 
are acquired. The phase variation is then subtracted to facilitate PRF shift computation and 
obtain measurements of tissue temperature in each individual pixel of the resulting image 
(Reike et al. 2008).  
 
There are a number of technical issues that can affect the accuracy of PRF-based 
thermometry including variations in B0 during the course of RF ablation, a small degree of 
tissue dependence of the chemical shift and temperature-dependent changes in the relative 
permittivity and electric conductivity of tissue which can affect the phase velocity (Winter et 
al. 2016). In addition, issues with motion (both cardiac and respiratory) is a ubiquitous 
problem for temperature mapping in the heart. Artifacts can be present due to inter-scan 
motion (PRF-shift with phase mapping is dependent on acquisition of reference scans prior to 
ablation and during ablation) and intra-scan motion causing blurring or object ghosting 
(Reike et al. 2008). Physiological motion can lead to important errors during estimation of 
tissue temperature and require correction (Mukherjee et. al. 2019).  Strategies for motion 
management include the use of respiratory gating, motion detection and movement 
registration with navigator echoes, multiple reference acquisitions to sample periodic changes 





The relationship between temperature elevation and tissue destruction is complex. The 
volume of tissue necrosis following delivery of RF ablation is not easily calculated and a 
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number of techniques to estimate lesion size derived from tissue temperature and duration of 
exposure to ablation have been described. In cardiac RF ablation, the calculation of thermal 
dose (MR-dosimetry) has been applied to determine when target tissue destruction has been 
achieved using an integral of temperature elevation and time to derive the thermal dose as 
follows (Mukherjee et al. 2018; Toupin et al. 2017): 
 



























where T(t) represents absolute tissue temperature; the concept of cumulative equivalent 
minutes (CEM43) is applied whereby for each degree increase above 43oC, a 2-fold decrease 
in the time required for the tissue to be thermally destroyed (Chang, 2010) based upon 
experimental studies of tissue injury. When the thermal dose reaches a critical threshold 
(43oC for a duration of 240 min), the tissue destruction is believed to have occurred.  
 
Other approaches to quantify lesion volumes include the use of iso-temperature contours 
from the temperature profiles to delineate ablation lesion boundaries or utilising the 
Arrhenius equation to determine the relationship between tissue temperature, exposure time 
and tissue injury (Chang, 2010).  
 
MR-dosimetry can therefore be used to determine the end-point of ablation therapy. In this 
thesis, the use of MR-thermometry and dosimetry using CEM43 to derive the thermal dose, is 
applied to calculate lesion size when delivering both endocardial and epicardial RF ablation 
in the left ventricle, inside the MRI scanner.  
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The ability of cardiac MRI to characterise arrhythmia substrate, guide procedures and 
evaluate ablation lesions has inspired the development of interventional MRI within 
electrophysiology whereby mapping and ablation can be completed within the MRI 
environment. Although many investigators have integrated anatomical and scar data from 
pre-acquired MRIs into the navigation system during catheter ablation (Andreu et al. 2017; 
Zghaib et al. 2018) these techniques invariably result in registration errors of up to 3.5mm 
(Roujol et al. 2013). Additionally, conformational changes within cardiac chambers as a 
result of different loading conditions between the time of imaging and intervention as well as 
translational changes due to patient movement, cardiac and respiratory motion could all lead 
to discrepancies between structural data and electrical substrate with potential consequences 
for the efficacy of catheter ablation (Mukherjee et al. 2018). The mean maximum amplitude 
of cardiac and respiratory motion for example, during EAM has been estimated to be in the 
region of 10.2 ± 2.7mm and 8.8 ± 2.3mm respectively (Roujol et al. 2013). 
 
Interventional MRI offers a potential solution to overcome the limitations of image 
integration as well as utilise the benefits of MR-based catheter tracking and lesion assessment 
that can only be performed inside a MRI scanner (Chubb et al. 2017). Over the last decade, 
development of MR-conditional devices and imaging techniques have led to the application 
of interventional MRI in the setting of cardiac electrophysiology but a number of challenges 
have been identified. These include the recording of high quality electrograms in an 
environment with significant electromagnetic interference, the development of clinical-grade 
MR-compatible devices with similar physical capabilities as their conventional counterparts 
and establishing robust tools for real-time lesion assessment (Mukherjee et al. 2018). On a 
 71 
practical level, effective communication is difficult between team members in a noisy 
environment and novel workflows are evolving to accommodate this hurdle. 
 
From an imaging perspective, there are a number of specific of requirements for 
interventional MRI compared to diagnostic MRI including the need for faster image 
acquisition and reconstruction. There are various stages of an interventional MRI procedure 
including the acquisition of an anatomic procedural roadmap, catheter navigation during the 
procedure, lesion delivery and evaluation. Each stage requires sequences optimised for their 
specific purpose. For example, the ‘roadmap’ sequence will typically need to have a good 
spatial resolution for definition of anatomy but can have a low temporal resolution. 3D 
respiratory-navigated, ECG-gated GRE or bSSFP sequences with or without contrast have 
been used for this stage (Dukkipati et al. 2008). For catheter navigation, sequences with a 
high temporal resolution are required, typically at least 5-10 frames/second (Bhagirath et al. 
2015). Ablation lesion visualisation may use a combination of T1-weighted, T2-weighted, 
LGE or thermometry sequences to evaluate lesion composition, measure lesion size and 
evaluate oedema and necrosis.  
 
 
2.7.2 Technical issues: electrogram fidelity, devices and defibrillation 
 
Accurate recording and characterisation of both surface electrocardiogram (ECG) and intra-
cardiac electrograms (EGM) are an essential component of cardiac electrophysiology 
procedures. During catheter ablation of simple arrhythmias such as atrial flutter, 
demonstration of bidirectional conduction block created at the cavo-tricuspid isthmus and 
proven by sequential, timed EGM recordings made along the ablation line during coronary 
sinus pacing are necessary (Shah et al. 2000). For complex arrhythmias such as ventricular 
tachycardia, substrate-based mapping techniques rely on the correct identification of low 
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voltage regions, annotation of abnormal potentials and robust characterisation of electrogram 
morphologies (Josephson et al 2015).  
 
The MRI environment is considered relatively ‘hostile’ for the rigorous recording of EGMs 
as there are many sources of artifact that may distort signals. During MR scanning, RF pulses 
are deployed that are coupled with fast-switching magnetic gradients which can induce 
electromagnetic fields around the subject and create voltage artifacts on both the surface ECG 
and intra-cardiac EGMs (Oster et al. 2010). A second source of signal distortion is the 
magneto-hydrodynamic effect (MHD). The static magnetic field (B0) can lead to MHD 
voltages due to the flow of electrically charged blood particles through the aortic arch in a 
direction perpendicular to B0. MHD voltages are superimposed primarily during the S-T 
phase of the cardiac cycle (period of peak flow) and can have a similar frequency spectrum 
and magnitude to real electrogram signals - Figure 2-2 (Tse et al. 2014). The size of MHD 
voltages may also be affected by the heart rate as a different volume of blood may be ejected 
from the left ventricle - this may be relevant during EGM recordings in the context of 
tachycardia or pacing. A third source of artifacts are time-varying magnetic fields that 
provide position-dependent variation in MR field strength but can lead to induced electric 
currents in conducting tissues as well as connecting wires (Felblinger et al. 1999).   
 
Figure 2-2: Recording surface ECG and intra-cardiac EGMs inside a MRI scanner.  
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Significant distortions inside a MRI scanner can occur on both the surface ECG and during intra-cardiac EGM acquisition 
due to 1) Time-varying MR gradient fields 2) RF pulses during MR scanning that couple to conductive material (A) and 3) 
Magneto-hydrodynamic (MHD) voltages due to the static magnetic field (B). Noise filtering technologies are required to 
improve intra-cardiac EGM fidelity and reduce baseline noise (C and D). Reproduced with permission from Mukherjee et 
al. 2019; Current Cardio Imaging Reports.  
 
Following the application of a low-pass filter (300Hz), high-pass filter (30Hz), notch filter 
(60Hz) and RF filters to reduce the 64MHz signal from the MRI scanner, Nazarian et al. 
(2018) demonstrated the ability to record both atrial and ventricular potentials in normal 
canines and healthy patients including distinguishing small His potentials with good fidelity. 
Subsequent studies in patients with atrial flutter have shown that double potentials can be 
detected along and conduction detour around an ablation line (Hilbert et al. 2016; Chubb et 
al. 2017). An experimental study in an ovine model estimated that the peak-to-peak 
amplitude of baseline noise inside the MRI scanner (without scanning) is 10-fold higher than 
in a conventional X-ray fluoroscopy laboratory (0.10 vs 0.01 mV) whilst the signal-to-noise 
ratio (SNR) may vary depending on the MRI sequence used during scanning (Elbes et al. 
2017). In this study, a low-pass filter with a cut-off frequency of 120Hz gave the best quality 
EGM signals compared to filter cut-offs at 240 and 500Hz (Elbes et al. 2017). It remains 
unclear, however, whether low-amplitude abnormal potentials such as fractionated EGMs or 
late potentials with an amplitude <0.1mV can be detected robustly inside a MRI scanner with 
limited evidence available from one study (Oduneye et al. 2015). Although a lower value 
low-pass filter may give the best quality normal EGM signals, it may risk losing the fine high 
frequency components of abnormal EGMs that are important in substrate evaluation. Further 
developments in signal processing technologies are needed to improve EGM fidelity and 
there has been interest in the application of techniques such as adaptive noise cancellation 
(Wu et al. 2011) artefact modelling and Bayesian filtering for this purpose (Oster et al. 2010). 
The majority of patients who undergo VT ablation have an implantable-cardioverter 
defibrillator (ICD) in situ (Tilz et al. 2018). A number of potential adverse effects could 
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occur during MRI in patients with cardiac devices including device movement, induced 
current due to rapidly changing gradient magnetic fields, thermal injury with subsequent 
effects on the sensing and capture thresholds, activation of the reed switch as well as over-
sensing and power-on-reset due to electromagnetic interference (Blissett et al. 2018). 
Although the risks of adverse effects have been reported as low, including imaging with 
legacy ICD systems (Nazarian et al. 2017), concerns regarding radiofrequency-induced tissue 
heating and device failure and their potential impact during long procedures lasting several 
hours, as is often the case during VT ablation, remains. The presence of ICDs also leads to 
the generation of artefacts; although wideband LGE sequences have been reported to 
adequately suppress artefacts and preserve diagnostic image quality for LGE imaging 
(Ranjan et al. 2015; Do et al. 2018) this remains a challenge for real-time MRI-guided 
procedures. 
 
During VT ablation, haemodynamically unstable arrhythmias are often induced and may 
require immediate defibrillation. If defibrillation was required inside the scanner bore, the 
subject would have to be removed from the bore, the MR coil and any connecting wires or 
catheter instruments would have to be disconnected, the MRI table would need to be 
undocked, the subject evacuated outside the scanner room and connected to defibrillation 
pads. This process can be completed in around 60s with practice but nevertheless represents 
an unacceptable delay and could increase mortality (Schmidt et al. 2016). The inability to 
perform defibrillation inside a MRI scanner is a major safety hurdle and is a pre-requisite for 
clinical studies in patients. To date, there are only limited reports of prototype MRI-
conditional defibrillation systems to enable electrical defibrillation both inside and outside 
the scanner bore in swine (Schmidt et al. 2016).  
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2.7.3 MR-compatible devices and tracking methods 
 
Catheters used in the conventional electrophysiology laboratory typically incorporate ferrous 
components to grant the mechanical characteristics to enable torque transmission and 
navigation of tortuous structures. However, these materials can lead to large susceptibility 
artifacts inside a MRI scanner - although this phenomenon may be used during passive 
tracking, the susceptibility artifacts from conventional catheters can severely degrade image 
quality. Instead, materials that create a lower burden of artifacts are preferred including gold, 
titanium and nitinol with polyester braiding (Ratnayaka et al. 2008). The mechanical 
performance of MR-compatible catheters is not currently equivalent to their conventional 
counterparts and this has proven to be an obstacle to more widespread implementation of 
interventional MRI. The process of RF excitation during MRI can also lead to heating in 
conductive materials such as wires and transmission lines and make them inherently unsafe 
requiring re-design of the devices themselves.  
 
There are two principle methods of intra-procedural guidance during interventional MRI - 
active and passive catheter tracking. Passive catheter tracking enables either positive or 
negative contrast visualisation by integration of susceptibility artefacts generated from 
ferromagnetic/paramagnetic materials embedded within a catheter (Grothoff et al. 2014) or 
using gadolinium or CO2/N2O-filled balloon catheters (Ratnayaka et al. 2013). Typically, 
during passive tracking an in-plane resolution of around 1mm, slice thickness of 6mm and 
temporal resolution of 4 frames/second has been reported (Nordbeck et al. 2013). Tip 
tracking accuracy using gadolinium-filled balloon catheters has been estimated to be in the 
region of ± 0.41mm with imaging reconstructions displayed at a frame rate of around 3 
frames/s (Omary et al. 2000). Recently, application of a positive-contrast based passive 
tracking sequence using partial saturation magnetisation preparation has been shown to 
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provide improved simultaneous visualisation of both anatomy as well as gadolinium-filled 
catheters (Velasco-Forte et al. 2017). However, susceptibility artefacts during passive 
tracking can make devices with ferromagnetic/paramagnetic materials appear larger than 
their actual size as well as potentially obscure surrounding tissue. Furthermore, with all 
passive tracking techniques, if the device moves out of the imaging plane, the operator is 
required to relocate the device which can be time-consuming (Campbell-Washburn et al. 
2017). It is also more difficult to track catheters within the expansive 3D space of cardiac 
chambers compared to in-plane tracking within the lumen of a vessel (e.g. aorta).  
 
Active catheter tracking is an alternative technique whereby micro-coils embedded within the 
catheter produce a receiver signal to determine location of the device - Figure 2-3. An active 
tracking sequence consisting of intermittent non-selective excitations combined with spatially 
encoding gradients enable measurement of 1D projections in each space dimension and 
estimation of the 3D coordinates of the position of the micro-coils (Chubb et al. 2017; 
Daniels et al. 2016). Real-time estimates of the position of micro-coils can be used to 
estimate catheter tip orientation. This information can also be used for real-time slice tracking 
to automatically maintain the catheter tip in the imaging plane during navigation (Chubb et 
al. 2017). The precision of active tracking during ex-vivo technical validation experiments 
has been estimated to be in the region of 0.90 ± 0.58mm along the axis of the catheter whilst 
the angular deviation of catheter orientation from its true direction was 8.50 ± 3.60 (Chubb et 
al. 2017). Active tracking has been used to perform coronary sinus intubation, activation 
mapping and trans-septal left atrial access in swine (Grothoff et al. 2017) as well as to guide 





Figure 2-3: Active catheter tracking.  
Active catheter tracking using a MR-compatible catheter with gold-tip electrodes and two 2.5mm solenoid receive coils (A). 
Using a dedicated tracking sequence, the X, Y and Z coordinates of the catheter micro-coils can be determined in 3D space 
(B) whilst the catheter tip can be displayed as a red icon in three orthogonal MRI projections to guide a MR-EP procedure 




The interventional MRI suite is a noisy environment compared to a conventional 
electrophysiology laboratory. There are also additional personnel required including a MR 
radiographer and MR physicists who are outside the interventional suite in the control room. 
Good communication between all team members is a mandatory element to drive 
interventional MRI procedures. During scanning, MR gradients generate significant acoustic 
noise to interfere with communication. Headsets with fibre-optic cables, opto-acoustic 
headsets to subtract gradient noise and wireless headphones have all been used to enable two-
way communication between members of the interventional and imaging team (Bhagirath et 
al. 2015).  
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2.7.5 Image guidance platforms 
 
EAM systems are in widespread use for catheter ablation of complex arrhythmias. They can 
facilitate an understanding of arrhythmia mechanism, permit annotation of single or multiple 
sites of interest, guide catheter navigation to target ablation sites and, when properly used, 
can dramatically reduce fluoroscopy times and may reduce procedural times (Knackstedt et 
al. 2008). There has therefore been interest in the development of graphical interfaces to 
integrate data from real-time imaging into interfaces that closely mimic those of clinical-style 
EAM systems in order to drive progress in real-time MRI-guided electrophysiology (Wang, 
2015). Several major MRI vendors have developed graphical solutions to represent electrical 
data, enable real-time imaging with active catheter tracking and workflows for catheter 
ablation - Figure 2-4. Philips Healthcare have developed the iSuite system that consists of 
hardware including a PC and monitor connected to the MR scanner console. A foot pedal 
also allows an operator to directly control the scanner in real-time from the scanner bore. 
Additional software capabilities include the ability to perform MRI-guided navigation 
combining pre-acquired imaging with real-time data, segmentation tools for procedural 
planning as well as custom modules to perform MR-based device tracking and support MR-
thermometry (Chubb et al. 2017).   
 
Similarly, Siemens Healthineers have developed their own interventional MRI platform that 
allows flexible control of scan plane orientation and image parameters from a dedicated PC 
connected to the scanner console, load and display volumetric data onto a custom software as 
well as perform automatic segmentations of pre-acquired data to ensure rapid image 
processing (Mukherjee et al. 2018). The mapping interface of the software gives the ability to 
change the colour or rendering styles of loaded segmentations and generate activation and 
voltage maps based on local activation time or voltage amplitude data using colour 
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interpolation between mapping points. Active tracking can be superimposed onto real-time 
imaging datasets allowing the system to deliver the features required of a clinical EAM 
system as well as having additional capabilities to exploit the benefits of real-time imaging 
(Mukherjee et al. 2018).  
 
The Vurtigo platform, which is compatible with GE systems is a real-time visualisation 
application (open-source) that can either import EAMs generated conventionally or compose 
one using MR-tracked catheters followed by fusion with acquired MR volumes (Campbell-
Washburn et al. 2017). A real-time scan control system (RTHawk research platform) which is 
based on the Heart Vista Cardiac operating system (Heart Vista, Los Altos, CA, USA) acts as 
a 2D viewer and allows acquisition of real-time sequences. The communication latency 
between the RTHawk application and Vurtigo has been estimated to be in the region of 6.3 ± 
7.7ms (Radau et al. 2011). The system has the ability to visualise, compare and overlay MRI 
volumes, real-time imaging planes, catheters and surface meshes of EAMs. Further 
development of features including motion correction of mapping data points and improved 




Figure 2-4: Image guidance platforms. 
Image guidance software platforms for procedure visualization have been developed by several MRI vendors that are 
capable of displaying 3D volume roadmaps, real-time imaging planes, cardiac chamber segmentations, electroanatomical 
maps and actively tracked catheters. Shown here are example screenshots from the Siemens iCMR platform (A) during MRI-
guided electroanatomical mapping of the left ventricle in a porcine infarct model and Philips iSuite platform (B) during 
MRI-guided catheter ablation of the cavotricuspid isthmus in a patient with atrial flutter. Reproduced with permission from 









2.7.6 Safety and patient monitoring 
 
There are several safety considerations to performing interventional procedures in the MRI 
environment including ensuring that ferromagnetic materials are not inadvertently brought 
near the magnet, adequate preparation of the patient, haemodynamic and ECG-monitoring 
during the intervention, comprehensive monitoring during anaesthesia and robust evacuation 
protocols in case of an emergency. Monitoring equipment used need to be MRI-conditional 
and there are commercially available options for anaesthesia (e.g. Drager Fabius ® MRI) and 
basic haemodynamic monitoring (Expression, Invivo) (Chubb et al. 2017).  
 
If the patient is sedated or under general anaesthesia during a prolonged interventional 
procedure, additional monitoring may be required to protect against skin burns due to rapidly 
switching magnetic gradients and RF pulses. Measurement of the specific absorption rate 
(SAR) during image acquisition and/or direct measurement of skin temperature can be 
employed (Lederman, 2005). Conductive material within the patient such as pacemaker/ ICD 
leads carries a risk of inducing severe burns due to RF-induced heating and all such devices 
must be carefully screened for safety (Wilson et al. 2019).  
 
In the event of a cardiac arrest or an emergency requiring evacuation of the patient from the 
MRI environment, specific roles should be assigned to the interventionalist, radiographer and 
anaesthetist. Staff working within an interventional MRI suite should undergo dedicated 


























In this section, methods which are applicable to one or more chapters are detailed to avoid 
repetition. Specific study protocols are retained within the individual chapters.  
 
3.1 Animal model 
The research protocols were approved by the local institutional review board and complied 
with French law on animal experiments and the Guiding Principles for the Care and Use of 
Laboratory Animals published by the National Institutes of Health (8th Edition, National 
Academies Press, 2011). All animal experiments were performed at the Institut de Chirurgie 
Guidée par l’image (IHU), Strasbourg, France. Domestic pigs were pre-sedated with a 
combination of intramuscular tiletamine and zolazepam. Following sedation, endotracheal 
intubation was performed and general anaesthesia induced and maintained with inhaled 
isoflurane (1.0 - 2.5%) with mechanical ventilation at 15-20 breaths/min. Percutaneous 
vascular access was gained from the right femoral artery (7-Fr introducer sheath) under 
ultrasound guidance. Following arterial access, a bolus of 7000 units of unfractionated 
heparin was administered intravenously followed by a maintenance infusion of 1000-2000 
units/hr. An intravenous lidocaine (1mg/min) and amiodarone infusion (200mcg/kg/min) was 
also initiated to reduce the risk of ventricular arrhythmias.  
 
3.1.1 Infarct preparation 
The protocol was adapted as previously described by Tschabrunn et al. 2016. A 6-Fr Hockey-
stick guide catheter (Medtronic, Minneapolis, MN) was advanced to the left main stem and a 
0.14in Choice PT extra-support angioplasty guidewire (Boston Scientific, Malborough, MA) 
was placed in the left anterior descending artery (LAD). A 3.0 x 12mm Emerge Monorail 
PTCA dilatation catheter (Boston Scientific, Malborough, MA) was placed over the 
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angioplasty wire in the LAD. A coronary angiogram was performed to assess pre-infarct 
anatomy, following which the balloon was inflated to 12-14 atm in the mid-LAD distal to the 
second diagonal branch and maintained for 3 hours. A coronary angiogram was performed at 
1 hour and 3 hours after inflation of the balloon to confirm that the artery was still occluded. 
The creation of infarct was also confirmed by the presence of ST-segment changes in lead 
V1. A continuous infusion of amiodarone (20mcg/kg/min) and lidocaine (12ml/hr) was 
administered to reduce the risk of arrhythmias. In the presence of haemodynamically unstable 
VT or VF at any time during the infarct procedure or at the end of procedure due to 
reperfusion arrhythmia, DC cardioversion was performed. At the end of the procedure, 
0.03mg/kg buprenorphine was administered intramuscularly and a fentanyl patch (125 
micrograms/hour) was applied for 72 hours. Animals then underwent a 6-week recovery 
period prior to imaging and electrophysiology study.  
 
 
3.2 Magnetic resonance imaging 
 
All MRI scans were performed on a 1.5T scanner (MAGNETOM Aera, Siemens, Erlangen, 
Germany) with an 18-channel body matrix coil and a 32-channel spine coil.  
 
3.2.1 3D Whole-heart imaging 
A 3D, ECG-triggered whole-heart bSSFP acquisition with a 1D diaphragmatic navigator (5 
mm gating window) was performed with the following parameters: transverse slice 
orientation, AP phase encoding, 1.25 × 1.25 mm2 in-plane resolution, 256 × 256 in-plane 
matrix size, 2.5 mm acquired slice thickness reconstructed to 1.25mm, typically around 100 
slices to cover the whole heart, TR/TE = 3.7/1.64 ms, flip angle = 90°, readout bandwidth 
(per pixel) = 592 Hz, fat suppression, GRAPPA acceleration factor = 2. The trigger delay was 
set so that the acquisition was performed during mid-diastole and the acquisition window was 
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set to correspond to the length of the diastolic period (typically ~110ms, corresponding to 30 
k-space lines acquired per heartbeat). Following acquisition, the left ventricle, right ventricle, 
left atrium, right atrium and aorta were manually segmented on each animal using an image 
processing platform based on a version of Medical Imaging Interaction Toolkit (MITK, 
Heidelberg, Germany) and saved as Stereolithography (.STL) files. Segmentations were 
loaded on the iCMR application (Siemens Healthcare) to create a roadmap for mapping and 
ablation studies.  
 
3.2.2 Active catheter tracking 
 
In order to project the location of the ablation catheter within the context of the cardiac 
chambers, active catheter tracking using a dedicated MRI tracking sequence, detected by 
micro-coils within the catheter was used. To perform active catheter tracking during MRI 
scans, the X, Y, Z coordinates of the catheter microcoils were determined using a custom 
active tracking sequence/module, which was optionally interleaved with a fast balanced 
steady state free precession (bSSFP) imaging sequence automatically following the current 
catheter position. The active tracking sequence comprised three non-selective projection 
acquisitions along the respective axis. A dynamic imaging coil detuning approach and pre-
spoiler were applied to avoid potential background noise, i.e. coil coupling and residual 
signal effects. Based on the acquired projections, the corresponding signal peaks were 
detected with a dynamic template-matching algorithm, which used the initial projections to 
calculate a template per coil and axis. The template was continuously updated with each new 
projection fulfilling a minimal peak-to-noise ratio to adapt to the changing shape of the 
projections while manoeuvring the catheter. The detected positions were fed back to both the 
iCMR platform (Siemens Healthcare) and the MRI scanner to update the rendered catheter 
position/orientation and imaging plane location respectively. The tracking module was 
further optimized to run with an ambient acoustic noise and had been found to perform 
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robustly with an open MR cabin door, in the presence of other electrical equipment (e.g. 
ventilator, ECG monitoring, etc.) and during RF ablation (Chubb et al. 2017). 
 
 
3.2.3 Late gadolinium enhancement imaging 
 
To perform 2D standard LGE imaging, a bolus of 0.1mmol/kg gadobutrol (Gadovist) was 
first administered. After a period of 10 minutes, an inversion time (TI) scout sequence was 
acquired in a single mid ventricular short-axis slice (bSSFP; TE/TR/α = 1.1ms/2.6ms/30o; 
slice thickness = 8mm; in-plane resolution = 1.8x1.8mm; FOV = 340x280mm2) to select the 
inversion time at which normal myocardium is nulled. A standard clinical 2D LGE was then 
acquired using a phase-sensitive IR (PSIR) sequence (SSFP; TE/TR/α	= 1.21ms/3ms/45°; 
slice thickness: 8mm; in plane resolution: 1.4 x 1.4mm2; FOV: 360 x 280 mm2). 
 
To enable achievement of contrast steady-state, gadolinium was administered via infusion at 
a rate of 0.0011mmol/kg/min. The TI scout was repeated initially at 5-minute intervals until 
inversion time reached equilibrium as previously described (Flett et al. 2010). High-
resolution 3D late gadolinium enhancement (LGE) imaging was then performed using a free-
breathing, respiratory navigator and ECG-gated (in diastole) inversion recovery sequences as 
described in the individual result chapters.  
 
 
3.2.4 MR-thermometry and dosimetry 
 
MR-thermometry using the proton resonance frequency shift (PRFS) technique, which is 
sensitive to temperature changes in real-time was employed to enable real-time monitoring of 
tissue temperature during MR-guided ablation. To perform MR-thermometry, an ECG-
triggered multi-slice single-shot echo planar imaging (EPI) sequence was used with spoiled 
gradient echo (TR/TE/α=50ms/17ms/60°, FOV=180×180mm2, voxel size=1.6×1.6mm2, slice 
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thickness=5mm, slice number=4, bandwidth=1565Hz/Px, GRAPPA factor=2, partial 
Fourier=0.75, orientation – short axis). Saturation slabs were used for reduced field of view 
imaging and inflow saturation to reduce blood signal (de Senneville et al. 2012). 
Reconstruction of temperature maps was performed offline using a customized multi-baseline 
approach extending the method previously proposed (Roujol et al. 2010) as follows: A look up 
table of co-registered MR-phase images was initially created and the MR-thermometry 
sequence was run for 20 heartbeats before each ablation. Images from the first heart beat served 
as the reference image. Non-rigid motion was then estimated between the reference and each 
subsequent magnitude image using an optical flow technique. Phase images were then 
registered to the reference position using the estimated motion fields. The registration was 
performed on the complex data instead of the phase images to prevent artifacts due to phase 
wrap. During ablation, each new phase image was registered to the reference, position as 
described above. The phase image from the lookup table that best matched the current 
registered phase image (i.e. minimal mean square error between pair-wise unwrapped phase 
images) was then selected and used for temperature estimation.  
 
MR-dosimetry derived from MR-thermometry is a technique that can be used to provide a real-
time accumulated thermal dose during radiofrequency energy delivery at the intended ablation 
point. Thermal dose (TD) mapping was calculated on a pixel-wise basis as follows as 

























Where )(tT represents absolute tissue temperature. Baseline temperature was approximated to 
39°C. The thermal dose was considered as lethal when exceeding the equivalent thermal dose 
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at constant heating of 43°C for 240 seconds. To correct for thermal dose error induced by noise 





Where corrTD is the corrected thermal dose and Ts is the temporal standard deviation of 
temperature estimates at baseline (measured from the first 20 measurements following the 
training thermometry step and before the heating process). Width and depth of lesion estimated 
from thermal dose mapping were measured from the middle slice containing the largest lethal 
dose area. 
 
 3.3 MR-EP Workflow 
3.3.1 MR-compatible ablation catheter 
A MR-compatible ablation catheter (Vision, Imricor, USA) was used in all animal studies. The 
catheter is designed to facilitate mapping, delivery of pacing stimuli and ablation lesions within 
a MRI environment. It contains a MR-conditional lumen with a deflectable tip to facilitate 
mapping and transmit RF current to the tip electrode for ablation. The shaft is 9Fr and the distal 
end contains a bipolar pair of tip and ring electrodes that can be used both for recording and 
stimulation. The electrodes are made out of gold to reduce artefact during MRI scanning (in 
comparison to conventional platinum). During catheter ablation, a conventional RF generator 
and a dispersive pad (indifferent electrode) is used in combination with the catheter. The tip 
electrode has irrigation holes for open loop irrigation of the ablation lesion site when connected 
to a conventional irrigation pump.  The catheter incorporates a fibre optic temperature sensor 
that is embedded in the tip electrode.   For catheter tip location in the MR environment, the 
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distal tip section of the catheter has two independent solenoid coils for receiving MR signal 
from the surrounding tissue.  These coils are connected to the MR scanner via coax cable inside 
the catheter body.  Additionally, the coax cable has in-line transformers to prevent unintended 
RF heating (Hilbert et al. 2016). 
 
The catheter has a high-torque shaft with a deflectable tip section.  Tip deflection is controlled 
at the proximal end by a hand-piece in which a piston slides; a thumb knob on the piston 
controls the piston travel. When the thumb knob is pulled back, the tip is deflected (curved). 
When the thumb knob is pushed forward, the tip straightens. The high torque shaft also allows 
the plane of the curved tip to be rotated to facilitate accurate positioning of the catheter tip at 
the desired site. 
 
At the proximal end of the catheter, an irrigation input port with a standard luer fitting 
terminates from the open lumen. This irrigation port serves to permit the injection of normal 
saline to irrigate the tip electrode. During ablation, heparinized normal saline was passed 
through the irrigation lumen of the catheter and through the tip electrode, to irrigate and cool 
the tip electrode (Chubb et al. 2017).  
 
3.3.2 ADVANTAGE-MR electrophysiology recording system 
The Advantage-MR EP recording system allows the operator to perform a range of 
electrophysiology operations including pacing, ablation, recording of EGMs, data review and 
monitoring. It is split into three components - a patient interface module (PIM), a digital 
amplifier/stimulator (DAS) and a host computer workstation. The DAS resides inside the 
magnet room and connects the catheters to the workstation. It receives, filters and digitizes 
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the EGM signals, which are optically converted and transmitted to the workstation via a fibre 
optic cable. Uninterrupted high resistivity wires are used to transmit the EGM signals. The 
cables are filtered to reduce RF-induced heating and minimise artifacts due to RF-induced 
noise. The DAS also receives commands from the workstation (e.g. to act as a programmable 
stimulator) and provides a pathway to transfer ablation energy to the MR-compatible catheter 
via a standard ablation generator. The computer workstation is located in the scanner control 
room. It is able to display and record EGMs as well as demonstrate tip temperature data. In 
addition, it passes cardiac waveform data (e.g. EGM amplitude, local activation time) to the 
Monte-Carlo image guidance system for cardiac mapping (Mukherjee et al. 2018).  
 
3.3.3 MR-EP Image guidance platform 
A custom interventional cardiovascular magnetic resonance (iCMR) image guidance platform 
(Monte-Carlo, Siemens Healthcare, Erlangen, Germany) was used in this study. The 
application has the ability to load volumetric data from MRI scans, display multi-plane 
reconstructions (MPR) in 3 orthogonal planes and transfer segmentations of cardiac chambers 
derived from previous imaging or imaging acquired at the time of the EAM procedure. An 
automatic segmentation tool is incorporated within the software to ensure rapid image 
processing. During the MR-EP procedure, the MPR slices on the iCMR application can 
follow the tip of the actively tracked catheter to display 3D location of the catheter within the 
segmentations of the cardiac chambers as well as on the MPR images. The position of the 
actively tracked catheter is displayed following the implementation of a temporal smoothing 
algorithm that limits its excursion due to cardiac motion.  
 
The software allows the imaging operator to start/stop sequences remote from the scanner 
console and configure parameters of each sequence on the MRI scanner. A MR-compatible 
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foot-switch is also available as part of the application to start or pause an interactive imaging 
sequence that the electrophysiologist can operate (e.g. to use MPRs to navigate the catheter to 
a region of interest). The mapping interface of the application allows for changes to the 
rendering style or colour of a loaded segmentation, as well as place markers in regions of 
interest (e.g. to highlight EGMs or mark sites of ablation). The iCMR application 
communicates directly with the Advantage EP Recording system to display recorded 
activation times and voltage amplitudes. Colour interpolation is used to display this data 
which is computed by a relaxation algorithm that takes the values on the mapping points as 
the fixed boundary condition and then performs a linear interpolation on the segmentation 
surface between these mapping points. These features enable the system to closely mimic that 
of a clinical EAM system whilst having additional capabilities to utilise imaging data for 
procedure guidance.  
 
3.3.4 Real-time MR-EP procedure 
 
All EAM studies were performed inside the MRI scanner without the use of fluoroscopy at 
any point. The left ventricle (LV), right ventricle (RV), left atrium (LA), right atrium (RA) 
and aorta were manually segmented from the 3D ECG-triggered whole heart bSSFP MRI 
dataset using the MITK-based platform. Image processing was performed during a 45-minute 
window following the completion of imaging studies and prior to the start of EAM. During 
this time, each animal remained inside the scanner in order to minimise translational changes 
due to subject movement between imaging and mapping. The 3D shells of each chamber 
were imported into the iCMR guidance platform and displayed using the 3D-whole heart 
dataset to act as a ‘road-map’ for mapping studies. The 3D segmentation of scar from the 
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LGE-MRI was also imported into the iCMR guidance platform and overlaid onto the 3D 
shell for the LV chamber.  
 
A custom 9Fr, MR-compatible steerable catheter with a single gold 3.5mm tip and ring 
bipolar electrode (3.5mm inter-electrode spacing) and six circumferential open irrigation 
ports (Vision-MR, Imricor, Burnsville, MN, USA) was advanced into the LV cavity via 
retrograde aortic access. A number of modifications were implemented to the MR-compatible 
catheter from previous versions used in the atria (Hilbert et al. 2016; Chubb et al. 2017) to 
enable manipulation in the left ventricle - Figure 3-1.  
 
Figure 3-1: 2nd generation MR-compatible ablation catheter 
Changes made in the 2nd generation MR-compatible Vision, Imricor ablation catheter to enable retrograde aortic access 
and improved manoeuvrability within the left ventricle. Previous clinical studies published with the Imricor catheter were in 
patients with atrial flutter using a 1st generation catheter. Images courtesy of Mr Tom Lloyd (Imricor Medical Systems).  
 
These changes enabled improved torque transfer within the ventricle, manoeuvrability and 
consistency of shape following deflection. The MR-compatible catheter has 2 solenoid 
micro-coils located 2mm and 11mm proximal to the ring electrode that enabled the location 



















tracking sequence. A custom-built MR-EP recording system (Advantage-MR, Imricor, 
Burnsville, MN, USA) consisting of a digital amplifier, stimulator and host workstation was 
used to record, display and analyse intra-cardiac electrograms as previously described 
(Mukherjee et al. 2018). A patient monitoring system suitable for use in the MRI 
environment (Invivo, Gainesville, Florida) was used to monitor a single lead ECG and 






























Statement of originality and candidate contributions: 
The contrast steady-state technique described in this chapter was first described by Dr 
Andrew Flett as a non-invasive technique to quantify diffuse myocardial fibrosis (Flett et al. 
2010). This technique was subsequently adapted by Dr John Whitaker (King’s College 
London) to enable high resolution 3D LGE imaging with an extended scar acquisition 
window (manuscript under review).  
 
In this chapter, I have applied the technique described by Dr John Whitaker in an 
independent cohort of animals to compare the performance of 3D LGE with contrast steady-
state to standard clinical 2D LGE. I have performed my own analyses, presented and 
interpreted the data in my own words. For qualitative comparisons, Dr Adriana Villa (SCMR 
Level 3, Consultant Radiologist) (King’s College London) performed an independent, 
blinded assessment of image quality as Reader 2 whilst I performed my own assessment of 
all images acquired as Reader 1.  
 
In addition, I acquired the raw data to facilitate comparisons between multiple 3D LGE 
sequences in the experimental model, completed all data analyses and wrote the results in my 
own words. I obtained ethical approval to perform additional MRIs in patients with a history 
of arrhythmias (including VT) and recruited the patients, acquired images and performed all 
data analyses described in this chapter. Dr Radhouene Neji assisted with optimisation of the 
image protocols and acquisition of imaging in the animal datasets. For data analysis, Dr 
Sebastien Roujol provided the custom software (Mediacare) developed in Matlab (The 
Mathworks, Natick, MA, USA) and wrote the script to integrate calculation of scar entropy 
into the Matlab code.  
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4 High-resolution imaging of ventricular scar: head-to-head 
comparison of three late gadolinium enhancement (LGE) 
sequences in a porcine infarct model and application in a cohort 




The use of cardiac MRI as an adjunctive tool to guide VT ablation is increasing (Mahida et 
al. 2017). Accurate determination of cardiac anatomy and scar distribution can aid in 
planning the access route for VT ablation, particularly when scar is intramural or epicardial 
(Bogun et al. 2009). Image integration of pre-procedural or intra-procedural imaging into the 
navigation system at the time of ablation, can also be used to define the extent and 
distribution of arrhythmogenic substrate, focus mapping efforts in regions of interest and 
potentially improve localisation of the target sites for ablation (Andreu et al. 2017).  
 
The underlying rationale of scar characterisation by cardiac MRI to define target sites for VT 
ablation is based on the understanding that heterogeneous scar tissue, containing a mixture of 
normal myocardium and scar, results in slow conduction and represents the substrate for re-
entrant VT. These target regions are often located within scar tissue or around scar border-
zones. LGE-MRI can be used to index the spatial heterogeneity of necrotic myocardium 
through the application of signal-intensity based thresholds and classify tissue into infarct 
core (dense scar) and borderzone (heterogeneous or grey-zone tissue). The extent of 
heterogeneous tissue, quantified from LGE-MRI, has been related to all-cause mortality in 
patients with ischaemic cardiomyopathy (Yan et al. 2006) and inducibility of monomorphic 
VT (Schmidt et al. 2007).  
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Heterogeneous tissue may have intermediate signal intensities (between that observed in 
normal myocardium and dense scar) which could be related to the partial volume effect 
whereby in a given voxel, a mixture of infarct tissue and normal tissue will result in a signal 
intensity that is an average of the two tissue types. Alternatively, at an interface between 
infarct and viable myocardium, a region of intermediate signal intensity may be present. 
During clinical imaging, the spatial resolution of LGE-MRI is frequently >1.5mm in-plane 
with a slice thickness between 6-10mm. In these scenarios, the partial volume effect can 
significantly overestimate the peri-infarct borderzone and reduce the accuracy of 
identification of ablation target sites compared to imaging with a sub-millimetre spatial 
resolution (Schelbert et al. 2010).   
 
An additional factor that could impact on the signal intensity of heterogeneous tissue is 
variability in the wash-in and wash-out kinetics of gadolinium within the infarct region and 
borderzone tissue. Depending on the degree of microvascular damage and remaining 
capillary perfusion near an infarct borderzone, the wash-out kinetics of gadolinium may vary 
leading to a higher signal intensity compared to normal myocardium but lower than that of 
dense scar (Kim et al. 1996; Schmidt et al. 2007).  
 
In order to accurately identify the scar areas critical for re-entry VT circuits, high-resolution 
3D imaging is required. Furthermore, isotropic 3D imaging (resolution which is identical in 
all dimensions) can detect smaller regions of scar and enable multi-planar reconstruction to 
facilitate visualisation of ‘channels’ of slow conduction and ablation target sites (Basha et al. 
2017). The major limitation of 3D high-resolution isotropic LGE imaging is prolonged scan 
times during which temporal changes in contrast kinetics can lead to artifacts due to 
difficulties in nulling healthy myocardium (Basha et al. 2017). Although image acceleration 
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techniques such as compressed sensing can be used to reduce scan times, recovery of images 
with under-sampled data can lead to additional artifacts and amplify noise leading to low 
signal-to-noise ratios (Otazo et al. 2010).  
 
Following delivery of a bolus of gadolinium contrast, there is a reduction in the TI of the 
blood pool and myocardium which gradually recovers over time. After a period of around 20-
30 minutes, an upward drift in the TI results in sub-optimal nulling of healthy myocardium 
which therefore limits the window during which LGE imaging can be optimally performed. 
In a seminal study, (Flett et al. 2010) described a method to quantify diffuse myocardial 
fibrosis using a bolus of gadolinium followed by a slow continuous infusion to achieve 
blood-myocardium contrast equilibrium. This was then followed by a blood test to measure 
the volume of distribution of contrast. Recently, (Whitaker et al. unpublished data) adapted 
this technique using a continuous infusion of contrast to achieve steady-state during LGE-
MRI and establish a stable myocardial T1 time, enabling extended acquisition of high-
resolution 3D imaging without significant changes in the TI of the blood pool and 
myocardium.  
 
High-resolution LGE with contrast steady-state could allow detailed characterisation of scar 
architecture and heterogeneity which is necessary to permit identification of VT ablation 
target sites. In this chapter, the use of contrast steady-state LGE imaging is applied in an 
experimental animal model of myocardial infarction to compare 3D post-contrast sequences 
with consistent contrast distributions and in a cohort of patients with ischaemic 
cardiomyopathy to demonstrate feasibility of the technique in clinical practice. High-
resolution ex-vivo MRI is used in the animal model to validate in-vivo imaging findings. 
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Qualitative and quantitative comparisons of the technique with conventional 2D LGE 




A porcine model of ischaemic cardiomyopathy was used to enable high-resolution imaging of 
ventricular scar using the contrast-steady state LGE protocol and systematically compare 
three 3D LGE techniques for assessment of scar and heterogeneous tissue. Two bright-blood 
3D LGE sequences and one black-blood 3D LGE sequence were compared against each other 
to define the optimal technique for assessment of scar architecture and borderzone.  Twelve 
male domestic pigs (weight 56.6 ± 5kg at the time of imaging) underwent a 180-minute 
occlusion of the mid left anterior descending artery as described in Section 3.1 followed by a 
6-week recovery. All animals then underwent MR imaging in-vivo, followed by euthanasia, 
extraction of the heart and high-resolution ex-vivo imaging, as described below.  
 
Ten patients with a known scar in the left ventricle underwent a cardiac MRI scan with an 
adapted contrast-steady state LGE protocol. Patients were recruited from an ‘Ablation’ MRI 
list at our institution whereby patients have a pre-procedural MRI prior to a catheter ablation 
procedure (AF/ PVC or VT ablation). Following demonstration of LV scar, patients were 
invited back for a research MRI study to undergo the adapted contrast-steady state protocol. 
In this cohort, 2 patients had a history of sustained VT whilst the remaining patients had 
either frequent PVCs or AF. The presence of LGE in patients with a history of AF was felt to 
be likely due to a previous thromboembolic infarct rather than an acute plaque rupture event. 
As a result, the patient cohort did have a history of arrhythmias but is not reflective of a 
typical ischaemic cardiomyopathy cohort. 
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Ethical approval was granted by the local institutional review board (17/LO/0150). Both 
standard clinical 2D LGE as well as high-resolution 3D LGE imaging were performed after 
establishment of contrast steady-state. 
 
4.2.1 Magnetic resonance imaging protocol in porcine model 
All MR imaging was performed on a 1.5T scanner (MAGNETOM, Aera, Siemens 
Healthcare, Erlangen, Germany). In the animal model, an assessment of LV function was 
made using cine imaging performed at end-expiration using a standard multi-slice balanced 
steady state free precession (bSSFP) technique. An ECG-triggered, 3D whole-heart bSSFP 
acquisition with a 1D diaphragmatic navigator was performed for cardiac chamber 
segmentation as described in Section 3.2.1. The following parameters were applied: 
transverse slice orientation, AP phase encoding, 1.25 × 1.25 mm2 in-plane resolution, 256 × 
256 in-plane matrix size, 2.5 mm acquired slice thickness reconstructed to 1.25mm, typically 
around 100 slices to cover the whole heart, TR/TE = 3.7/1.64 ms, flip angle = 90°, readout 
bandwidth (per pixel) = 592 Hz, fat suppression, GRAPPA acceleration factor = 2.  
 
A bolus of gadolinium contrast (Gadovist, Bayer, Berlin, Germany) at 0.1mmol/kg was then 
administered. After a period of 10 minutes, a standard 2D LGE scan was performed during 
end-expiration using a phase-sensitive inversion recovery (PSIR) sequence with the 
following parameters: bSSFP read-out, 8 short-axis slices, 1.40 x 1.40 mm2 in-plane 
resolution, 8.0 mm slice thickness, TR/TE = 3/1.21 ms, flip angle = 45°, FOV = 
360x281mm2, Pixel bandwidth = 780 Hz/Px. The inversion time (TI) to optimally null 
normal myocardium was determined using a standard TI scout sequence acquired in a mid-
ventricular, short-axis slice during free-breathing, prior to the 2D LGE scan, with the 
following parameters: bSSFP read-out, 1.80 x 1.80 mm2 in-plane resolution, 6.0 mm slice 
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thickness, TR/TE = 2.6/1.1 ms, flip angle = 55°, FOV = 340 x 276mm2, Pixel Bandwidth = 
1095 Hz/Px.  
 
Following completion of the standard 2D LGE scan, a slow infusion of gadolinium contrast 
was initiated at a rate of 0.0011mmol/kg/min as previously described (Flett et al. 2010; 
Whitaker et al. unpublished data). The TI scout sequence was repeated at 3-5 minute intervals 
to measure the blood and myocardial TI until a steady-state was achieved. Steady-state was 
maintained for up to 3 hours in each animal to permit the acquisition of multiple 3D isotropic 
LGE sequences under consistent contrast conditions. Three LGE sequences (bSSFP and GRE 
read-outs and a black-blood LGE sequence) were then acquired sequentially as follows in 
6/11 animals: 
 
1. 3D bSSFP IR LGE - ECG triggered, respiratory navigator-gated, bSSFP read-out, 
coronal orientation, spatial resolution = 1.2 x 1.2 x 1.2 mm3, TR/TE = 3.6/1.58 ms, 
flip angle = 90°, FOV = 400 x 257 x 96 mm3; Pixel Bandwidth = 930 Hz/Px, 2 R-R 
interval; GRAPPA acceleration factor = 2; trigger delay = subject-specific determined 
from a breath-held 2D cine coinciding with the mid-diastolic rest period - acquisition 
window ranging from 100 to 125ms. 
 
2. 3D GRE IR LGE - ECG triggered, respiratory navigator-gated, GRE read-out, coronal 
orientation, spatial resolution = 1.2 x 1.2 x 1.2 mm3, TR/TE = 5.3/1.87 ms, flip angle 
= 20°, FOV = 380 x 380 x 92 mm3; Pixel Bandwidth = 365 Hz/Px, 2 R-R interval; 
GRAPPA factor = 2; trigger delay = subject-specific determined from a breath-held 
2D cine coinciding with the mid-diastolic rest period - acquisition window ranging 
from 100 to 125ms. 
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3. 3D BOOST LGE (Bright-blood and black-blOOd phase sensiTive inversion recovery 
sequence) - this sequence exploits alternating T2-prep-IR and T2-prep modules to 
acquire two interleaved bSSFP bright-blood datasets. The T2-prep acquisition is used 
as the reference dataset for phase computation and a complimentary, co-registered 
black-blood LGE PSIR is reconstructed as previously described (Ginami et al. 2017). 
Prior to data acquisition, a low-resolution 2D image-based navigator (iNAV) is 
acquired at each heart beat to enable beat-to-beat 2D translational respiratory motion 
estimation and compensation to achieve 100% scan efficiency leading to predictable 
scan times compared to diaphragmatic navigator gated sequences with the same 
acquisition parameters. Image parameters for the 3D BOOST LGE sequence were as 
follows: ECG triggered, image-navigated, coronal orientation, spatial resolution = 1.2 
x 1.2 x 1.2 mm3, TR/TE = 4.7/1.47 ms, flip angle = 90°, T2-prep duration = 40ms, 
FOV = 320 x 320 x 100 mm3, Pixel Bandwidth = 990 Hz/Px, right-left phase 
encoding, trigger delay = subject-specific determined from a breath-held 2D cine 
coinciding with the mid-diastolic rest period - acquisition window ranging from 100 
to 125ms. A dedicated 2D BOOST TI scout was acquired prior to acquisition of the 
3D LGE sequence. This consisted of a magnetisation-prepared cine sequence where 
an alternate T2-prep IR module (odd heartbeats) and T2-prep module alone (even heart 
beats) is performed during alternate heartbeats as previously described (Ginami et al. 
2017). The optimal TI to null the blood pool was determined from the cine frames 
acquired during odd heartbeats (T2-prep IR portion of the sequence).  
 
Following completion of in-vivo imaging, animals were recovered. One week later, ex-vivo 
studies were performed to validate in-vivo imaging findings. An additional dose of 
gadolinium contrast (Gadovist, Bayer, Berlin, Germany) at 0.2mmol/kg was administered 10 
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minutes prior to death of the animal. Rapid intravenous injection of potassium chloride 
(20mL 10% KCl) was administered to arrest the heart in diastole. The chest cavity was 
opened and blunt dissection used to extract the heart. Each heart was rinsed in 0.9% normal 
saline. In order to prevent collapse of the LV, each heart was filled with kinetic sand to 
maintain the shape of the LV cavity - Figure 4-1.  
 
 
Figure 4-1: Preparation of hearts for ex-vivo imaging.  
The LV and RV cavities have a tendency to collapse when removed from the thoracic cavity. In order to maintain the shape 
of the ventricles during ex-vivo imaging, kinetic sand was used to fill both cavities, preventing collapse (A) and maintaining 
their shape (B).  
 
Each heart was then submerged in a bath of 0.9% normal saline and ex-vivo imaging 
performed within 1 hour of euthanasia. A high-resolution 3D T1-weighted spoiled gradient 
echo sequence was used for ex-vivo imaging with the following parameters: spatial 
resolution - 0.4 x 0.4 x 0.4 mm3, TR/TE = 5.4/ 11.2 ms, flip angle = 20o, Pixel Bandwidth = 
130 Hz/Px, FOV = 150 x 150 x 100 mm3.  
 
4.2.2 Magnetic resonance imaging protocol in patients  
An adapted CMR protocol was used to enable application of contrast steady-state in patients 
with ischaemic cardiomyopathy - Figure 4-2. Imaging was performed on a 1.5T scanner 
(MAGNETOM, Aera, Siemens Healthcare, Erlangen, Germany). Each patient was 
 104 
cannulated and had a single bolus of contrast (0.1mmol/kg) administered prior to entering the 
scanner. Standard planning scans (localiser, 2-chamber, 4-chamber, short-axis) were acquired 
followed by commencement of a slow infusion of gadolinium at a rate of 0.0011 
mmol/kg/min within 15 minutes after the initial bolus of contrast. Standard 2-chamber, 3-
chamber, 4-chamber views and a short-axis stack were then acquired. A TI scout was then 
repeated until the blood and myocardial TI demonstrated <5% variability and steady-state 
was achieved. A 2D multi-slice, breath-hold, clinical LGE (bSSFP, PSIR) sequence was 
performed with the following parameters: TR/TE = 6.0/1.2 ms, flip angle = 45o, in-plane 
resolution = 1.4 x 1.4 mm, slice thickness = 8 mm, pixel bandwidth = 780Hz/Px, FOV = 292 
x 150 mm2. A 3D isotropic bSSFP IR LGE sequence was then performed whilst contrast 
steady-state was maintained with the following parameters: ECG triggered, respiratory 
navigator-gated, coronal orientation, spatial resolution = 1.2 x 1.2 x 1.2 mm3, TR/TE = 
3.6/1.44 ms, flip angle = 90°, FOV = 400 x 260 x100 mm3; Pixel Bandwidth = 1395 Hz/Px, 
GRAPPA acceleration factor = 2.  
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Figure 4-2: Imaging protocol for application of contrast steady-state to enable high-resolution imaging in patients with 
ischaemic cardiomyopathy.  
A single bolus of gadolinium (0.1mmol/kg) is administered outside the scanner. Following localiser and planning scans, the 
slow infusion of gadolinium diluted in normal saline (0.0011mmol/kg/min) is commenced. Following achievement of steady-
state, determined when the myocardial and blood pool TI has <5% variability during multiple TI scouts, the high-resolution 
3D LGE sequence is commenced. Total contrast dose does not exceed 0.2mmol/kg at the end of the study.  
 
 
4.2.3 Qualitative assessment of scar 
All imaging datasets were anonymised and stored in a randomised order prior to qualitative 
assessment. Two independent readers (RKM and AV) graded images using a 5-point Likert 
scale on the following criteria: scar conspicuity relative to the LV cavity, scar conspicuity 
relative to adjacent myocardium, presence of artifacts and overall image quality. On this 
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scale, 0 represents non-diagnostic image quality, 1 = poor image quality, 2 = moderate, 3 = 
good, 4 = excellent image quality. For lesion conspicuity, 0 = not able to differentiate, 1 = 
poor differentiation, 2 = moderate differentiation, 3 = good differentiation, 4 = excellent 
differentiation. For the presence of artifacts, 0 = no artifacts, 1 = minor artifacts, 2 = 
moderate artifacts, 3 = high artifact level, 4 = non-diagnostic. For transmural scar extent a 4-
point scale was used with 0 = 0-24%, 1 = 25-49%, 2 = 50-74%, 3 = 75-100%.  
 
4.2.4 Quantitative assessment of scar 
Signal-to-noise (SNR) and contrast-to-noise (CNR) ratios were calculated for the clinical 2D 
LGE and 3D bSSFP IR LGE sequences in both the animal model and patients. Images were 
analysed off-line on a OsiriX workstation (www.osirix-viewer.com). SNR and CNR were 
quantified using the mean signal intensities (SI) within a circular region of interest (ROI) 
drawn manually within scar, blood pool, and myocardium. An additional ROI positioned 
within the lungs was used to calculate the background noise intensity and noise standard 
deviation. For SIscar, a circular ROI was placed encompassing the infarct region (range of 
ROI size = 50mm2 - 250mm2 depending on infarct size). SImyocardium was determined from 
adjacent non-infarct tissue within the same slice. SIblood was determined using a 200mm2 
circular ROI in the LV blood pool whilst a 200mm3 ROI was used for estimation of 
background noise standard deviation in the lungs.  
 
The LV endocardium and epicardium was manually segmented within a custom software 
(Mediacare) developed in Matlab (The Mathworks, Natick, MA, USA). Quantification of 
core infarct and borderzone tissue volume was made through automatic application of the full 
width at half maximum (FWHM) and 35-50% of maximal pixel signal intensity thresholds 
respectively to segmentations.  
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4.2.5 Entropy evaluation 
Tissue entropy was used as a parameter derived from LGE imaging to evaluate tissue 
heterogeneity independent of signal intensity thresholds. Entropy is a statistical measure of 
randomness that can be used to characterise the texture of an image. The underlying 
assumption is that regions with varying signal intensity values within scar may represent 
tissues of different compositions. A narrow signal intensity distribution suggests low entropy 
whilst a wide distribution suggests high entropy. A histogram distribution of pixel signal 
intensities with each LGE sequence was created in Matlab with each histogram divided into 
256 equidistant bins. The endocardial and epicardial segmentations were applied to each 
sequence to quantify entropy across the LV myocardium. The number of pixels within each 
bin was counted and entropy (H) calculated using the following formula: 
 
Equation 4: Entropy calculation:  H = -∑(p.*ln2(p)) 
 
 
Where ∑ = sum; p = normalised histogram counts 
 
The signal intensity (SI) values across subjects and sequences were normalised to a range 
between 0 - 1024 in order to avoid SI variation between sequences and subjects from 
influencing the results.  
 
4.2.6 Statistical analysis 
Statistical analyses were performed using GraphPad PRISM Version 7.0 (GraphPad Inc, CA, 
USA) or SPSS (v24, IBM Corporation, New York, USA). All data was screened using 
skewness and kurtosis tests and the normality of distribution assessed using the Shapiro-Wilk 
test. Qualitative data are reported as means and quantitative continuous data expressed as 
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mean ± SD. On qualitative analysis, inter-observer variation was evaluated using weighted 
kappa statistics with extent of agreement rated as follows: K ≥ 0.81 = excellent; K = 0.61 - 
0.80, good; K = 0.41 - 0.60, moderate; K < 0.40 = poor. Statistical significance of kappa 
values was assessed using a z-statistic. Different sequences were compared using a paired t-
test, Wilcoxon matched-pairs signed rank test or a repeated-measures analysis of variance 
test. Non-parametric ordinal data between two or more groups were compared using a 
Kruskal-Wallis test. Tukey post-hoc test was used for multiple comparisons. A level of p < 




Twelve pigs underwent successful balloon occlusion of the mid left anterior descending 
artery and were subsequently recovered - Figure 4-3. One pig died post-MI during MR 
scanning and did not complete the imaging protocol. In eleven pigs, 2D LGE, 3D bSSFP IR 
LGE and ex-vivo imaging was successfully acquired with the in-vivo imaging performed 
during contrast steady-state - Figure 4-4. In six of these pigs, three high-resolution 3D LGE 
sequences (bSSFP, GRE, BOOST) were acquired during contrast steady-state at the same 
spatial resolution - Figure 4-5.  
 
Figure 4-3: Coronary angiograms 
Coronary angiograms acquired pre-occlusion (A), during balloon inflation in the mid left anterior descending artery (B) 




Figure 4-4: Representative LGE and ex-vivo images 
Representative slices from three animals demonstrating regions of scar obtained during 2D LGE (A-C), 3D bSSFP LGE (D-





Figure 4-5: Representative images from three LGE sequences 
Representative examples of scar seen in the same animal, in the same slice position with the 3D bSSFP LGE (A), 3D GRE 
LGE (B) and 3D BOOST (C) sequences.  
 
Contrast steady-state was successfully established for LGE imaging in all animals with a total 
contrast dose not exceeding 0.2mmol/kg - Figure 4-6. The mean variation in TIblood and 
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TImyocardium was 6.5% and 4.8% respectively between the start and end of 2D LGE imaging 
whilst the mean variation during 3D LGE imaging was <2%. The mean scan duration during 
2D LGE imaging was 6.1 ± 1.3 minutes. Mean scan duration during 3D bSSFP LGE, 3D 
GRE LGE and 3D BOOST were 46.7 ± 3.8, 52.1 ± 5.4 and 26.0 ± 1.2 minutes respectively - 
Table 1.  
 




 2D LGE 3D bSSFP LGE 3D GRE LGE 3D BOOST 
Scan duration (mins) 6.1 ± 1.3 46.7 ± 3.8 52.1 ± 5.4 26.0 ± 1.2 
Variation in TIblood between start and 
end of imaging sequence (%) 
6.5 ± 5.0 1.2 ± 2.4 0.44 ± 0.76 0.45 ± 0.60 
Variation in TImyocardium between start 
and end of imaging sequence (%) 
4.8 ± 4.2 2.0 ± 3.0 0.39 ± 0.67 0.40 ± 0.54 
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Figure 4-6: Establishment of contrast steady-state 
Representative blood and myocardial TI following a bolus of contrast and during a continuous infusion in a pig. Continuous 
infusion of contrast with steady-state was maintained for up to 180 minutes facilitating extended LGE imaging during 
consistent contrast conditions.  
 
Ten patients with ischaemic cardiomyopathy were scanned as part of the study protocol. No 
patients had an implanted device in-situ. One patient was unable to complete the protocol due 
to a long scan time during 3D imaging and was excluded from the analysis. One patient 
developed acute kidney injury (AKI) 72 hours after undergoing the contrast steady-state 
protocol. This patient also underwent a VT ablation during this 72-hour period and had 
multiple episodes of haemodynamic compromise requiring DC cardioversion during the 
procedure. He also developed a significant femoral haematoma post-procedure with a >2g/dL 
drop in haemoglobin. Given these additional factors, it was felt that the contrast steady-state 
protocol was not responsible for the development of AKI but was reported as a serious 
adverse event (SAE) to the ethics committee but no change in study protocol was 
recommended. Patient characteristics are displayed in Table 2. The mean acquisition time to 
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complete the scan protocol was 89.8 ± 4.5 minutes whilst the mean acquisition time for the 
3D bSSFP LGE sequence was 49.0 ± 3.5 minutes. Representative images acquired using the 
2D LGE and 3D bSSFP LGE sequences are shown in - Figure 4-7.  
Patient 
number 
Age Gender Pathology LVEF (%) Rhythm during 
scan 
1 79 Male ICM 38 Sinus with 
occasional PVCs 
2 66 Female Thromboembolic 45 Sinus 
3 60 Male Thromboembolic 44 Sinus 
4 62 Male Thromboembolic 42 AF 
5 57 Male Thromboembolic 36 AF 
6 55 Male Thromboembolic 40 AF 
7 67 Male ICM 27 Sinus with runs 
of slow VT 
8 62 Male Thromboembolic/ 
Possible DCM 
43 AF 
9 58 Male Thromboembolic 39 AF 
 
Table 2: Patient characteristics. The LVEF values reported may be underestimated in the context of scans performed when 





Figure 4-7: Representative LGE images in patients  
Representative slices from approximately the same level in three patients demonstrating regions of scar obtained during 2D 
LGE (A,C,E), 3D bSSFP LGE (B,D,F). Arrows indicate location of scar. An area of possible mid-wall scar in the septum is 
also noted in Patient 8 raising the suspicion of underlying dilated cardiomyopathy.  
 
 
4.3.1 Qualitative data analysis - animal study 
On qualitative assessment of 2D LGE compared to 3D LGE, there was no difference in scar 
conspicuity relative to the LV cavity (1.9 vs 2.0; p=0.42) and assessment of transmural scar 
extent (2.5 vs 2.6; p=0.19). However, scar conspicuity relative to adjacent myocardium (2.0 
vs 3.7; p<0.0001) and overall image quality (2.4 vs 3.9; p<0.0001) were significantly 
improved with 3D LGE imaging. There were significantly more artifacts with 2D imaging 
(2.3 vs 1.5; p<0.001).  
 
On 3D LGE imaging, inter-rater agreement was moderate on assessment of scar conspicuity 
adjacent to normal myocardium (K = 0.56; p = 0.039) and presence of artifacts (K = 0.49; p = 





p = 0.014) and overall image quality (K = 0.62; p = 0.026). Inter-rater agreement was poor on 
assessment of scar conspicuity relative to LV cavity (K = 0.10; p = 0.511). On 2D LGE 
imaging, inter-rater agreement was good on assessment of overall image quality (K = 0.81; p 
= 0.006) and transmural scar extent (K = 0.667; p = 0.011) whilst agreement on the presence 
of artifacts was moderate (K = 0.55; p = 0.009). Inter-rater agreement was poor on 
assessment of scar conspicuity relative to LV cavity and adjacent to normal myocardium, K = 
0.13; p = 0.54 and K = 0.10; p = 0.46, respectively - Figure 4-8.  
 
Figure 4-8: Qualitative assessment: 2D vs 3D LGE in animals 
Qualitative assessment by 2D and 3D LGE techniques on assessment of scar, presence of artifacts and overall image 
quality. Mean Likert scores are displayed as assessed by 2 independent readers on a 4-point scale for assessment of scar 
transmurality and a 5-point scale for all other factors. Error bars represent standard deviation.  
 
During qualitative comparison between the three 3D LGE sequences the BOOST sequence, 
relative to GRE and bSSFP, had improved scar conspicuity relative to the LV cavity (3.3 vs 
2.2 vs 1.8; p<0.001). The bSSFP sequence, however, had improved scar conspicuity relative 
to adjacent normal myocardium (4.0 vs 3.5 vs 2.6; p<0.0001). The GRE sequence had a 
higher degree of artifacts whereas the BOOST sequence had the lowest degree (2.1 vs 1.4 vs 
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scar extent (bSSFP vs GRE vs BOOST = 2.5 vs 2.6 vs 2.6; p = 0.98). Overall image quality 
was better with the bSSFP sequence compared to GRE and BOOST (3.6 vs 2.8 vs 2.6; p = 
0.0029).  
 
Inter-rater agreement on assessment of transmural scar extent was good to excellent between 
bSSFP, GRE and BOOST (K = 0.67 vs 0.67 vs 1.00; p<0.05, respectively). Agreement on 
overall image quality was good to excellent between bSSFP and GRE (K = 0.67 vs 1.00; p = 
0.083) but poor on BOOST (K = 0.286; p = 0.361). Agreement on the presence of artifacts 
was good to excellent between GRE and BOOST (K = 0.71 vs 1.00; p<0.05) but poor on 
bSSFP (K = 0.182; p>0.05). Agreement on scar conspicuity relative to the LV cavity was 
good on the BOOST sequence (K = 0.67; p=0.04) but poor on bSSFP and GRE (K = 0.28 vs 
0.37; p>0.05, respectively). Agreement on scar conspicuity relative to normal adjacent 
myocardium was excellent with bSSFP (K = 1.00; p<0.05), moderate with GRE (K = 0.41; p 
































































Figure 4-9: Qualitative assessment: three high-resolution 3D LGE sequences 
Qualitative assessment of scar, presence of artifacts and overall image quality as assessed between 3 high-resolution 3D 
LGE sequences. Mean Likert scores are displayed as assessed by 2 independent readers on a 4-point scale for assessment of 
scar transmurality and a 5-point scale for all other factors. Error bars represent standard deviation. 
 
4.3.2 Quantitative data analysis - animal study 
 
On comparison of 2D vs 3D LGE imaging, the 3D bSSFP dataset provided a statistically 
significant improvement in the SNRscar and SNRblood (25.2 vs 9.5; p<0.0001 and 16.9 vs 10.4; 
p = 0.01, respectively) but not SNRremote myocardium (3.3 vs 2.9; p = 0.28). An improved CNR 
between scar and remote myocardium as well as scar and blood pool was also observed with 
the 3D bSSFP sequence (21.9 vs 6.6; p<0.0001 and 8.3 vs -0.9; p=0.0011, respectively) - 
Figure 4-10.  
 
 
Figure 4-10: Quantitative analysis: SNR and CNR in animal study 
Signal to noise ratio (SNR) in scar tissue, blood pool and remote myocardium between 2D and 3D bSSFP LGE and contrast 
to noise ratio (CNR) between scar and remote myocardium and scar and blood pool. N = 11 animals.  
 
Dense scar volume (FWHM threshold) was not significantly different between 3D bSSFP 
LGE and high-resolution ex-vivo MRI (p=0.90) or between 2D LGE and 3D bSSFP 
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(p=0.09), however scar volume was significantly higher on 2D LGE vs ex-vivo MRI 
(p=0.04), likely related to overestimation of scar due to the partial volume effect. Borderzone 
tissue volume (35-50% maximal signal intensity threshold) was not significantly different 
between 3D bSSFP LGE and ex-vivo MRI (p=0.28) but was significantly higher with 2D 
LGE compared to 3D bSSFP (p=0.0033) and ex-vivo MRI (p<0.0001) - Figure 4-11.  
 
 
Figure 4-11: Core scar and borderzone volumes in animal study - 2D vs 3D vs ex-vivo MRI 
Dense (core) scar (A) and borderzone tissue volume (B) as assessed using a 2D LGE, 3D bSSFP LGE and high-resolution 
ex-vivo MRI. N=11 animals. *p<0.05, **p<0.0001.  
 
During comparison between the three, 3D LGE datasets and ex-vivo MRI, there was no 
significant difference in dense (core) scar volume (p=0.71) or borderzone tissue volume 
(p=0.64) - Figure 4-12.  
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Figure 4-12: Core scar and borderzone volumes: three high-resolution 3D LGE sequences vs ex-vivo MRI 
During high-resolution 3D LGE imaging under consistent contrast conditions, there was no difference in dense (core) scar 
volume (A) or borderzone tissue volume (B) between the bSSFP, GRE or BOOST sequences and ex-vivo MRI.  
 
4.3.3 Mean entropy for assessment of scar heterogeneity - animal study 
Mean entropy as a measure of tissue inhomogeneity was used to further evaluate the 
differences in scar seen with the 2D and 3D LGE sequences. A higher mean entropy was 
present on 3D bSSFP LGE compared to standard clinical 2D LGE in the same animals with 
the same scar (7.4 vs 4.8; p<0.0001) suggesting that calculation of scar entropy is sequence 
and spatial resolution dependent - Figure 4-13. A significant difference in mean entropy was 
also observed during comparison of the 3D bSSFP, GRE and BOOST sequences (p=0.0036). 
On multiple comparisons, there was no difference between the bSSFP and BOOST sequences 
(p=0.96) but a significantly higher entropy was observed when these sequences were 
compared to the 3D GRE (p=0.009 and p=0.007, respectively) - Figure 4-14.  
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Figure 4-13: Mean entropy of scar - animal study - 2D vs 3D LGE 
Mean entropy, as a quantitative marker of scar heterogeneity, was higher with 3D bSSFP LGE imaging compared to 2D 
LGE. Representative images of the same scar, in approximately the same slice position with 2D LGE (A) and 3D bSSFP 
LGE (B). Signal intensity histograms in the same animal with 2D LGE (C) and 3D LGE (D) and overall mean entropy in 11 
animals (E).*p<0.0001.  
 
 
Figure 4-14: Mean entropy of scar - three high-resolution 3D LGE sequences 
Mean entropy of scar using the 3D bSSFP, GRE and BOOST sequences. No difference in entropy was observed between the 
bSSFP and BOOST sequences but the GRE sequence had a statistically significant lower entropy compared to the remaining 
3D sequences. *p=0.009; **p=0.007.  
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4.3.4 Qualitative data analysis - clinical study 
Subjectively, in patients with ischaemic cardiomyopathy, scar conspicuity relative to LV 
cavity and overall image quality were improved with 3D bSSFP with contrast steady-state 
compared to 2D LGE (2.1 vs 1.6; p = 0.0039 and 2.1 vs 1.7; p=0.02). However, no 
differences were seen between 3D and 2D LGE on scar conspicuity relative to adjacent 
myocardium, presence of artifacts or transmural scar extent (2.3 vs 2.2; p=0.45 and 2.1 vs 
2.4; p=0.21 and 2.3 vs 2.3; p=0.99, respectively).  
 
Inter-rater agreement on assessment of scar conspicuity relative to LV cavity was moderate 
across 3D and 2D LGE imaging (K = 0.55 vs 0.41). Agreement on scar conspicuity relative 
to adjacent normal myocardium was good for 2D LGE (K = 0.79) but poor with 3D LGE (K 
= 0.23). Agreement on the presence of artifacts was poor across 3D and 2D imaging (K = 
0.33 vs 0.27, respectively) whilst agreement on scar transmurality was moderate to excellent 
for 3D and 2D LGE respectively (K = 0.59 and 1.00). Agreement on overall image quality 
was poor for 3D imaging (K = 0.25) but moderate for 2D imaging (K = 0.60) - Figure 4-15.   
 
Figure 4-15: Qualitative analysis - clinical study 
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Qualitative assessment by 2D and 3D LGE techniques on assessment of scar, presence of artifacts and overall image quality 
in patients with ischaemic cardiomyopathy. Mean Likert scores are displayed as assessed by 2 independent readers on a 4-
point scale for assessment of scar transmurality and a 5-point scale for all other factors. Error bars represent standard 
deviation. N=9 subjects.  
 
4.3.5 Quantitative data analysis - clinical study 
On comparison of 2D vs 3D LGE imaging, in contrast to the animal studies, there was no 
difference in SNRscar, SNRblood or SNRremote between sequences (p=0.13, 0.36 and 0.63, 
respectively). However, CNRscar-remote and CNRscar-blood was improved with 3D bSSFP LGE 
and reached statistical significance (p=0.032 and 0.046, respectively) - Figure 4-16. There 
was no significant difference in dense (core) scar volume (FWHM threshold) or borderzone 
tissue volume (35-50% maximal signal intensity threshold) between the sequences (p=0.48 
and 0.38, respectively) - Figure 4-17.   
 
Figure 4-16: Quantitative analysis - clinical study - SNR and CNR 
Signal to noise ratio (SNR) in scar tissue, blood pool and remote myocardium between 2D and 3D bSSFP LGE and contrast 
to noise ratio (CNR) between scar and remote myocardium and scar and blood pool in patients with ischaemic 




Figure 4-17: Core scar and borderzone volume - clinical study 
Dense (core) scar and borderzone tissue volume as assessed using a 2D LGE, 3D bSSFP LGE in patients with ischaemic 
cardiomyopathy. N=9 patients. 
 
4.3.6 Mean entropy for assessment of scar heterogeneity - clinical study 
Mean entropy was significantly higher with 3D bSSFP LGE compared to 2D LGE, consistent 
with the animal data, however the magnitude of this effect was lower (6.0 vs 5.2; p=0.029) - 
Figure 4-18.  
 
Figure 4-18: Mean entropy - clinical study 
Mean entropy of scar using the 3D LGE and 2D LGE sequences in patients with ischaemic cardiomyopathy. A higher 
entropy value was observed with the 3D sequence, consistent with the results obtained in the animal study.  
 
4.4 Discussion 
The principle findings of this study are: 
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1. A slow infusion of gadolinium to maintain consistent contrast conditions enabled 
extended scar imaging and a direct head-to-head comparison between multiple 3D 
sequences. 
2. In an animal model, high resolution 3D LGE during contrast steady-state resulted in 
improved image quality on subjective assessment, improved SNR, CNR and more 
accurate estimation of dense scar and borderzone tissue volumes compared to 
standard 2D LGE imaging. 
3. The contrast steady-state protocol can be applied in patients but results in prolonged 
scan times whilst differences between 2D and 3D LGE acquisition modes were 
attenuated, compared to the animal model. 
4. Mean entropy of scar as a measure of scar heterogeneity is dependent on sequence 
acquisition mode. 
 
Although LGE-MRI has been extensively used for diagnostic purposes to characterise scar 
location and extent, conventional 2D LGE is of a low spatial resolution with a typical slice 
thickness of 8-10mm. The ‘critical’ substrate for re-entrant VT is surviving myocardium 
within an infarct zone which pathologically consists of surviving myocyte bundles 
interspersed by fibrous tissue resulting in anisotropic conduction (de Bakker et al. 1993). 
High resolution ex-vivo imaging has revealed that VT pathways are preferentially located in 
zones of infarct with a thickness <2mm suggesting that standard LGE techniques are of 
insufficient resolution to accurately identify surviving tissue (Pashakhanloo et al. 2018).  
 
Furthermore, not all scar is arrhythmogenic and there has been interest in using MRI-derived 
parameters to discriminate arrhythmogenic from non-arrhythmogenic scar. These include 
scar borderzone (or gray-zone), transmurality of scar as well as scar complexity (entropy). 
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Assessment of scar borderzone and transmurality are signal intensity-dependent and increase 
in proportion to spatial resolution of the MRI sequence used due to partial volume averaging 
(Schelbert et al. 2010). Scar entropy estimation appears a promising technique for risk 
stratification of patients at risk for VT (Muthalaly et al. 2018; Gould et al. 2019; Androulakis 
et al. 2019) but has previously been investigated using standard 2D LGE sequences.  
 
Given the technical challenges in detection of ‘critical’ regions of VT substrate, higher 
resolution 3D datasets may lead to improved identification of target areas. Previous studies 
using MRI to delineate the parts of scar required to sustain VT have mainly employed 
standard 2D LGE sequences to characterise imaging substrate with in-plane resolution 
ranging from 1.4 - 2.2 mm but with a slice thickness between 5-8mm (Gupta et al. 2012; 
Wijnmaalen et al. 2011; Perez-David et al. 2011). More recently, some investigators have 
used 3D imaging and reported an improved matching of ‘conducting channels’ to EAM with 
a 3D GRE LGE sequence compared to 2D GRE LGE and a 2D bSSFP LGE sequence 
(Andreu et al. 2015). In order to harness the power of MRI during real-time MR-EP, 
optimisation of LGE protocols to better visualise scar morphology is necessary. The optimal 
in-vivo LGE spatial resolution reported to date was 1.4mm3 with a mean scan acquisition 
time of 16.4 ± 7.2 minutes (Andreu et al. 2015). Using the contrast-steady state protocol, an 
improved spatial resolution was achieved (1.2mm3) in this thesis whilst maintaining the 
optimal TI for myocardial nulling.  
 
4.4.1 2D vs 3D acquisition modes   
On qualitative assessment, in both the animal model and patients, an improved overall image 
quality was reported on 3D vs 2D LGE. In addition, CNR between scar and normal 
myocardium and scar and blood pool were significantly improved with 3D LGE. A higher 
scar entropy was present with 3D LGE imaging highlighting the resolution-dependent nature 
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of entropy estimation. In the animal model, both core scar volume and borderzone tissue 
volume on 3D LGE more closely approximated the reference standard ex-vivo datasets 
compared to 2D LGE.  
 
When high resolution 3D LGE with contrast steady-state was applied in patients, the 
magnitude of difference with 2D LGE was reduced on both qualitative criteria (scar 
conspicuity, presence of artifacts) and quantitative criteria (SNR in scar and blood pool, core 
scar/ borderzone tissue volume) resulting in no statistically significant difference in these 
parameters. These differences could be explained by a number of factors. The animal scans 
were performed during general anaesthesia with close control of the respiratory cycle and 
improved scan acquisition efficiency. In contrast, clinical scans were performed in conscious 
patients with greater variation in their respiratory cycles during prolonged acquisitions. Scan 
times were longer in patients with reduced acquisition efficiency. In addition, prolonged scan 
times could have led to patient discomfort and movement affecting overall image quality 
compared to animals under general anaesthesia. The majority of patients scanned (6 out of 9) 
experienced episodes of arrhythmia during 3D imaging including slow VT, PVC or atrial 
fibrillation which resulted in mis-triggering and could have affected image quality. In 
contrast, only 1 animal experienced an episode of arrhythmia (PVC) during 3D imaging. All 
animals scanned had received prior treatment with amiodarone and lignocaine (Section 3.1) 
which could have reduced the incidence of arrhythmias. Given the requirement of high 
resolution MRI sequences needing repeated cyclical cardiac events to ensure robust imaging, 
the use of premedication and/or DC cardioversion in patients who are not in sinus rhythm at 
the time of imaging, prior to ablation, needs further exploration.  
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4.4.2 Head-to-head comparison between 3D sequences 
 
Direct head-to-head comparisons between multiple LGE sequences can be challenging due to 
contrast wash-out. In particular, 3D imaging can require prolonged scan durations and few 
comparisons have previously been made. (Viallon et al. 2011) reported improved image 
quality and CNR with a 3D GRE LGE technique compared to a 3D bSSFP LGE technique 
and multiple 2D techniques. However, spatial resolution of all sequences used were lower 
and did not always include full ventricular coverage compared to this thesis. The order of 
LGE sequences were randomised to prevent systematic errors due to a change in optimal TI 
over time. 3D imaging was performed during breath-holds instead of using a free-breathing 
protocol and isotropic 3D imaging was not performed.  
 
In this thesis, the use of contrast steady-state enabled acquisition of multiple high-resolution 
isotropic 3D LGE sequences under consistent contrast conditions. In this setting, overall 
image quality was better with the bSSFP technique qualitatively, but scar conspicuity relative 
to the LV cavity and absence of artifacts was best with the black-blood LGE technique 
(BOOST). Black-blood LGE has recently been proposed as an alternative sequence to 
improve scar-blood contrast and may be useful for detection of sub-endocardial scar and 
smaller scar regions (Basha et al. 2018; Ginami et al. 2018). Overall there were no significant 
differences in assessment of core scar volume and borderzone tissue volume between the 
three, 3D sequences and reference ex-vivo MRI datasets. However, a higher scar entropy was 
present with the bSSFP and BOOST techniques compared to GRE. Scan acquisition time for 
the BOOST sequence was also significantly lower and more predictable compared to the 
bSSFP and GRE sequences due to 2D image-based navigation enabling 100% scan 
efficiency.  
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Although conventional LGE imaging uses a GRE readout, it may be desirable to use a SSFP 
readout due to a higher SNR (Detsky et al. 2007). However, a higher bandwidth may be 
required with IR-SSFP in order to optimise TR leading to a lower CNR (Viallon et al. 2011). 
A 22% loss in CNR has been reported during comparison of 2D bSSFP LGE with a 2D 
segmented GRE LGE acquisition (Huber et al. 2005). The determination of T1 time may be 
underestimated during IR-GRE acquisitions due to the impact of low flip-angle excitation 
pulses on longitudinal magnetisation recovery but continuous refocusing of transverse 
magnetisation with IR-SSFP results in reduced impact on longitudinal magnetisation 
recovery and subsequently excellent T1 quantification (Scheffler et al. 2001). In this study, 
the were no differences between the 3D bSSFP and GRE LGE sequences on assessment of 
core scar and borderzone volumes but qualitatively an improved scar conspicuity relative to 
adjacent myocardium was noted and subsequently overall image quality. There were also 
more artifacts with the GRE sequence and longer scan acquisition times. These differences 
suggest that bSSFP protocol may be the optimal readout acquisition mode for high-resolution 
3D LGE imaging in most circumstances. The BOOST sequence may be optimal in the 
presence of sub-endocardial scar.  
 
4.4.3 Technique for quantification of myocardial scar 
In this thesis, the FWHM threshold and 35-50% of maximal signal intensity thresholds were 
used to quantify dense scar and borderzone tissue, respectively. A variety of methods have 
been reported in the literature to quantify scar and compared to EAM data. (Andreu et al. 
2011) reported that a cut-off of 60% of maximal signal intensity resulted in the best 
correlation between conducting channels on MRI and EAM. The same group used an 
automatic algorithm to classify pixels with a signal intensity between 40-60% as borderzone - 
channels identified using this method identified ~75% of the critical isthmus of clinical VTs 
(Fernandez-Armenta et al. 2013). Other groups have used a n-SD method whereby core scar 
 128 
was defined as pixels with a signal intensity ≥3SD above mean signal intensity whilst 
borderzone tissue was between 2-3SD above mean signal intensity (Estner et al. 2011; Yan et 
al 2006; Watanabe et al. 2014).  
 
Although LGE volume can vary significantly depending on the thresholding technique used, 
direct comparisons of quantification methods suggest that the FWHM threshold is the most 
reproducible and similar to manual quantification (Flett et al. 2011). There is no agreement 
on the optimal technique for borderzone tissue quantification, however the 35-50% of 
maximal signal intensity method had a mildly improved ability for the prediction of VT in 
patients with ischaemic cardiomyopathy compared to the n-SD method, although this did not 
reach statistical significance (de Haan et al. 2011).  
 
4.4.4 Entropy as a measure of tissue heterogeneity 
The measurement of scar entropy has emerged as a novel signal-intensity independent 
parameter to evaluate the complexity of scar. A narrow signal intensity distribution represents 
low entropy and less inhomogeneity. Tissue harbouring the substrate for VT could 
theoretically have higher local entropy as a result of inhomogeneity caused by the presence of 
both surviving myocardium and scar tissue. (Androulakis et al. 2019) reported that patients 
with ischaemic cardiomyopathy who had a scar entropy ≥ 7.82 had a lower VT-free survival 
compared to patients with scar entropy <7.82, after adjustment for multi-vessel disease, acute 
revascularisation, LVEF, scar gray-zone and transmurality. Two subsequent independent 
cohort of patients with ischaemic and non-ischaemic cardiomyopathy have reported that 
mean entropy is predictive of subsequent VT (Muthalay et al. 2018; Gould et al. 2019) and 
could prove useful as a risk stratification tool to determine the need for ICD implantation. All 
three reports used standard clinical 2D LGE sequences during measurement of entropy.  
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In this thesis, scar entropy values were sequence and spatial resolution-dependent with higher 
entropy values with 3D LGE compared to 2D LGE. Furthermore, 3D bSSFP LGE and 
BOOST also gave significantly higher entropy values compared to 3D GRE LGE imaging. 
For application during real-time MR-EP, evaluation of higher regional scar entropy values 




The LGE sequences evaluated in this study were not compared to histological assessment for 
validation. Instead, high resolution ex-vivo MRI datasets were used as the reference standard. 
Despite attempts to maintain the shape of the LV cavity ex-vivo using kinetic sand, there is a 
tendency for the LV to collapse ex-vivo with subsequent changes to tissue volumes 
(Whitaker et al. 2019) and this data should therefore be interpreted with caution.  Although 
eleven pigs completed 3D bSSFP LGE imaging combined with 2D LGE, the additional 3D 
GRE and BOOST sequences could only be completed in six animals due to time constraints 
within the imaging facility. The 3D GRE sequence was attempted in a further 2 animals but 
had to be abandoned due to the presence of PVCs in these animals which was increasing the 
time required for scan acquisition. The 3D bSSFP sequence was chosen as the technique to 
evaluate high-resolution imaging with contrast steady-state in patients. Due to patient 
comfort and tolerance considerations, the addition of 3D GRE and BOOST sequences were 
not evaluated and it is unknown if different results would have been obtained with those 
techniques. In order to evaluate the performance of high-resolution 3D LGE imaging with 
contrast steady-state without the confounding effect of device-related artifacts, patients 
without an ICD in-situ were deliberately studied. Given that VT ablation is primarily an 
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adjunctive treatment, the majority of patients referred for ablation will have a device in-situ. 
The performance of high resolution 3D LGE imaging with contrast steady-state in the 
presence of an implanted device remains unknown and further investigation is required.   
 
The qualitative and quantitative measurements reported in this study are dependent on signal 
intensity within the acquired MRI scans. Variation in signal intensity between MR images 
may occur due to type of sequence, haematocrit, renal function, field strength and surface coil 
proximity and these factors should be taken into account when extrapolating these results to 
different scenarios.  
 
Although histological evaluation is generally considered the gold-standard to validate 
imaging data, there are several limitations to using whole-mount 3D histology including the 
high costs and labour intensive endeavour of creating reconstructed histology slabs from 
individual slices, challenges in the registration of data between MRI and histology when 
significant deformations/shrinkage of tissue occurs during histological processing and the 
lack of a clear histological definition of borderzone tissue (Pop et al. 2013; Glashan et al. 
2018). In addition, the definition of borderzone tissue (on histology) can be affected by 
multiple factors during processing including the magnification technique used, stain used for 
collaged quantification or using a 2D vs 3D technique for assessment of fibrosis (Schelbert et 
al. 2010). Given that high-resolution ex-vivo MRI can be used to achieve sub-millimetre 
spatial resolution, is not affected by perfusion or motion-related artifacts and can be 
accurately co-registered to in-vivo imaging (Whitaker et al. 2019), this was used to validate 




This study demonstrates the use of the contrast steady-state protocol to enable high resolution 
imaging of myocardial scar under consistent contrast conditions and provide an experimental 
model whereby multiple 3D sequences may be compared against each other. Overall, the 3D 
bSSFP LGE sequence provided the optimal readout mode in most circumstances whilst the 
3D BOOST sequence may be optimal in the presence of sub-endocardial scar. Scar entropy, 
as a measure of tissue inhomogeneity is sequence and spatial resolution dependent.  
 
Although the contrast steady-state protocol can be applied in patients, both qualitative and 
quantitative measures of image quality were lower with 3D imaging due to prolonged scan 
acquisitions, patient tolerance and the presence of arrhythmias.  
 
In the next chapter, the contrast steady-state protocol is applied during real-time MR-EP 
procedures in the animal model of ischaemic cardiomyopathy to acquire high-resolution 3D 
bSSFP LGE datasets and assess the association between structural and electrophysiological 
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derived from MRI and voltage maps. All segmentations and statistical analyses were 
performed by me.  
 
 
5 Evaluation of a real-time MRI-guided electrophysiology 
system for structural and electrophysiological ventricular 





There is growing interest in the use of real-time magnetic resonance imaging-guided 
electrophysiology (MR-EP) to treat patients with cardiac arrhythmias (Chubb et al. 2017; 
Hilbert et al. 2016). Potential advantages of MR-EP procedures include soft tissue 
visualisation with a high contrast-to-noise ratio, improved assessment of arrhythmia 
structural substrate using late gadolinium enhancement (LGE) scar imaging, navigation of 
catheters using dedicated tracking techniques, online monitoring of ablation lesion formation 
and an evaluation of anatomic and physiologic changes during mapping and lesion delivery 
(Mukherjee et al. 2018).  
 
Although most preliminary real-time MR-EP studies have been performed in the atria, where 
significant technical challenges remain for accurate substrate evaluation (Hilbert et al. 2016; 
Chubb et al. 2017; Paetsch et al. 2019), MRI is the gold standard imaging modality for 
assessment of ventricular function and scar burden (Dawson et al. 2013). Combined MR-EP 
techniques could offer synergistic benefits for the evaluation and ablation of ventricular 
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tachycardia (VT) substrate. Previous studies using conventional mapping systems and image 
integration where the association between electrical substrate for VT and MRI-derived scar 
have been investigated, have reported conflicting results. (Wijnmaalen et al. 2011) found that 
bipolar voltage decreased with increasing scar transmurality in patients undergoing VT 
ablation. Similarly, (Sasaki et al. 2012) reported an inverse association between bipolar 
voltage and endocardial and mid-wall scar transmurality. However, other groups have 
reported a mis-match in scar areas between EAM and MRI in up to 33% of cases (Codreanu 
et al. 2008). These studies acquired pre-procedural imaging days or weeks prior to an 
ablation procedure and possible changes in loading conditions and/or rhythm could have 
occurred since the time of imaging and time of mapping. Furthermore, registration errors on a 
scale between 3.8 - 4.3mm (Wijnmaalen et al. 2011; Desjardins et al. 2009) have invariably 
been reported, which could be a significant source of mis-match. The choice of optimal 
thresholds to define both electrical scar and MRI-derived scar is also an important 
consideration. Using an optimal bipolar voltage threshold of 1.0mV, a sensitivity of 79% and 
specificity of 84% was reported in the identification of LGE regions on MRI (Desjardins et 
al. 2009). Using a signal intensity threshold of 60% of maximum to identify dense scar on 
MRI, a degree of agreement was reported between bipolar voltage and MR-derived scar, but 
this agreement remained moderate (Cohen K co-efficient = 0.70) (Andreu et al. 2011). 
Furthermore, in regions of intermediate bipolar voltage (0.5 - 1.5mV), a disagreement with 
MR-derived borderzone tissue regions was present in 21.7% of locations (Andreu et al. 
2011). The method of analysis has also varied between studies. (Wijnmaalen et al. 2011) 
divided each short-axis MRI slice into 20 segments to compare the association with bipolar 
voltage. A similar approach was employed by (Sasaki et al. 2012). A segmental approach for 
analysis may be less precise compared to a point-by-point registration approach (Audette et 
al. 2000).  
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The influence of spatial resolution of MRI on classification of scar areas was also recently 
described (Lopez-Yunta et al. 2019). In a swine model of myocardial infarction, 25% of 
voltage-derived scar areas in the LV endocardium were classified as non-enhanced on in-vivo 
MRI (spatial resolution - 1.5mm3) whilst 43% of voltage-derived scar areas were non-
enhanced on high-resolution ex-vivo MRI (spatial resolution - 0.6mm3), highlighting the 
importance of image resolution on the specificity of scar characterisation.  
 
Against this background, this study sought to assess the relationship between structural and 
electrophysiological substrate using a real-time MR-EP system, a high-resolution 3D LGE 
sequence (based on work described in the previous chapter) and a point-by-point analysis 
technique. Real-time MR-EP enables image registration to be performed within a single 
imaging modality, acquire imaging and electrical data in the same coordinate system and 
minimise translational changes due to beat-to-beat cardiac motion and respiratory motion.   
 
In this study, we describe the ability of a novel real-time MR-EP system to perform 
endocardial voltage mapping and limited assessments of delayed conduction in a porcine 
ischaemia-reperfusion model taking advantage of custom technical developments in a second 
generation MR-compatible catheter and a dedicated prototype image-guidance platform for 
interventional procedures. We hypothesised that with the minimisation of registration errors 
and translational changes expected using a real-time MR-EP platform, an improved 




5.2.1 Animal model and infarct preparation 
The research protocol was approved by the local institutional review board and complied 
with French law on animal experiments and the Guiding Principles for the Care and Use of 
Laboratory Animals published by the National Institutes of Health (8th Edition, National 
Academies Press, 2011). The research was performed at the Institut de Chirurgie Guidée par 
l’image (IHU), Strasbourg, France. Seven male domestic pigs (weight - 35.7 ± 5kg; 2 
healthy, 5 post infarction) were treated with 800mg amiodarone, twice daily for 4 days prior 
to and following an infarct procedure and/or imaging and electrophysiology studies. A 
closed-chest model of myocardial infarction was used as described in Section 3.1.1. The 
purpose of using two normal heart pigs was to ensure a robust workflow was in place for 
mapping prior to attempting the procedures in the scar model as well as ensuring that the 
SNR of EGMs recorded in the normal LV from inside a MRI scanner was sufficient to justify 
proceeding with experiments in the infarct model where low voltage regions would be 
present.  
 
5.2.2 Imaging study 
All animals underwent a MRI scan for substrate assessment 6 weeks after infarct on a 1.5T 
scanner (MAGNETOM, Aera, Siemens Healthcare, Erlangen, Germany). Each animal was 
sedated, intubated and mechanically ventilated as per the infarct procedure for all imaging 
studies. A 3D ECG-triggered whole heart bSSFP MRI dataset was acquired to enable manual 
segmentations of cardiac chambers (transverse slice orientation, AP phase encoding, 256 x 
256 in-plane matrix size, TR/TE/α = 3.7ms/1.64ms/90o, voxel size = 1.25x1.25x2.5mm3, 
bandwidth = 895Hx/Px, GRAPPA factor = 2). For scar imaging, contrast was administered 
(Gadovist, Bayer, Germany) using an initial bolus (0.1mmol/kg) followed by slow infusion of 
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gadolinium contrast was initiated at a rate of 0.0011mmol/kg/min, as described in Section 
4.2.1. High-resolution 3D late gadolinium enhancement (LGE) imaging was performed using 
a free-breathing, respiratory navigator and ECG-gated (in diastole) inversion recovery, b-
SSFP sequence ((TR/TE/α=3.45ms/1.5ms/90°, FOV=339×264×100mm3, voxel 
size=1.2×1.2×1.2mm3, bandwidth=895Hz/Px, GRAPPA factor=2, 2RR acquisition). The 
choice of 3D LGE sequence was based on the results described in Chapter 4. Based on the 
LGE-MRI, scar was manually segmented using a version of the Medical Imaging Interaction 
Toolkit (MITK, Heidelberg, Germany) with the full-width-half-maximum (FWHM) 
threshold used to define scar and help guide electroanatomic mapping (EAM) during the 
subsequent procedure.  
 
5.2.3 Real-time MRI-guided electrophysiology procedure 
Vascular access was obtained via the femoral artery and vein under ultrasound guidance (9Fr 
or 10Fr introducer sheath) followed by administration of 100 units/kg of intravenous heparin. 
Using retrograde aortic access, the custom 9Fr, MR-compatible steerable catheter with a 
single gold 3.5mm tip and ring bipolar electrode (3.5mm inter-electrode spacing) and six 
circumferential open irrigation ports (Vision-MR, Imricor, Burnsville, MN, USA) was 
advanced into the LV cavity without the use of fluoroscopy at any point. Active catheter 
tracking (Section 3.2.2) was used to place the catheter within the LV and manoeuvre to 
different locations - Figure 5-1. The iCMR image guidance platform (described in Section 
3.3.1) displayed the 3D segmentations of each cardiac chamber (LV, RV, LA and RA) 
imported from the MITK-based platform. The 3D segmentation of scar from the LGE-MRI 
was overlaid onto the shell of the LV to guide EAM.  
 
A custom MR-EP recording system (Advantage-MR, Imricor, Burnsville, MN, USA) was 
used to record, amplify, filter, display and analyse intra-cardiac EGMs. The system consisted 
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of an integrated stimulator which was used to generate pacing stimuli. This system allowed 
mapping of activation time and voltage to be combined synergistically with real-time 
imaging of anatomy and LGE substrate.  
 
Figure 5-1: MR-compatible catheter, tracking coils and tracking signal 
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Example images of catheter tracking coils (A) which are used to determine catheter position in 3D space using the active 
tracking sequence. The catheter and handle (B and C) have been optimised to operate within the ventricle inside a MRI 
scanner. The robustness of the active tracking sequence can be assessed from the signal-to-noise ratio of the proximal and 
distal tracking coils which are displayed (D) when the sequence is run on the MRI scanner. The image (D) shown represents 
the signal from the tracking coils of 2 separate catheters - one in the right atrium (top 2 signals) and one in the left ventricle 
(bottom 2 signals).  
 
5.2.4 Intra-cardiac electrogram recording and characterisation 
Activation and voltage data were acquired during sinus rhythm. For each sampling point, the 
time delay (LAT) from a fixed intra-cardiac reference point to the initial deflection of the 
local LV electrogram was measured manually on the EP recording system and data 
transferred to the iCMR image guidance platform. Similarly, the peak-to-peak voltage 
amplitude was also measured manually and transmitted to the guidance platform - Figure 5-
2. Both datasets were used to generate colour-coded activation and voltage maps on the 
iCMR platform. Areas of focused mapping were based on the location of LGE-derived scar. 
In order to avoid EGM artifacts due to poor catheter-tissue contact, at least 2 consecutive 
EGMs had to have the same morphology prior to acceptance of each mapping point. Regions 
of abnormal myocardium were defined as areas with a bipolar voltage threshold <1.5mV 
(Tung et al. 2016). EGMs were reviewed off-line at a sweep speed of 100mm/s.  
 
After acquisition of activation and voltage maps, the LV catheter was used to pace during 
stable sinus rhythm (10mA, 3ms, cycle length 10% shorter than sinus cycle length) from sites 
of normal myocardium and scar. The time from the stimulus artefact to the surface QRS 
onset was used to distinguish regions of normal and delayed conduction. Following 
confirmation of capture, the time duration between the stimulus artefact to QRS onset was 
recorded. The MR-compatible catheter was sequentially manoeuvred to sites within normal 
myocardium and scar using active catheter tracking to generate a colour-coded map of 
stimulus-QRS duration times (S-QRS). Sites with a S-QRS >40ms during pace-mapping in 
sinus rhythm were considered regions of slow conduction as previously described 
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(Brunckhorst et al. 2003). Following completion of the MR-EP procedure, pigs were 
euthanised with potassium chloride and hearts were rapidly dissected for gross pathological 
examination. Hearts were photographed with areas of ischaemic scar delineated.  
 
 
Figure 5-2: MR-EP system set-up 
 
5.2.5 Image registration, scar segmentation and comparison to voltage maps 
The LGE-MRI imaging was registered to the 3D whole heart MRI datasets using a point-
based (landmark) rigid registration to guide EAM. Points were selected within the RV, LV 
and LA blood pools of each image dataset. Registration was performed on the Medical 
Imaging Interaction Toolkit (MITK) [https://doi.org/10.1016/j.media.2005.04.005]. Scar was 
segmented on the LGE-MRI using the FWHM method to normalise signal intensity relative 
to maximum myocardial signal intensity. First, the LV wall was manually segmented using a 
custom version of MITK. This was performed using the ‘Paint Tool’ on the MITK-based 
platform to derive the endocardial and epicardial border on a slice-by-slice basis with 3D 
interpolation to minimise discontinuities between slices. Then, the maximum signal intensity 
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within the LV wall was computed and the voxels with signal intensity above 50% of the 
maximum intensity (FWHM) were labelled as scar - Figure 5-3.  
 
 
Figure 5-3: Image processing 
Representative examples of segmentations of the LV wall (A and B) from 3D LGE-MRI images generated using the custom 
version of MITK and corresponding 3D shell (C) generated.  
 
To compare the scar segmentation with regions of low voltage, the scar segmentation was 
mapped onto the voltage map surface mesh. This was achieved in two steps. First, the scar 
segmentation image was rotated and translated so that it was aligned with the surface mesh. 
Second, the scar points were mapped onto the surface mesh using the iterative closest point 
(ICP) method. In addition, the voltage map was converted to a binary map of scar (1) and 
normal tissue (0). In this ischaemia-reperfusion model, scar has been noted to be transmural 
in the majority of myocardial segments with LGE (Tschabrunn et al. 2016). The Sorensen-
Dice similarity coefficient (DSC) between the two binary maps was then computed on a 
nodal basis for all regions, scar regions only and regions of normal myocardium. The DSC 
between LGE scar maps and voltage maps following thresholding at different cut-offs 
(0.5mV-3.5mV) was also derived. The normal heart pigs (n=2) were not used for assessment 
of scar concordance and all data reporting ROC curves and DSC refer to infarct hearts only.  
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5.2.6 Statistical analysis 
Data analysis was performed using GraphPad Prism version 7.0 (GraphPad Software, CA, 
USA) or SPSS v24.0 (IBM Corp. Armonk, NY, USA). Continuous data are represented as 
mean ± SD and compared using the Student’s two-tailed T-test. A 2-sided p value <0.05 was 
considered statistically significant. For assessment of the accuracy of the MR-EP system to 
correctly identify scar and delayed conduction, the location of LGE-derived scar was taken as 
the ‘gold standard’ of structural substrate. The sensitivity, specificity, positive predictive 
value and negative predictive value of low voltage points and S-QRS times using the MR-EP 
system to identify LGE-scar was assessed and used to derive receiver operator characteristic 
(ROC) curves.  
 
5.3 Results 
All pigs that underwent a LAD infarct developed antero-septal scar which was visualised on 
the LGE images (mean scar volume - 6.80 ± 0.88ml) - Figure 5-4. There was no LGE present 
in healthy pigs that did not undergo the LAD infarct procedure.  
 
Figure 5-4: LGE-MRI images of infarct 
LGE-MRI images acquired 6 weeks post infarct showing region of anteroseptal scar (D-E) - short-axis, 4-chamber and 3-
chamber views shown. Red arrows show location and extent of LGE.  
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5.3.1 Real-time MRI-guided electroanatomical mapping 
Segmentations of scar from the LGE-MRI were displayed on the iCMR image-guidance 
platform as coloured shells to guide EAM - Figure 5-5. 445 EGMs (range 30-186) were 
recorded from all animals in sinus rhythm (including 138 EGMs from regions located within 
the LGE scar segmentation). Using the MRI-derived LGE segmentation to differentiate 
between normal myocardium and scar, the mean signal-to-noise ratio (SNR) of EGMs within 
normal tissue and scar was 44.78 ± 21.91 and 11.67 ± 6.99 respectively (p<0.0001) - Figure 
5-6. Pacing captured at 103 sites whilst 10 sites which were all in regions of LGE-derived 
scar did not capture; 56 (54.4%) sites had S-QRS delay £40ms, 47 (45.6%) sites had a delay 
of ³40ms whilst 15 (14.5%) had a delay ³80ms. Representative examples of voltage and S-
QRS maps obtained using the system are shown in Figure 5-7.  
 
 
Figure 5-5: Depiction of scar, catheter, segmentations and MRI scans on image guidance platform 
Representative depiction of image guidance platform showing 3 orthogonal MRI views demonstrating location of catheter in 
relation to LV endocardium, 3D segmentation of the left ventricle derived from MRI and scar segmentation from LGE 




Figure 5-6: Intra-cardiac EGMs obtained inside the MRI scanner and signal-to-noise ratios within normal myocardium and 
scar tissue 
Representative examples of intra-cardiac EGMs obtained using the MR-EP system in a region of normal myocardium (Point 
1) and area of scar (Point 2) (A-C). The baseline noise level inside the MRI scanner was in the region of 0.1mV 
(approximately 10-fold higher than that in the conventional electrophysiology laboratory). Dot-plot showing signal-to-noise 







Figure 5-7: Representative examples of segmented LGE scar, voltage and S-QRS maps obtained using real-time MR-EP 
system in 2 animals (Panel A and B) 
 
5.3.2 Relationship between MRI-derived scar, voltage and delayed conduction 
Using conventional (0.5mV-1.5mV) bipolar voltage thresholds, the sensitivity and specificity 
of voltage mapping using the MR-EP system to identify MR-derived LGE was 57% and 96% 
respectively (ROC area under curve = 0.907; p<0.0001). A S-QRS threshold of >40ms using 
this system resulted in a sensitivity of 76% and specificity of 73% to identify MR-derived 
LGE (ROC area under curve = 0.840; p<0.0001) - Figure 5. At a threshold of 1.5mV to 
define abnormal myocardium, the positive predictive value (PPV) and negative predictive 
value (NPV) of voltage mapping to identify LGE was 86% and 83% respectively. At a 
threshold of 40ms, the PPV and NPV of S-QRS time using the system to identify LGE was 
73% and 79% respectively - Figure 5-8.  
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Figure 5-8: ROC curves for prediction of LGE regions using voltage mapping and S-QRS 
ROC curves (A and C) for prediction of LGE regions using voltage mapping and S-QRS. Frequency histograms (B and D) 
displaying the true positive, false positive, true negative and false negative counts of voltage mapping and S-QRS 
measurements using the real-time MR-EP system to predict MRI-derived scar. Sensitivity, specificity, PPV and NPV of 
measurements using the system using different normal voltage cut-offs and S-QRS times (E-H).  
 
There was a moderate relationship between low voltage regions in the LV endocardium and 
LGE-derived scar mapped onto the endocardial surface mesh - Figure 5-9. At a voltage 
threshold of 1.5mV, mean DSC across all nodes was 79.0% ± 6.0%, whilst mean DSC within 
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scar regions only was 35.0% ± 10.1% and 90.4% ± 8.6% in normal myocardium regions 
only. An improvement in DSC within scar regions was observed using a higher voltage cut-
off of 2.0mV and 2.5mV (47.3 ± 9.9% and 60.2 ± 22.4%) at the expense of reduced 
agreement across regions of normal myocardium - Figure 5-10.  
 
 
Figure 5-9: Sorenson-Dice similarity co-efficient between MR-derived scar shells and endocardial voltage maps with 




Figure 5-10: Dice similarity co-efficients (DSC) between MR-derived scar shells and endocardial voltage maps acquired 
using MR-EP system following application of normal cut-off thresholds of 0.5-3.5mV. DSC is shown for overall similarity, 
similarity across scar nodes and normal myocardium nodes. 
 
5.4 Discussion 
This study shows that the prototype real-time MR-EP system can be used to guide catheters 
to regions of scar using active catheter tracking and to distinguish regions of low voltage and 
delayed conduction from healthy myocardium. There is a moderate relationship between low 
voltage and LGE scar using conventional bipolar voltage thresholds. An improved sensitivity 
for LGE detection may be achieved using higher bipolar voltage cut-offs with this system.  
 
The relationship between local EGM amplitude and scar is complex, in part due to the 
dependence of voltage on infarct size, heterogeneity and transmurality (Lopez-Yunta et al. 
2019). Conventional bipolar voltage thresholds for scar detection may lack sensitivity to fully 
detect scar as variations in inter-electrode spacing and recording electrode size may affect the 
representation of EGMs (Tung et al. 2016). Furthermore, although LGE-MRI is the current 
gold standard for visualisation of ventricular scar post myocardial infarction, the limited 
spatial resolution of in vivo LGE-MRI can result in partial volume effects and limit the 
specificity of scar characterisation (Lopez-Yunta et al. 2019). Increasing mapping resolution 
using multi-electrode catheters may also result in detection of a smaller area of low bipolar 
voltage as each data point represents a smaller tissue area with less far-field contamination 
(Tschabrunn et al. 2016). The use of multi-electrode catheters could improve the correlation 
between EAM and imaging as has been shown in a randomised study (Acosta et al. 2018). 
An additional source of discrepancy when correlating EAM and pre-procedural imaging is 
registration error due to translational changes (patient movement, cardiac or respiratory 
motion) or changes in volume, orientation or rhythm of the heart between time of imaging 
and EAM (Roujol et al. 2016).  
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The real-time MR-EP system minimises registration error through registration of electrical 
and structural data within a single imaging modality with the same coordinate system. The 
3D whole heart sequence used for chamber segmentation was acquired during the same phase 
of the cardiac cycle as the 3D LGE to minimise translational changes due to beat-to-beat 
cardiac motion. Furthermore, both sequences were performed when animals were under 
general anaesthesia with reduced variability in respiratory motion thereby minimising 
translational changes due to respiratory motion. Compared to image integration approaches, 
where positional errors are introduced when registering catheter position to pre-procedural 
imaging, the MR-EP system tracks catheter position directly using a dedicated tracking 
sequence that is acquired in the same coordinate system as the 3D whole heart and LGE 
scans. The main sources of error with the MR-EP system include within scan registration 
error and catheter tip displacement on the 3D shell with the active tracking sequence. In a 
cohort of conscious patients scanned with an angiography sequence to create an endocardial 
mask and a 3D LGE acquisition, the within scan translation error was noted to be 1.9 ± 
1.6mm with a rotation error of 0.62 ± 0.41o (Chubb et al. 2018). This is, however, likely to 
overestimate within scar error with the MR-EP system where translational movements were 
minimal as animals were under general anaesthesia. Using ex-vivo technical validation, the 
average tip displacement of the actively tracked catheter using the MR-EP system was 
measured as 0.90 ± 0.58mm along the axis of the catheter (Chubb et al. 2017) and is likely to 
be the best estimate of error with this set-up.  
 
In this study, we show that despite the minimisation of registration and translational errors, 
the relationship between scar delineated using a custom MR-compatible catheter and high 
resolution isotropic LGE imaging (1.2mm3) remains moderate when using standard voltage 
thresholds. An improvement in scar concordance with this system can be achieved using a 
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higher normal bipolar voltage cut-off. Some investigators have found that abnormal 
potentials targeted for ablation may be present in tissue classified as ‘normal’ (>1.5mV) 
voltage and manual adjustment of bipolar voltage thresholds to higher cut-off values may 
identify more confluent scar regions incorporating all abnormal signals (Jais et al. 2012). 
Regions of slow conduction could also be present in tissue of normal bipolar voltage and 
unmasked during extrastimulus pacing (Acosta et al. 2018).   
 
Although the majority of real-time MR-EP studies published previously have focused on the 
atria, the full potential of substrate and lesion assessment afforded by such systems is likely 
to be realised in the context of VT ablation. There are limited data available evaluating real-
time MR-EP systems in the ventricle (Nazarian et al. 2008; Oduneye et al. 2013; Oduneye et 
al. 2015). Our study builds on previous work to characterise the relationship between LGE-
derived scar and electrophysiological measurements of low voltage and delayed conduction 
inside a MRI scanner.  
 
Currently, limited visualisation of soft tissue structures is possible in the electrophysiology 
laboratory with the use of intra-cardiac ultrasound (ICE), however MRI offers an improved 
contrast-to-noise ratio and ability to acquire 3D whole heart images or 2D slices in any 
imaging plane. Furthermore, tissue characterisation techniques such as LGE can be used to 
identify arrhythmogenic substrate whilst dedicated sequences can be used to monitor tissue 
temperature during ablation and provide a real-time method of calculating lethal thermal dose 
(Mukherjee et al. 2018). The novel MR-EP system described is capable of visualising the 
location and orientation of catheters relative to soft tissue, assess scar with MRI at the time of 
EAM, enable rapid segmentation and registration of cardiac chambers and potentially 
monitor formation of ablation lesions (Mukherjee et al. 2018). These features of the MR-EP 
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system could offer an alternative to conventional fluoroscopy-guided or ICE-guided 
procedures and improve catheter navigation, delivery of therapy and assess anatomical and 
physiological changes during VT ablation with the potential to reduce risks and improve 
outcomes.  
 
A number of technical developments are required prior to the realisation of real-time MRI-
guided VT ablation. The development of a MRI-compatible defibrillation system will be a 
prerequisite prior to any clinical studies and prototypes are currently under evaluation 
(Schmidt et al. 2016). Current surface ECG monitoring systems inside a MRI scanner are 
limited to 4-6 surface electrodes; in order to aid the diagnostic electrophysiology 
requirements of VT ablation, robust 12-lead ECG systems are required. Although high-
fidelity 12-lead ECG recordings are possible (Tse et al. 2014), the impact of magneto-
hydrodynamic effects and gradient switching-induced voltages within the MRI scanner can 
still corrupt ECG signals. There is currently a limited availability of MR-compatible devices; 
the development of MR-compatible multi-electrode catheters with similar capabilities to their 
conventional counterparts will accelerate progress in the electrophysiological assessment of 
substrate inside the scanner (Elbes et al. 2017).  
 
5.4.1 Limitations 
There are several important limitations to this study. We did not define the bipolar voltage 
threshold that best correlates to histological scar using the MR-compatible catheter - rather 
two indirect methods of scar assessment were compared to each other. During assessment of 
S-QRS intervals to assess slow conduction, a single ECG lead was used to derive 
measurements due to the lack of availability of a MRI-compatible 12-lead ECG; as a result, 
no assessment of QRS morphology using a 12-lead ECG was performed during pacing. 
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These measurements should therefore be interpreted with caution as we could not account for 
local latency although this would be expected to be minimal at the pacing cycle length used. 
Furthermore, the technique of S-QRS measurements may have limited sensitivity for the 
detection of regions of myocardium with slow conduction compared to an approach 
analysing the evoked response to extrastimuli (Acosta et al. 2018). In this model, 
haemodynamic compromise and death of the animal was inevitable if VT was induced. As 
there was no means to defibrillate the animal inside the scanner, we deliberately avoided the 
induction of VT which in turn precluded entrainment mapping. As the location of LGE was 
used to guide ventricular mapping, there is a degree of sampling bias introduced during 
collection of mapping points. The purpose of the system being used in this way was to 
demonstrate the potential advantages and workflow of the MR-EP system. However, in order 
to perform a stepwise comparison of concordance between imaging scar and electrical scar, it 
would be necessary to remove this sampling bias by performing EAM independently 
(without LGE overlaid onto 3D shell) and retrospective evaluation.  
 
There was a large variability in the number of points collected per animal (range: 30-186). 
This was in part due to the difficulty with catheter manoeuvrability to access different parts 
of the LV inside the MRI scanner. We used retrograde aortic access to enter the LV rather 
than trans-septal puncture, due to the difficulties in performing trans-septal puncture inside a 
MRI scanner. It was difficult to access certain parts of the LV (e.g. LV summit) from 
retrograde aortic access. As a result, we tried to collect points from the region of LGE as well 
as a variety of locations where normal myocardium was expected. If it was not possible to 
sequentially move the catheter to certain locations, we decided not to collect multiple points 
from the same region as it was likely to add very little to the overall map.  
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In one particular animal, we were able to successfully acquire 186 points - however this was 
a relatively prolonged procedure and required > 3 hours of mapping. The animal frequently 
developed runs of NSVT during the procedure. The decision to stop mapping was influenced 
by the haemodynamic status of each animal, development of arrhythmias and changes in the 
manouverability of the catheters during a prolonged procedure. 
 
The MR-EP system used in this study consisted of a single electrode catheter and required 
manual annotation of activation times and voltages for each point on the EP recording system 
resulting in substantially lower mapping densities than with contemporary EAM systems. 
This could have lowered the precision of the sensitivity and specificity measures reported in 
the study. The development of automated mapping systems and multi-polar catheters for use 
inside the MRI scanner could better define the relationship between electrophysiological 
substrate and MR-derived substrate.  
 
5.5 Conclusions 
There is a moderate association between low voltage regions and sites of altered conduction 
determined using a novel real-time MR-EP system with scar derived from LGE-MRI. An 
improved sensitivity for LGE detection could be achieved using a higher normal voltage cut-
off with this system and the respective catheter. Further technical developments in MR-
compatible devices will accelerate progress towards real-time MRI-guided VT ablation.  
 
The next chapter builds on the work described to evaluate the accuracy of the MR-EP system 
in delivering ablation lesions. In addition, a MR technique to assess ablation lesions in real-
time (MR-thermometry and dosimetry) is also evaluated.  
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6 Catheter ablation and lesion imaging in the porcine left 
ventricle under real-time MRI-guidance  
 
6.1 Introduction 
The long-term recurrence rate following catheter ablation of VT in patients with structural 
heart disease has been reported as between 40-60% (Kuck et al. 2010; Stevenson et al. 2008; 
Al-Khatib et al. 2015). Meanwhile, the risks of VT ablation are considerable with a 5% risk 
of procedure-related mortality (Santangeli et al. 2017). Significant complications including 
cardiac tamponade, major bleeding and stroke are also not uncommon. Causes of treatment 
failure may include an inability to create fully transmural scar, difficulty in reaching regions 
of myocardium containing arrhythmogenic substrate and inaccurate lesion targeting (Tokuda 
et al. 2013).  
 
In the conventional electrophysiology laboratory, assessment of the location of ablation 
lesions is limited and based on either X-ray fluoroscopy with EAM, with no evaluation of 
soft tissue or through the use of intra-cardiac ultrasound (ICE). Although ICE can be used to 
assess catheter position and tip-tissue contact, it requires invasive placement, provides a 
limited field of view and image plane orientation. Furthermore, conventional techniques to 
determine the size of ablation lesions rely on mathematical modelling of limited surrogate 
markers including local impedance change, RF power, RF application time, electrode tip 




Real-time MRI guidance during catheter ablation could allow a direct assessment of catheter 
position and its relation to soft tissue with a high contrast-to-noise ratio (CNR) (Nordbeck et 
al. 2011). In addition, MRI could be used to monitor lesion development, alongside 
visualisation of anatomic and physiologic changes during lesion delivery (Guttman et al. 
2018). The combination of improved navigation, accurate lesion placement and online 
visualisation of lesion characteristics could potentially reduce risks and improve the outcome 
of VT ablation.  
 
Contrast-enhanced MRI with LGE has been used to non-invasively assess RF ablation lesions 
(Dickfeld et al. 2006) however, acute LGE may grossly overestimate chronic lesion size 
(Kholmovski et al. 2018). Contrast can also only be given once during a procedure which 
limits the utility of LGE for real-time interventions. In order to facilitate repeated lesion 
assessments, the development of non-contrast MR sequences is required. A combination of 
T1-weighted imaging to visualise lesion necrosis (Guttman et al. 2018) and T2-weighted 
imaging to assess myocardial oedema can be used concurrently to assess the physiological 
response post ablation and monitor acute lesion composition (Krahn et al. 2018). However, 
these sequences are typically performed at the end of a procedure and not in real-time. 
Recently, there has been significant interest in the development of MR tools to evaluate 
lesions in real-time and MR-thermometry and dosimetry have emerged as an exciting means 
to directly monitor tissue temperature and estimate lesion size, respectively (de Senneville et 
al. 2012).   
 
In this chapter, the accuracy of the MR-EP system previously described, is evaluated to 
deliver ablation lesions in the porcine left ventricle. In addition, the use of MR-thermometry 
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and dosimetry to enable real-time visualisation in normal porcine hearts is described 
including ex-vivo technical development.  
 
6.2 Methods 
6.2.1 Ex-vivo technical validation of MR-thermometry 
Ex-vivo studies were performed to assess the temperature stability of the MR-thermometry 
sequence without catheter ablation. In addition, catheter ablation was performed to 
demonstrate a rise in temperature in the absence of blood flow. Experiments were performed 
on an ex-vivo porcine thigh preparation which was placed in a custom plastic container and 
bathed in normal saline. Images were acquired on a 1.5T scanner (MAGNETOM, Aera, 
Siemens Healthcare, Erlangen, Germany) using an ECG-triggered multi-slice single-shot 
echo planar imaging (EPI) sequence with spoiled gradient echo with the following 
parameters: TR/TE/α=50ms/17ms/60°, FOV=180×180mm2, voxel size=1.6×1.6mm2, slice 
thickness=5mm, slice number=4, bandwidth=1565Hz/Px, GRAPPA factor=2, partial 
Fourier=0.75. The ex-vivo porcine thigh preparation was kept stationary to avoid motion 
artifacts. Temperature stability was assessed in 10 locations on the thigh preparation through 
averaging of the temporal standard deviation of temperature within a manually drawn ROI. 
The MR-thermometry sequence was run for 100s for assessment of stability. For catheter 
ablation, a MR-compatible ablation catheter (Vision-MR, Imricor, USA) was introduced into 
the plastic container via a port and placed on the surface of the thigh preparation. A RF 
ablation generator (Ampere IBI T1500, St Jude Medical, USA) and irrigation pump (Cool 
Point, St Jude Medical, USA) was positioned outside the scanner room and connected to the 
catheter. Ten irrigated RF ablation lesions were delivered in different locations at 50W for 
60s (irrigation rate -17mL/min) inside the MRI scanner whilst running the MR-thermometry 
sequence. The sequence was initiated 20s prior to ablation and continued for 20s after the end 
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of ablation. Reconstruction of the temperature maps was performed offline as described in 
Section 3.2.4.  
 
6.2.2 Animal model 
Animal studies complied with French law on animal experiments and were performed at the 
Institut de Chirurgie Guidée par l’Image (IHU), Strasbourg, France. Eight female domestic 
pigs (49.7 ± 8 kg) were pre-sedated with a combination of intramuscular tiletamine and 
zolazepam. General anaesthesia was induced and maintained with inhaled 1-5% isoflurane 
and the animals were intubated and mechanically ventilated (20-25 breaths/min). Vascular 
access (7Fr introducer sheath) for invasive monitoring and administration of medications was 
obtained through the right and left femoral artery and femoral vein using ultrasound 
guidance. Epicardial access was successfully gained in four pigs using an anterior 
percutaneous subxiphoidal puncture under X-ray guidance in a fluoroscopy suite. A custom 
MR-compatible 10Fr deflectable sheath (Imricor, USA) was placed within the pericardial 
space for epicardial access. A MR-compatible 9Fr steerable catheter with open irrigation 
(Vision-MR, Imricor, USA) was manoeuvred into the epicardial space - Figure 6-1.  
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Figure 6-1: Fluoroscopic images demonstrating epicardial access.  
Following subxiphoidal puncture, a guidewire is advanced and shown coursing around the heart in the left anterior oblique 
view (A) and right anterior oblique (B) views. The sheath is in the pericardial space with the MR-compatible catheter 
coursing in front of the aorta in (C). Photographs showing location of puncture and sheath in a pig (D and E).  
 
The catheters have been described in detail previously (Grothoff et al. 2017). In the 
remaining four pigs, epicardial access was not possible due to the presence of pericardial 
adhesions and access to the LV endocardium was gained via retrograde aortic access as 
described in Section 5.2.3. A custom MR-EP recording system (Advantage-MR) consisting 
of a digital amplifier and stimulator, patient information module and a host workstation was 
used to record, display and analyse intracardiac signals, act as a programmable stimulator and 
deliver ablation energy as previously described (Grothoff et al. 2017). All animals underwent 
invasive blood pressure and surface ECG monitoring (Invivo Medical, FL, USA) throughout 
the study. Anticoagulation was maintained with an intravenous bolus of 70units/kg of 
heparin. A continuous infusion of intravenous lidocaine (12ml/hr) and amiodarone 
(20mcg/kg/min) was administered prior to ablation. A bolus of intravenous amiodarone 
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(150mg in 60mls dextrose) was administered as a slow push prior to each ablation lesion 
delivered. Animals were transferred to a MRI suite following epicardial access for mapping 
and ablation studies whilst retrograde aortic access was achieved within the MRI scanner 
using images for guidance. 
 
All MRI scans described below were performed on a 1.5T MR scanner (MAGNETOM, Aera, 
Siemens Healthcare, Erlangen, Germany). 3D whole-heart MRI for cardiac chamber 
segmentation, display on the iCMR platform and active catheter tracking was performed as 
described in sections 3.2.1 and 3.2.2.  
 
6.2.3 Ablation studies 
Ablation of the left ventricle was performed by delivering radiofrequency energy (40-60W, 
irrigation rate 17mL/min, 50-60s duration). Impedance change and catheter tip temperature 
were continuously assessed. Nineteen discrete ablation lesions were delivered in 8 animals 
with nine epicardial lesions and ten endocardial lesions. Lesion position was automatically 
recorded in 3D space and annotated upon the 3D rendering of each heart on the iCMR 
application. The aim was to create transmural lesions during each discrete ablation. In order 
to assess the conformational accuracy of lesions on the iCMR application, lesions were 
placed in discrete locations in the left ventricle and where possible, in a ‘X’ or ‘L’ shape to 
enable the calculation of angles between lesions. Using measurements on gross macroscopic 
examination as gold standard, conformational accuracy of lesion annotation on the iCMR 
application was assessed using the angle of intersection between points on two ablation lines 
measured to the nearest degree. Spatial accuracy was referenced to an anatomical landmark 
with low spatial variability -  the LV apex and was measured to the nearest millimetre.  
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The total number of ablations delivered in each animal was limited for the following reasons: 
1. Large animal models are particularly susceptible to arrhythmias following 
ablation in the ventricle resulting in ventricular fibrillation (VF) and death of the 
animal (Toupin et al. 2017), despite the use of anti-arrhythmic medications. In 
order to maximize the data collected from imaging and reduce the risk of death, 
we elected to limit the total number of ablations in each animal.  
 
2. In order to characterize RF delivery on CMR without bias from overlapping 
lesions, discrete lesions were placed in the LV with a distance of at least 1cm 
from two separate lesions.  
6.2.4 MR-thermometry and dosimetry 
Real-time lesion imaging could offer an attractive means to titrate energy delivery which 
could potentially decrease overall procedural time, increase efficacy and reduce procedural 
risk during MR-guided EP procedures. MR-thermometry and dosimetry using the proton 
resonance frequency shift (PRFS) technique was employed in this study which is sensitive to 
temperature changes in real-time and has been most widely studied in non-cardiac ablation 
(Roujol et al. 2010). The experimental details of the techniques are described in Section 
3.2.4.  
 
6.2.5 Non-contrast 3D gradient-echo inversion recovery sequence (GRE IR)  
In order to compare MR-dosimetry lesion dimensions with a non-contrast lesion imaging 
sequence, a subset of animals (4 animals, 8 ablation lesions) underwent additional imaging 
with a recently described gradient-echo sequence with a long TI (Guttman et al. 2018; Toupin 
et al. 2017) as follows: T1-weighted, 3D diaphragmatic navigator-gated gradient-echo (GRE) 
inversion recovery (IR) sequence; image sequence parameters were: TR/TE/Flip angle = 
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4ms/2.3ms/20°, TI = 700ms; FOV=360x360x100mm3, matrix = 272 x 272 px, number of 
slices = 35, voxel size=1.3×1.3×3mm3, bandwidth=250Hz/Px, GRAPPA factor=2; 2RR 
acquisition. Regions of signal enhancement on the 3D GRE IR sequence have been recently 
validated against regions of necrosis on gross pathology in a porcine model of LV ablation 
(Guttman et al. 2018). 
 
6.2.6 Gross macroscopy and histological assessment 
Following completion of imaging studies, animals were euthanized with potassium chloride 
and the heart was rapidly excised and dissected to expose individual ablation lesions. The 
gross specimens were photographed and fixed in 10% formalin. The ablation lines and 
surrounding tissue were excised en bloc and cut into sections perpendicular to the ablation 
line. Lesions were photographed and dimensions measured with a ruler. Each cross section 
was dehydrated, embedded in paraffin, sectioned (6µm sections) and then stained with 
haematoxylin and eosin.  
 
6.2.7 Lesion size measurements 
In order to compare 2D thermal dose lesion sizes to gross macroscopy, each heart was 
dissected to resemble the orientation of the thermal dose images. For measurement of lesion 
dimensions, the ablation lesion was defined as both the zone of pallor and the surrounding 
oedematous zone. Depth and width was measured on gross macroscopy and compared to the 
depth and width dimensions of the lesion on 2D thermal dose maps. For comparison of 2D 
thermal dose lesion sizes with the GRE IR sequence, four slices were reconstructed from the 
3D volume to resemble the equivalent slices and orientation on the thermal dose images. The 
depth and width was measured for each lesion on both sets of image datasets.  
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6.2.8 Statistical analysis 
Statistical analyses were performed using GraphPad PRISM Version 7.0 (GraphPad Inc, CA, 
USA). Continuous variables were compared using the Student’s two-tailed t-test. Linear 
regression analysis was performed to assess the relationship between lesion dimensions on 
image datasets with pathological dimensions and spatial accuracy of the iCMR guidance 
platform with gross pathology. Bland-Altman analysis and agreement are presented as 
average difference ± 95% confidence interval (CI). All other data are reported as mean ± SD 
unless otherwise specified. A level of p < 0.05 was considered statistically significant.   
 
6.3 Results 
6.3.1 Ex-vivo assessment of MR-thermometry 
Within the ex-vivo thigh preparation, the mean temperature variation was 3.2oC ± 1.2 in 
>80% of pixels within each ROI. During RF catheter ablation, a maximum rise in mean 
temperature variation of 48.2oC ± 4.7 was observed in the focal point position at the catheter 
tip within the ROIs. Within remote ROIs of the thigh preparation, distant from the region of 
catheter ablation, mean temperature variation was 2.8oC ± 0.9 - Figure 6-2.   
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Figure 6-2: Ex-vivo assessment of MR-thermometry.  
In a porcine thigh preparation, during catheter ablation, the magnitude image shows the susceptibility artifact created by 
RF heating at 65s after the start of imaging (A). The temperature map is overlaid onto the corresponding magnitude image 
(B) and temperature profiles in a remote region (C) and at the focal point position of the catheter tip (D) are shown.  
 
6.3.2 Spatial and conformational accuracy of the MR-EP system during delivery of catheter 
ablation 
All RF ablation lesions in animals were delivered on either the epicardium or endocardial LV 
surfaces using active catheter tracking (n=19). The locations of ablation lesion delivery were 
annotated onto the anatomical shells on the iCMR image guidance platform. The spatial 
accuracy of lesion delivery, compared to the gold standard pathological measurement, was 
0.95mm ± 1.03. Linear regression analysis showed a strong association between lesion 
location on the iCMR platform and gross pathology (r2 = 0.93; p<0.0001) whilst Bland-
Altman analysis revealed minor bias (-0.947; 95% CI: -8.99 - 7.09). Conformational accuracy 
of the MR-EP system as assessed by the angle of intersection between ablation lines, was <7 




Figure 6-3: Spatial and conformational accuracy of MR-EP system 
Ablation lesion location on the iCMR application (A) matched well to absolute site of lesion location on gross pathology (B). 
A strong association was observed (C) with mean spatial accuracy of <1mm between the iCMR application and gross 
macroscopy (n=19) with good agreement and minor bias (D). A conformational accuracy <7 degrees was also observed (E) 
in all angles measured between discrete ablation lesion lines (n=6) on the iCMR application and gross macroscopy. 
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6.3.3 In-vivo RF ablation with MR-thermometry and lesion size measurements with MR-
dosimetry 
MR-thermometry was able to demonstrate a localised temperature elevation near the catheter 
tip during delivery of radiofrequency ablation. Raw magnitude and phase images obtained 
during RF ablation demonstrated local phase variations associated with ablation-induced 
susceptibility changes - Figure 6-4. Following post-processing, temperature and thermal dose 
maps were generated and overlaid onto the corresponding magnitude images - Figure 6-5.   
 
 
Figure 6-4: Magnitude and phase images of MR-thermometry 
Magnitude (A) and phase raw images (B) obtained during RF ablation with the MR-thermometry sequence. Four adjacent 
slices (5mm slice thickness) are obtained at the level of RF application. Slice selection was determined based on the 3D 
catheter location determined from the active tracking signal and fed back to the scanner console via the iCMR guidance 






Figure 6-5: ∆Temperature maps  
∆Temperature maps across four slices during RF ablation (A) after 60s are shown overlaid over the corresponding 
magnitude images. Achieved thermal dose maps (B) are shown across the same slices at the end of treatment.  
 
A maximum temperature difference of 35oC (relative to pixel in area of more remote septum) 
was observed within 2mm of the irrigated catheter tip (Point 1) whilst a lower temperature 
difference was observed further away from the catheter tip in the myocardium (Point 2) and 
no temperature change in a more remote area of myocardium >8mm away from the catheter 
tip (Point 3) - Figure 6-6.   
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Figure 6-6: MR-thermometry and dosimetry of a representative epicardial ablation lesion with gross pathological lesion 
dimensions 
In-vivo Dtemperature maps (A) shown at different time points relative to the start of the RF heating. Localised temperature 
elevation can be clearly visualized on the epicardial side of the left ventricle. Temporal profiles (B) obtained using MR-
thermometry during epicardial ablation in swine. A maximum temperature elevation of 35°C was observed in a pixel within 
2mm of the catheter tip – point 1 (relative to a more remote pixel in myocardium > 8mm away from the catheter tip – point 
3). No significant temperature elevation was observed in a pixel located in a remote area. 2D lesion dimensions measured 
using MR-dosimetry (C) correlate well with measurements on gross macroscopy with mild overestimation of lesion width.  
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Lesion dimensions measured using MR-dosimetry on thermal dose maps correlated 
moderately with lesion dimensions on gross pathology (lesion width: r2 = 0.77; lesion depth: 
r2 = 0.76). On assessment of lesion width, Bland-Altman analysis revealed good agreement 
and minor bias (0.684; 95% CI: -2.24 - 3.61) whilst on assessment of lesion depth, bias was 
1.842; 95% CI: -0.79 - 4.48 - Figure 6-7.  
 
Figure 6-7: Relationship between ablation lesion dimensions on thermal dose maps and gross pathology 
Linear regression between ablation lesion width (A) and depth (C) on 2D thermal dose maps and gross pathology (n = 19 
lesions). Bland-Altman plots showing the agreement on lesion width (B) and depth (D) size to those dimensions obtained on 
gross pathological measurements. Dashed/dotted lines indicate 95% confidence bands (A and C) and 95% confidence 
intervals (B and D). Several points may represent more than one measure given that several lesion dimensions were 
identical.  
 
6.3.4 Assessment of lesion sizes with non-contrast 3D GRE IR with a long TI and MR-
dosimetry 
 
On the 3D GRE IR images, ablation lesions had an increased signal intensity compared to 
adjacent myocardium, similar to recently described findings (Guttman et al. 2018). The long 
TI ensured that the blood pool signal was suppressed enhancing the visualisation of lesions - 
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Figure 6-8. There was a moderate association on lesion width between the 3D GRE images 
and thermal dose maps (r2 = 0.50) but an improved association on lesion depth between 
image datasets (r2 = 0.81). Agreement on lesion size measurements between sequences was 
good (Lesion width bias = 1.201; 95% CI: -2.498 - 4.901; Lesion depth bias = 1.294; 95% 
CI: -0.466 - 3.054) - Figure 6-9.  
 
 
Figure 6-8: Representative images of ablation lesions acquired using a 3D GRE IR sequence with a long inversion time. 
Lesions are indicated with white arrows.  
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Figure 6-9: Relationship between lesion dimensions on thermal dose maps and 3D GRE IR imaging.  
Linear regression between ablation lesion width (A) and depth (C) on 2D thermal dose maps and 3D GRE IR with a long TI 
(n = 8 lesions). Bland-Altman plots showing the agreement on lesion width (B) and depth (D) size to those dimensions 
obtained on 3D GRE. Dashed/dotted lines indicate 95% confidence bands (A and C) and 95% confidence intervals (B and 
D). Several points may represent more than one measure given that several lesion dimensions were identical.  
 
6.3.5 Gross macroscopy and histological assessment 
On gross macroscopy, a zone of pallor could be clearly delineated corresponding to the 
ablation lesion core with a surrounding haemorrhagic zone. Lesion transmurality of >75% 
was seen in 16/19 ablation lesions. Microscopic histology of acute ablation injury on 
haematoxylin and eosin staining demonstrated partial loss of membrane borders, nuclear 
elongation and interstitial oedema - Figure 6-10.  
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Figure 6-10: Gross pathological and histological appearances of ablation lesion 
A zone of pallor with a surrounding oedematous zone is clearly visible on ablation lesions (A). 16/19 lesions showed a 
>75% transmurality. On microscopic examination (haematoxylin and eosin stain), at 10x and 20x magnification, evidence of 
loss of membrane borders, interstitial oedema and nuclear elongation was visible within regions of ablated tissue (B and C).  
 
6.4 Discussion 
This study demonstrates the feasibility of using real-time MRI guidance to perform both 
epicardial and endocardial radiofrequency ablation using active catheter tracking in a porcine 
model. Real-time visualisation of ablation lesions can be achieved using a dedicated MR-
thermometry sequence whilst estimated lesion dimensions by MR-dosimetry corresponded to 
those obtained on gross pathology and a non-contrast 3D GRE IR sequence with a long TI. 
 
Lardo et al. (2000) first described the use of MRI for the spatial and temporal characterisation 
of RF lesions during MR-guided ablation in mongrel dogs. Regional changes in ablated tissue 
within the right ventricular (RV) apex were observed using a T2-weighted fast-spin-echo and 
gadolinium-enhanced T1-weighted gradient-echo sequences. There was a strong correlation 
between MR-derived lesion area and post-mortem lesion area. Subsequently, in a canine 
model, four distinct phases of contrast-enhanced signal enhancement were described over a 
10-hour time period following epicardial RF delivery (Dickfeld et al. 2006). RF lesions 
initially had a low signal intensity with increasing enhancement seen in the lesion periphery 
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at 4-minutes post-ablation which progressively extended to the centre of a given lesion. Full 
delayed enhancement was observed at approximately 21-minutes post ablation and lesions 
remained detectable up to 10 hours later. These findings suggested different wash-in and 
wash-out kinetics of gadolinium in ablation lesions compared to myocardial infarction and 
may reflect different underlying pathophysiological processes (Dickfeld et al. 2006). More 
recently, in a canine recovery model, using LGE and T2-weighted oedema imaging, 
microvascular obstruction volume at 26-minutes post contrast administration appeared to be 
the best predictor of chronic lesion volume (Ghafoori et al. 2017).  
 
However, administration of exogenous contrast agents can only be given once during a MR-
guided ablation procedure. In order to perform repeated assessments at multiple stages of an 
ablation procedure to characterise lesion formation and potentially titrate therapy based on 
MR information, the development of sequences without the use of contrast agents are 
required, ideally which can be performed in real-time.  
 
Celik et al. (2014) described changes in the intrinsic T1 value in lesion cores and intrinsic T2 
values in the oedematous regions of RF ablation using MR-relaxometry. Shortening of T1 
values were correlated to the presence of ferric iron which could have resulted from a change 
in iron state inside lesion cores due to conversion of haemoglobin to methaemoglobin during 
tissue heating. The authors concluded that non-contrast characterisation of T1 changes in 
ablation lesions may be more reliable than LGE where contrast agent distribution could be 
affected by changes in membrane permeability and microvascular obstruction (Celik et al. 
2014). Dickfeld et al. (2007) characterised the temporal evolution of non-contrast T1 and T2-
weighted imaging of RF lesions over a 12-hour time period in mongrel dogs. T2-weighted 
images demonstrated an elliptical high signal core and a surrounding low intensity rim whilst 
 174 
T1-weighted images lacked a surrounding rim. These changes were related to central tissue 
necrosis and transition zone respectively on histopathological examination. More recently, a 
T1-weighted sequence with a long inversion time (TI = 700ms) has been used to discriminate 
between chronic scar in a porcine model of myocardial infarction and acute ablation lesions. 
Enhancement on the non-contrast T1-weighted sequence appeared to be more specific and 
stationary than LGE (Guttman et al. 2018).  
 
In this study, a real-time technique of lesion assessment (MR-thermometry) was used for 
lesion imaging, given its potential utility during MR-EP procedures and compared to both 
non-contrast GRE imaging with a long TI and gross pathological examination.  
 
6.4.1 Demonstration of MR-EP tracking and therapy accuracy 
The use of active catheter tracking with a dedicated tracking sequence, detected by 
microcoils in a MR-compatible catheter has been employed previously (Chubb et al. 2017). 
The microcoil method is advantageous due to its ability to track multiple coils along the body 
of the catheter, a faster rate of tracking and choice of guidance using acquired road-maps or 
real-time imaging (Chubb et al. 2017). Grothoff et al. (2017) reported the use of active 
catheter tracking to guide intubation of the coronary sinus, trans-septal puncture, activation 
mapping of the left atrium and ablation of the AV node in pigs. Catheter position was 
confirmed by passive real-time imaging. Our group have previously demonstrated the 
feasibility of real-time MRI-guided catheter ablation in patients with typical atrial flutter 
using active catheter tracking (Chubb et al. 2017). Using a combination of active tracking and 
catheter visualisation with real-time MR imaging, Hilbert et al. (2016) also performed 
cavotricuspid isthmus ablation in six patients with a mean procedural time of 109 +/- 58 
mins. Complete isthmus block was achieved in 3/6 patients without additional fluoroscopy. 
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There are little data, however, demonstrating the accuracy of radiofrequency ablation in a 
real-time MR environment, in the ventricle. Given the challenges of catheter manipulation 
and lesion delivery inside the MRI environment within the LV, a spatial accuracy of <1mm 
and conformational accuracy <7 degrees is encouraging. Further work to assess the spatial 
accuracy of lesion delivery to the scar borderzone tissue with the MR-EP system will be 
required to ensure that progress is made on a complete MR-based solution for VT substrate 
modification.  
 
6.4.2 Real-time lesion visualisation 
There has been significant interest in the development of MR tools to assess ablation lesions 
in real-time. Direct monitoring of tissue temperature using MR-thermometry and dosimetry 
offers an exciting means of exploiting acute physiological changes and could potentially be 
used to improve the safety and efficacy of catheter ablation. Kolandaivelu et al. (2010) first 
described the use of MR-thermometry using the Proton Resonance Frequency (PRF) shift 
technique to quantify tissue temperature changes that lead to ablation lesion formation. In 
mongrel dogs, the maximum ablation lesion extent during endocardial radiofrequency 
ablation on MR-thermometry corresponded well to the lesion location, depth on LGE-MRI 
and pathological examination (Kolandaivelu et al. 2010). Lesion transmurality with MR-
thermography was within 20% of that measured by pathology and LGE-MRI. Recently in an 
ovine model, Toupin et al. (2017) demonstrated that endocardial ablation lesion dimensions 
on thermal dose images correlated well with 3D T1-weighted images acquired immediately 
after ablation. The precision of lesion extent in the myocardium was in the region of 1mm – 
potentially offering a useful MR tool in real-time to guide the safety and efficacy of 
radiofrequency ablation. The same group have also optimised their thermometry pipeline to 
improve the spatial resolution achieved (1.6 x 1.6 x 3mm) and display of several slices per 
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heartbeat to resolve temperature distribution in the myocardium during catheter ablation 
(Ozenne et al. 2017). Their thermometry method relies on ECG-triggered echo-planar 
imaging, similar to this thesis, but utilises an optical flow algorithm to perform voxelwise 
registration of temperature maps in real-time. In addition, a principal component analysis 
method is employed to compensate for motion-related susceptibility artifacts and a temporal 
filter applied to increase the precision of temperature measurements (Ozenne et al. 2017). 
Initial results in healthy volunteers showed excellent temperature stability and in an ovine 
model of RF ablation, thermal lesion dimensions on dosimetry images were in good 
agreement with those at gross pathology (Ozenne et al. 2017). The presence of arrhythmia 
may also impact the precision of temperature measurements. In patients with frequent ectopic 
beats, the temporal standard deviation of temperature was 2.5oC, compared to a temporal 
standard deviation of 1.6oC in patients who were in sinus rhythm (Ozenne et al. 2019). A 
rejection strategy where corrupted phase images during arrhythmia-related beats are removed 
resulted in an improvement in the precision of temperature measurement whilst maintaining 
the frame rate (Ozenne et al. 2019). The feasibility of performing MR-thermometry in the 
presence of persistent arrhythmia, however, remains to be established.  
 
In this thesis, the MR-thermometry pipeline is extended to provide an assessment of 
epicardial lesion extent during radiofrequency ablation in a separate large animal model. 
There was a moderate association between lesion width on 3D GRE IR imaging and thermal 
dose maps but an improved association on lesion depth. This difference could be explained 
by the accuracy of correspondence between the orientation and position of the 2D magnitude 
images from MR-thermometry and 3D slices on the GRE imaging. As can be seen in Figure 
6-5, lesion depth appears consistent across thermometry slices but lesion width can vary 
considerably depending on the slice chosen for measurements.  
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Further work is required to assess how real-time lesion imaging relates to chronic transmural 
lesions – a porcine recovery model of ventricular ablation could be used to confirm long-term 
efficacy in future studies. In this study, the thermal dose model was used for the prediction of 
ablation lesion size. Other approaches have also been proposed such as using the maximum 
temperature peak for each voxel (Toupin et al. 2017; Kolandaivelu et al. 2010). Further work 
is needed to establish the most accurate model for the prediction of permanent ablation 
lesions. Of the various approaches available to assess acute ablation injury (LGE, T1-
weighted, T2-weighted, MR-thermometry), thermometry remains the only technique with the 
ability to assess lesions in real-time and would be ideally suited for MR-EP interventions. 
However, there are several limitations to the technique in its current form that need to be 
overcome (described below). 
 
6.4.3 Limitations 
Following ventricular radiofrequency ablation, large animal models frequently become 
tachycardic and/or develop ventricular arrhythmias which may affect the quality of the 
myocardium, blood and phase signal during MR-thermometry. MR-thermometry in the 
presence of irregular heart rhythm was not evaluated in this study and its feasibility remains 
to be established, particularly during RF ablation. Further refinements in the thermometry 
technique may be needed to overcome these limitations (see Section 7.2.3). We did not 
evaluate chronic ablation injury in this model, therefore further work is needed to evaluate 
whether thermal dose achieved during acute lesions corresponds to permanent lesion 
formation in a recovery model. The sensitivity and specificity of MR-thermometry for lesion 
monitoring during ablation was not assessed whilst the limited number of lesions delivered 
precluded our ability to assess if the extent of temperature rise could be predictive of lesion 
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transmurality – these areas could be an important focus of future work. The thermometry data 
required post-processing offline to generate the data on lesion dimensions. For this data to be 
useful to the electrophysiologist, a real-time pipeline with visualisation of the thermal dose 
onto an anatomical shell and demonstration of lesion dimension needs to be developed to 
guide catheter ablation although this was beyond the scope of this preliminary work.  
 
In order to facilitate VT ablation under MRI guidance in patients, there are still significant 
hurdles to overcome such as the availability of MRI-conditional defibrillation systems and 
MR-compatible 12-lead ECG systems. Patients undergoing VT ablation frequently require 
defibrillation – the time delay associated with removing a patient from the scanner bore 
before delivery of cardiopulmonary resuscitation and defibrillation could potentially increase 
the risk of mortality. Although there are prototype MR-compatible defibrillation systems 
currently undergoing testing, until there are robust systems that are shown to be successfully 
able to defibrillate patients without increasing the time needed for defibrillation, the uptake of 
higher-risk MR-guided interventions is likely to be limited.  
 
6.5 Conclusions 
This study demonstrates that the real-time MR-EP system can be used to target ablation 
lesions within the porcine left ventricle with a high degree of spatial and conformational 
accuracy. Furthermore, MR-thermometry and dosimetry enabled real-time visualisation of 
ablation injury and estimation of lesion dimensions. There was a good agreement between 
lesion sizes obtained from thermal dose maps to those obtained from 3D GRE IR imaging 















7 Summary and future directions 
7.1 Original contributions 
The aim of this thesis was to explore the use of a real-time MR-EP system for the evaluation 
of structural and electrophysiological ventricular tachycardia substrate and its application for 
catheter ablation. The potential benefits of MR-guided ablation include accurate 3D substrate 
assessment at the time of intervention with minimisation of registration error between 
structural and electrical data, intra-procedural guidance using dedicated MR-tracking 
techniques and assessment of ablation lesions in real-time. The main drawbacks of the system 
include limited availability of MR-compatible electrophysiology catheters, 12-lead ECG 
systems and defibrillators. The procedures are generally more time-consuming, expensive 
and require a steep learning curve for an electrophysiologist. There is also a lack of evidence 
currently that the use of MR-EP systems can impact on the safety, efficacy or efficiency of 
catheter ablation. Although most studies to date utilising MR-EP systems have focused on the 
atria, where significant technical challenges remain for accurate substrate assessment, the 
benefits of these systems are likely to be realised in the context of VT ablation. Given these 
issues, this thesis explored three main areas with respect to MR-guided VT ablation in order 
to guide the development of this new platform: 
 
1. Substrate assessment - There have been numerous studies published using LGE-
MRI to assess the substrate for VT. However, the assessment of LV scar 
heterogeneity which is crucial for identification of target sites for catheter ablation, is 
dependent on the spatial resolution of the MR sequence used. Differences in the type 
of LGE sequence used can also influence the image quality, signal-to-noise ratio, 
contrast-to-noise ratio as well as overall acquisition times. 3D isotropic LGE 
sequences may provide the optimal method to accurately assess LV borderzone 
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regions and thereby evaluate regions of scar heterogeneity, however, these require 
prolonged acquisition times and/or image acceleration techniques. To date, there have 
been few head-to-head comparisons of LGE sequences to determine the optimal 
method of LV scar and borderzone tissue assessment. In this thesis, using an 
experimental infarct model and a slow infusion of contrast to maintain steady-state, a 
direct comparison between three high-resolution LGE sequences was performed 
under consistent contrast conditions, alongside ex-vivo validation of results. The use 
of contrast steady-state enabled LGE imaging at a resolution of 1.2mm3 with 
improved performance compared to standard 2D clinical LGE in the animal model. 
Furthermore, a 3D LGE sequence with a bSSFP read-out was qualitatively improved 
compared to a GRE read-out and a black-blood LGE sequence. These findings have 
important implications for clinical MRI protocols in patients pre-VT ablation where 
use of standard 2D LGE may be insufficient to aid the electrophysiologist in planning 
an ablation procedure. The accurate identification of VT substrate can be challenging 
and ablating a region which does not harbour the critical re-entry circuit is an 
important factor determining the success of the procedure. 2D LGE is widely used for 
diagnostic purposes but may simply not have sufficient resolution to robustly identify 
the target sites for VT ablation. Although application of high-resolution 3D LGE with 
contrast steady-state in conscious patients proved challenging due to prolonged 
acquisition times, incorporation of the protocol immediately pre-ablation in an 
anaesthetised patient as part of a MR-EP procedure may prove to be feasible, but 
further work will be required to optimise the workflow.  
 
2. Comparison between structural and electrophysiological substrate - Multiple 
studies have also been published where the association between electrophysiological 
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substrate (generally bipolar voltage) and MRI-derived scar have been compared. 
Generally, these studies have relied on pre-procedural imaging acquired days or 
weeks prior to an ablation procedure where possible changes in loading conditions 
and/or rhythm between the time of imaging and time of mapping could introduce a 
registration error and result in mis-match of data. In addition, few studies have 
utilised high-resolution (<1.5mm3) LGE imaging for scar assessment. This thesis 
provides an objective comparison between structural and electrophysiological 
substrate whereby LGE imaging was optimised using the contrast steady-state 
protocol, data was acquired within a real-time MR-EP setting where registration error 
was minimised and a point-by-point analysis technique implemented to achieve 
improved precision. The main disadvantage of this approach was the limited 
resolution of EAM data with the MR-EP system due to inherent limitations in the 
design of the MR-compatible catheter and lack of an automated mapping system for 
use inside the MR scanner. Nevertheless, a moderate association was found between 
measurements of bipolar voltage, S-QRS and LGE with this system, despite the 
minimisation of registration error, highlighting the difficulty in using structural data 
to predict electrophysiological substrate.  
 
3. Catheter ablation in the left ventricle with the MR-EP system and real-time 
lesion imaging - The ability of the MR-EP system to use active catheter tracking to 
reach the target region within the LV and ablate both from the endocardium and 
epicardium was evaluated in this thesis. The MR-EP system provides an opportunity 
to evaluate anatomical and physiological changes during ablation as well as monitor 
lesion formation in real-time, in a way which is not possible in the conventional 
catheter laboratory. This thesis investigated the use of temperature mapping (MR-
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thermometry) to directly monitor lesion formation in real-time whilst MR-dosimetry 
was used to estimate lesion dimensions. There was a good correlation between lesion 
dimensions using MR-dosimetry to those obtained with a non-contrast T1-weighted 
sequence and gross pathology. These findings are consistent with those recently 
reported by the Bordeaux group (Toupin et al. 2017; JCMR) in an ovine model and 
extend the use of MR-thermometry to assessment of epicardial ablation. Much work 
is still required to optimise the imaging techniques and demonstrate its ability to 
predict chronic lesion size, but the study demonstrated the feasibility of the 
application of MR-thermometry to ventricular ablation.   
 
It is well known that scar pattern can be substantially different in different etiologies of 
structural heart disease. Typically, in ischaemic cardiomyopathy, compact scar may be 
present extending from the sub-endocardium to the epicardium with sparing of the 
endocardial rim. Patients with non-ischaemic cardiomyopathy may have a highly variable 
scar pattern - previous work has suggested that fibrosis architecture is rarely compact but 
typically patchy and/or diffuse (Glashan et al. 2018). In dilated cardiomyopathy, scars may 
be subendocardial, subepicardial, mid-wall or transmural whilst the architecture may be 
patchy or diffuse. In hypertrophic cardiomyopathy, interstitial fibrosis may be present 
preferentially involving the septum followed by the lateral and apical LV wall. In ARVC, 
fibrofatty replacement of myocardium may start in the subepicardium, usually affecting the 
RV but may also be present in the LV (Sramko et al. 2019).  
 
In order to evaluate the real-time MR-EP system used in this thesis including clinical-grade 
MR-compatible catheters, a large animal model was required. Although there are small 
animal models of non-ischaemic cardiomyopathy utilising surgical techniques, genetic 
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modifications or pharmacological approaches, large animal models of non-ischaemic 
cardiomyopathy are generally lacking, mainly due to the increasing costs involved. As a 
result, a porcine model of ischaemic cardiomyopathy was used in this thesis which has 
recently been well characterised from an electroanatomic, imaging and histopathologic 
perspective (Tschabrunn et al. 2016).  
 
The imaging techniques used in this thesis were deliberately performed at high spatial 
resolution in order to evaluate patchy/heterogeneous scar more accurately. It is therefore not 
expected that the inclusion of patients with non-ischaemic cardiomyopathy with different scar 
patterns would have necessarily changed the findings reported. It is possible that non-
ischaemic scar patterns may have been more difficult to detect, particularly diffuse fibrosis 
with the imaging techniques described in this thesis. However, the principle that extended 
scar imaging under conditions of contrast steady-state would enable more detailed scar 
characterisation would still be expected to apply in non-ischaemic cardiomyopathy patients 
(where scar would otherwise be detected using standard LGE imaging). The concordance 
between imaging substrate and electrical substrate may have been affected if non-ischaemic 
scar was evaluated as patchy and/or diffuse scar remote from the endocardial surface could 
be difficult to detect on assessment of bipolar voltage due to its limited field of view 
(compared to unipolar voltage). No group has successfully evaluated unipolar voltage inside 
a MRI scanner due to the presence of low frequency noise/artifact at a frequency and 
amplitude that could corrupt near-field signals - this can make signal evaluation challenging. 
Improvements in noise cancellation and filtering techniques are required to resolve this 
challenge. 
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7.2 Future directions 
 
7.2.1 High resolution imaging of scar and integration into MR-EP systems 
 
Respiratory-navigated 3D LGE is known to improve the diagnostic yield of MRI in patients 
with VT, particularly when other diagnostic tests have been negative or even when 
conventional 2D LGE has revealed no substrate (Hennig et al. 2018). High resolution LGE 
(<1.5mm3) may be valuable in providing detailed characterisation of 3D scar architecture and 
aid the delineation of VT ablation target sites. Using a 3D LGE sequence with an in-plane 
spatial resolution of 1.25 x 1.25mm, slice thickness of 2.5mm and image reconstruction into a 
stack of 1mm thick slices, (Yamashita et al. 2016) showed that image integration of scar 
architecture from MRI into the navigation system during VT ablation was successful in 
identification of 89% of critical isthmuses and 85% of LAVA sites. Furthermore, image 
integration impacted on procedural management through motivating additional mapping in 
regions of interest or modifying ablation strategy (Yamashita et al 2016). Given that the 
ability of MRI to identify heterogeneous tissue of intermediate signal intensity is spatial 
resolution-dependent (Schelbert et al. 2010), techniques to improve the spatial resolution of 
clinical protocols are needed. Image acceleration techniques such as compressed sensing can 
allow acquisition of high-resolution isotropic LGE imaging within scan times of 
approximately 3-4 minutes (Akcakaya et al. 2012). However, the under-sampled data 
obtained with compressed sensing protocols invariably results in a lower SNR and 
consequently CNR. Additionally, non-linear reconstruction of data may reduce the SNR 
further in the final images (Akcakaya et al. 2012; Basha et al. 2017). The contrast steady-
state technique described in this thesis enables extended scar image acquisition, thereby 
pushing the boundaries of achieved spatial resolution to 1.2mm3. However, the animal model 
used was studied under optimal conditions and all clinical scans were performed in patients 
who did not have cardiac devices in-situ.  
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The majority of patients undergoing VT ablation will have an ICD in-situ. Performing MRI 
scans in the presence of devices has been shown to be safe with minor changes in device 
parameters occurring occasionally (Nazarian et al. 2017). However, image quality can be 
degraded significantly in the presence of ICDs. In a cohort of patients undergoing VT 
ablation, 3D LGE acquisitions were successfully performed but ICD-related artifacts often 
appeared as a central signal void with a surrounding rim of increased signal intensity 
(Dickfeld et al. 2011). As a result, LGE could only be fully assessed in 9±4 out of 17 AHA 
segments and partially assessed in 12±3 segments, limiting the registration of the 3D MRI 
scar map to the voltage map (Dickfeld et al. 2011). Typically, the inversion pulse used in 
conventional LGE imaging is spatially non-selective with a spectral bandwidth of 1.1kHz. 
The resonance offset of the myocardium in the presence of a cardiac device is around 2-
6kHz, outside the bandwidth of the inversion pulse and as a result, the myocardium is not 
adequately nulled which can cause hyper-intense regions mimicking scar tissue (Rashid et al 
2014). The incorporation of wideband adiabetic inversion pulses into LGE imaging to 
facilitate adequate myocardial signal nulling in the presence of devices has enabled a 
reduction of metal-related artifacts, optimised the clinical yield from MRI and frequently 
changed clinical management (Bhuva et al. 2019).  
 
Most studies evaluating wideband LGE have used 2D multi-slice LGE with limited spatial 
resolution and SNR (Do et al. 2018). During 3D LGE imaging in the presence of an ICD, 
extended signal voids and ripple artifacts can appear compared to 2D imaging due to the 
spatially varying off-resonance introduced by the ICD and resulting distortion of the 
slice/slab profile. Recently, a modified wideband 3D LGE technique (spatial resolution: 1.4 x 
1.4 x.4mm) has been described in patients with ICDs which replaced the conventional 
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inversion pulse with a 3.8kHz wideband inversion pulse and increased the bandwidth of the 
RF excitation pulse to reduce signal voids and ripple artifacts (Rashid et al. 2016). Further 
work is required to address if the contrast steady-state protocol can be applied to improve the 
spatial resolution of the 3D wideband sequence and its consequent impact on in-plane 
artifacts (e.g. readout distortion from the frequency encode process, intra-voxel dephasing) 
and through-plane artifacts.  
 
In addition to the need for high-resolution 3D LGE imaging to identify VT substrate, real-
time MR-EP requires rapid image processing including segmentation and registration. In this 
thesis, manual segmentation of whole heart anatomy was employed which required around 30 
minutes of processing time after imaging and before EAM. Semi-automated segmentation 
methods (e.g. thresholding), use of shape-constrained deformable models (Chubb et al. 2017) 
or probabilistic models (Karim et al. 2016) could speed up this process considerably and 
reduce overall procedure times.  
 
Registration methods to integrate MR-derived scar images to EAM data typically use a 
combination of landmark and/or surface registration techniques, as employed in this thesis. 
However, real-time MR-EP provides an opportunity to acquire real-time reference images 
(e.g. bSSFP cine showing catheter position, regional wall motion, regions of wall thinning) 
and compare to prior 3D whole-heart road-maps or 3D scar maps. Registration of real-time 
imaging acquired with different spatial resolutions, plane orientation and acquisition 
parameters to 3D road-maps can be challenging. Updating the 3D road-map with 2D real-
time images with a dynamic registration using extracted image-based features within a multi-
scale framework has been described (Xu et al. 2015). This approach requires further 
validation in the setting of catheter ablation to assess if the accuracy of target delineation can 
be improved within the framework.  
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7.2.2 MR-guided EAM 
 
The major limitation of MR-EP is the limited availability of catheters and devices which can 
be used inside the MRI scanner. Single electrode mapping catheters were used in this thesis 
requiring manual annotation of individual electrograms to derive activation, voltage and S-
QRS data. The development of multi-electrode catheters which can be used inside the MRI 
environment has recently been reported (Elbes et al. 2017). Further development in catheter 
technology combined with the production of automated mapping systems that can be used as 
part of a MR-EP procedure is likely to accelerate progress in the field.  
 
As described in Section 2.7.2, there are multiple sources of signal distortion inside a MRI 
scanner which can affect the fidelity of EGM signals. It remains unclear at present whether 
fine myocardial signals (e.g. LAVA) can be robustly detected inside a MRI scanner. Further 
work to investigate the impact of MR interference on EGM signal characteristics are required 
and a study is planned to evaluate scar signals in an infarct model with the MR-compatible 
catheter both inside and outside the MRI scanner. The best approach to track the MR-
compatible catheter outside the MR scanner is unclear and may require a combination of 
fluoroscopy and ICE.  
 
In order to demonstrate the accuracy of MR-guided EAM, a direct comparison with 
conventional EAM will be required. Given the technical challenges of performing VT 
ablation under MRI guidance and lack of MR-compatible defibrillation systems currently 
available, a study is instead planned to use the MR-EP system in patients with adult 
congenital heart disease undergoing an atrial ablation. This study will afford the opportunity 
to image atrial substrate with high-resolution 3D LGE and perform EAM using the MR-
compatible catheter. As part of the study design, all patients will then be moved to the 
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catheter laboratory to have a conventional EAM with standard equipment and ablation, as 
required. In this way, a direct comparison of electrophysiological substrate between MR-
guided EAM and conventional EAM can be performed.  
 
Unless the technology available to perform EAM inside the MRI scanner develops 
sufficiently to compete with conventional EAM, it is possible that the role of MR-EP may 
simply be to optimise lesion targeting and perform lesion imaging after a conventional EAM 
has defined targets. Future studies will also have to demonstrate the ability of MR-EP to 
provide clinical benefit at a reasonable cost.  
 
 
7.2.3 Development of MR-thermometry and dosimetry protocol 
 
The reliability of MR-thermometry during catheter ablation is highly dependent on the 
quality of ECG-triggering. There are multiple factors which can lead to inadequate ECG-
triggering during catheter ablation including the need for additional RF equipment, poor skin 
contact with ECG electrodes and strong gradient fields associated with echo-planar imaging 
sequences. In addition, the large animal models used in this thesis are known to be pro-
arrhythmogenic and frequently experienced episodes of catheter-induced ventricular ectopy 
and occasional runs of VT during catheter ablation. Alternative methods to enable 
prospective cardiac triggering of the thermometry sequence could resolve these issues.  
 
The MR-compatible catheters used in this thesis contained micro-coils used for tracking of 
the catheters in 3D space. Using the continuously measured active tracking position as a 
surrogate for cardiac motion could provide a method to prospectively trigger the thermometry 
acquisition. Preliminary work in a beating heart phantom - Figure 7-1, where the active 
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tracking modules were interleaved with the thermometry sequence, was performed to 
evaluate feasibility and temperature stability.  
 
Figure 7-1: Cardiac motion phantom 
A MR-compatible cardiac motion phantom (Shelley Medical Imaging Technologies, Canada) (A) comprised of a pneumatic 
control, acrylic tank, hydrogel heart and cardiac motion control software was used for phantom experiments to evaluate 
MR-thermometry with active tracking. The phantom containing the hydrogel heart (B) mimics systolic and diastolic motion 
of the heart and contains ports for catheter devices to be introduced into the heart (C). MR images of the phantom with a 
catheter in situ acquired during systole and diastole are shown in (D). Images courtesy of Dr Ronald Mooiwer.  
 
In a series of experiments, the MR-thermometry sequence was acquired on an apical slice of 
the phantom at a heart rate of 60bpm. The sequence was interleaved with active tracking and 
compared to no triggering and evaluated in a scenario with no cardiac motion. An additional 
set of measurements were acquired with the phantom beating at 60bpm but triggering using a 
simulated ECG signal at 80bpm, in order to mimic mis-triggering. The following 
measurements were then made:  
 
1. Segmentation of visible area of myocardium with all acquisitions - to quantify 
stability of acquisition 
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2. Temperature stability - using temperature maps generated from phase data and 
stability determined through calculation of the standard deviation during all dynamics 
 
During active tracking-based triggering, all heartbeats were successfully detected. There was 
a strong similarity between myocardial areas detected during active-tracking based triggering 
and no motion. The temperature stability was 1.12 ± 0.36oC during active tracking-triggered 
measurements and >2.5oC during the mis-triggered scenario - Figure 7-2. Future work will 
focus on translation of this method during in-vivo cardiac RF ablation and will also need to 
model respiratory motion for accurate estimation of temperature.  
 
Figure 7-2: MR-thermometry with active-tracking triggering, no triggering and during no cardiac motion 
Magnitude images acquired during five time-points using active tracking-triggered thermometry, no triggering and during 
no cardiac motion (A). The visible myocardial area during each of the three scenarios is also shown (A). A large variation 
in myocardial area is present in the absence of triggering. Temperature stability measurements are displayed for the three 
scenarios (B). Images courtesy of Dr Ronald Mooiwer and presented as an abstract at ISMRM 2019 (Mooiwer et al. 2019; 
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Appendix Figure 1: Additional raw MRI images showing 2D LGE, 3D LGE and ex-vivo 






Appendix Figure 2: Additional raw MRI images showing 3D bSSFP, 3D GRE and 3D black-




Appendix Figure 3: Additional raw ex-vivo MRI datasets showing multi-plane 





Appendix Figure 4: Activation and voltage map acquired in normal porcine hearts under real-
time MRI guidance.  
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